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Summary 
Over the past years, molecular modeling and simulation techniques have had a major 
impact on experimental life sciences. They are capable of providing accurate insight 
into microscopic mechanisms, which are usually difficult to investigate 
experimentally. Moreover, the integration of experimental data with molecular 
modeling appears to be a promising strategy to better understand complex biological 
processes.  
In this thesis, molecular dynamics simulation has been used in combination with 
experimental data to investigate two transmembrane proteins: (i) the bacterial 
chemoreceptor PhoQ and (ii) the Amyloid Precursor Protein (APP).  
(i) Bacterial two-component system PhoQ and bacterial membranes 
Two-component systems (TCSs) are signaling complexes essential for bacterial 
survival and virulence. PhoQ is the histidine kinase chemoreceptor of the PhoQ-
PhoP tandem machine that detects the concentration of cationic species at the inner 
membrane of Gram-negative bacteria. A full understanding of the PhoQ signal 
transduction mechanism is currently hindered by the lack of a complete atomistic 
structure. In this thesis project, the first structural model of the transmembrane (TM) 
portion of PhoQ from Escherichia coli was assembled, by using molecular 
simulations integrated with cross-linking disulfide scanning data. Its structural and 
dynamic features induce a concerted displacement of the TM helices at the 
periplasmic side, which modulates a rotation at the cytoplasmic end. This supports 
the idea that signal transduction is promoted through a combination of scissoring and 
rotational movements of the TM helices. Knowledge of this complex mechanism is 
essential in order to understand how the chemical stimuli sensed by the periplasmic 
sensor domain trigger, via the relay of the HAMP domain, the histidine auto-
phosphorylation and kinase/phosphatase activity at the cytoplasmic end.  
The PhoQ sensor domain lies in close proximity to the membrane. Interaction with 
anionic lipids, such as phosphophatidylglycerols (PG) and cardiolipins (CL), are 
thought to play a key role in PhoQ activity. Present in bacterial and mitochondrial 
membranes, cardiolipins have a unique dimeric structure, which carries up to two 
charges, i.e. one per phosphate group, and under physiological conditions, can be 
unprotonated or singly protonated. Exhaustive models and characterization of 
cardiolipins are to-date scarce; therefore an ab initio parameterization of cardiolipin 
species for molecular simulation consistent with commonly used force fields is 
proposed here. Molecular dynamics (MD) simulations based on these models 
indicate a protonation-dependent lipid packing. A noteworthy interaction with 
solvating mono- and divalent cations is also observed. The proposed models will 
contribute to the biophysical and biochemical characterizations of bacterial and 
mitochondrial membranes and membrane-embedded proteins. 
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(ii) Structural and dynamic properties of the Amyloid Precursor Protein 
The Amyloid Precursor Protein (APP) is a type I membrane glycoprotein present at 
the neuronal synapsis. The proteolytic cleavage of its C-terminal segment produces 
amyloid-! (A!) peptides of different lengths, the deposition of which is an early 
indicator of Alzheimer"s disease (AD). Recently, the backbone structure of the APP 
transmembrane (TM) domain in detergent micelles was determined by nuclear 
magnetic resonance (NMR, independently by two different experimental groups). The 
TM conformations of these two structures are however markedly different. One is 
characterized by a highly kinked #-helix, whereas the other is mainly straight. 
Molecular dynamics simulations showed that the APP TM region is highly flexible and 
its secondary structure is influenced by the surrounding lipid environment. The size of 
the embedding detergent micelles strongly affects the conformation of the APP #-
helix, with solvation being the main driving force for the development of a helical 
curvature. Once embedded in a membrane bilayer, APP systematically prefers a 
straight helical conformation. This is also confirmed when analyzing in silico the 
atomistic APP population observed in double electron-electron resonance (DEER) 
spectroscopy. In summary, the APP transmembrane domain is highly flexible due to 
the presence of glycine residues and can readily respond to the lipid environment, a 
property that might be critical for proteolytic processing by $-secretase enzymes. 
The presented thesis work clearly shows how molecular simulations and their 
interplay with available experimental input can help advance the understanding of the 
mechanism of complex biological systems and processes on a molecular scale. 
These results, in particular, go well beyond the current understanding of the 
functioning of two transmembrane proteins relevant for human health. Furthermore, 
the computational approaches and procedures developed in these projects will 
hopefully promote novel integrated strategies for investigating biological systems. 
!
Keywords: molecular dynamics, molecular modeling, integrative modeling, 
antimicrobial peptides, two-component system, PhoQ, cardiolipin, membrane, 
membrane-protein, Alzheimer"s, Amyloid Precursor Protein 
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Résumé 
Au cours de ces dernières années, les techniques de modélisation in silico ont eu un 
impact majeur sur les sciences expérimentales. Ces techniques sont capables de 
fournir des informations précises sur les mécanismes moléculaires, qui sont 
généralement difficiles à mesurer expérimentalement. De plus, l'intégration des 
données expérimentales avec la modélisation moléculaire semble être une stratégie 
prometteuse pour mieux comprendre les processus biologiques complexes. 
Dans le cadre de ce travail de thèse, des simulations de dynamique moléculaire ont 
été utilisées en association avec des données expérimentales pour étudier deux 
protéines transmembranaires: (i) le récepteurs bactérien PhoQ et (ii) la protéine 
précurseur de l'amyloïde (APP). 
(i) Le système à deux composants PhoQ et les membranes bactériennes 
Les systèmes à deux composants (TCS) sont des protéines de signalisation 
essentielles pour la survie des bactéries et leur virulence. PhoQ est le récepteur à 
activité histidine kinase du tandem PhoP-PhoQ qui répond aux variations de 
concentrations de ligands cationiques à la surface de la membrane interne des 
bactéries Gram-négatives. La compréhension du mécanisme de transduction du 
signal de PhoQ est actuellement entravée par l'absence d'une structure atomique 
complète. Dans ce projet de thèse, le premier modèle structurel du domaine 
transmembranaire (TM) de PhoQ de Escherichia coli était assemblé en combinant 
des simulations de dynamique moléculaire avec des données expérimentales de 
cross-link disulfure. Un déplacement concerté des hélices TM au niveau 
périplasmique induit une rotation des hélices à l'extrémité cytoplasmique. Ces 
observations supportent l"hypothèse d"une transduction du signal par une 
combinaison de cisaillement et de mouvements de rotation des hélices 
transmembranaires. Ce changement conformationnel complexe est essentiel pour la 
compréhension du mécanisme qui lie la détection des stimuli chimiques par le 
domaine périplasmique au déclenchement de l'activité kinase / phosphatase du 
domaine cytoplasmique de PhoQ. 
Le domaine senseur de PhoQ se trouve à proximité immédiate de la surface de la 
membrane. Les interactions avec les lipides anioniques, tels que les 
phosphophatidylglycerols (PG) et les cardiolipines (CL), sont supposées jouer un rôle 
clé dans l'activité de PhoQ. Les cardiolipines ont la particularité d"avoir une structure 
dimérique unique, qui leur permet de posséder jusqu'à deux charges négatives en 
fonction de l"état de protonation des groupes phosphates. Elles sont présentes dans 
la membrane des bactéries et des mitochondries. Les modèles et caractérisations 
des cardiolipines disponibles à ce jour sont limités. Une paramétrisation ab initio des 
différents états de protonation de la cardiolipine est proposée dans le cadre de ce 
travail. Les simulations de dynamique moléculaire basées sur ces modèles indiquent 
une organisation des lipides dépendante de leur état de protonation. Des interactions 
caractéristiques entre les cardiolipines et des cations mono et divalents ont 
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également été observées. Les modèles proposés contribueront à la caractérisation 
biophysique et biochimique des membranes bactériennes et mitochondriales, ainsi 
que des protéines membranaires. 
 
(ii) Les propriétés structurales et dynamiques de la protéine précurseur de 
l!amyloïde 
La protéine précurseur de l"amyloïde (APP) est une glycoprotéine membranaire de 
type I présente dans les synapses neuronales. Le clivage protéolytique de son 
segment C-terminal produit des peptides amyloïdes ! (A!) de longueurs variables. 
Le dépôt de ceux-ci est un indicateur précoce de la maladie d'Alzheimer (AD). 
Récemment, deux structures du domaine transmembranaire (TM) de l'APP ont été 
déterminées par résonance magnétique nucléaire (RMN) dans des micelles. Les 
conformations TM de ces deux structures sont cependant très différentes. L'une est 
caractérisée par une hélice # très incurvée, tandis que l'autre est essentiellement 
droite. Les simulations de dynamique moléculaire ont montré que la région APP-TM 
est très flexible et sa structure secondaire est fortement influencée par son 
environnement. La taille des micelles englobantes affecte fortement la conformation 
de l'hélice # de l"APP, la solvatation étant la principale cause qui induit la courbure de 
l"hélice. Une fois incorporée dans une membrane, l'APP préfère systématiquement 
une conformation hélicoïdale droite. Ces résultats ont été également confirmés lors 
de l'analyse in silico de la population APP observée en spectroscopie double 
electron-electron resonance (DEER). En résumé, le domaine transmembranaire APP 
est très flexible grâce à la présence de plusieurs glycines et peut facilement 
s'adapter à son environnement. Cette propriété peut être critique lors du clivage 
protéolytique par les enzymes $-sécrétase. 
Ce travail de thèse montre clairement comment des simulations moléculaires 
combinées avec des données expérimentales peuvent aider à faire progresser la 
compréhension, à l'échelle moléculaire, de mécanismes et processus de systèmes 
biologiques complexes. En particulier, les résultats présentés permettent d"aller au-
delà de la connaissance actuelle du fonctionnement de deux protéines 
transmembranaires impliquées dans des maladies humaines. En outre, les 
approches de calcul et les procédures développées dans ces projets pourraient 
promouvoir de nouvelles stratégies intégrées pour l'étude des systèmes biologiques. 
 
Mots-clés: dynamique moléculaire, modélisation moléculaire, peptides 
antimicrobiens, système à deux composants, PhoQ, cardiolipine, membrane, 
protéines membranaires, maladie d'Alzheimer, protéine précurseur de l"amyloïde 
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!
1 Introduction
This thesis deals with the computational modeling and simulations of integral 
membrane proteins at the atomistic scale. 
1.1 Membranes and membrane-embedded proteins 
The biological membrane constitutes an essential envelop for all living organisms, 
forming a selective barrier that prevents synthesized molecules from leaking out of 
the cell and unwanted molecules from diffusing into the cell. The plasma membrane 
defines the outer boundaries of the cell and allows it to regulate the composition of 
the cytoplasm. Inner compartments, called organelles, are also formed in the cell and 
carry out more specialized functions. Biological membranes are mainly composed of 
a complex and dynamic distribution of lipids, proteins and sugars (Figure 1).  
 
 
Figure 1: Biological membrane. (a) Phospholipid chemical structure: the fatty acids are 
highlighted in gray, the glycerol in red and the phosphocholine in gold and blue, and (b) 
structure of a biological membrane with embedded integral proteins. 
The lipids composing the membrane are small amphipathic molecules that can be 
divided into three major species: phospholipids, glycolipids and cholesterol. 
Phospholipids are the predominant class in biological membranes and are composed 
of a hydrophilic head group and hydrophobic tails (Figure 1a). They can be divided 
into two classes: phosphoglycerides and sphingolipids. A glycerol group forms the 
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backbone of phosphoglycerides, which are attached to fatty acid chains and 
phosphorylated alcohol. They make up most of the plasma membrane lipids. 
Sphingolipids have a structure that is similar to phosphoglycerides, but contain a 
sphingoid base instead of the glycerol.  
In contact with a polar solvent, amphipathic molecules usually arrange themselves 
into micelles to reduce the free energy.  Phospholipids however are too bulky and 
therefore arrange themselves into bimolecular sheet-like structures mostly driven by 
hydrophobic interactions. These bilayers are composed of two leaflets, where the 
polar heads interact with the solvent, and the acyl chains form the hydrophobic core. 
The bilayers are typically 60 – 100 Å thick. Since they are energetically stable, 
disruptions and holes can readily be self-sealed, thus preserving the integrity of the 
cellular barrier (Figure 1b).  
The chain length and degree of saturation of the acyl chains strongly affect the 
physicochemical properties of the membrane. The acyl chains are usually composed 
of an even number of carbon atoms, typically ranging from 14 – 24. The packing of 
the lipids strongly depends on the composition of the acyl chains. Longer or 
saturated acyl chains interact more favorably with each other. They therefore 
increase the melting temperature of the membrane and consequently reduce the 
membrane fluidity. For most biological membranes, the transition temperature is 
between 10 – 40o C. The presence of cholesterol in the eukaryotic membrane also 
influences its fluidity. The cholesterol fits between the phospholipids and stiffens the 
acyl chains, making the membrane less fluid.  
The physicochemical properties of the different lipid species are therefore essential 
for the structural and functional organization of the biological membrane. They play a 
key role in the segregation of membrane domains, the formation of the non-bilayer 
structure, and the interaction with proteins. Several essential biological functions, 
such as signaling, mitosis and homeostasis rely on the specific lipid composition of 
the membrane and molecular interactions with other lipids, proteins and small 
molecules.  
More than half of all proteins interact with the membrane. The protein content of the 
plasma membrane can be up to 50 %, or even 75 % for the outer membrane of the 
mitochondria. Depending on the function of the membrane, the lipid and embedded 
proteins differ. There are close interactions and modulations between the proteins 
and the membrane lipids. The major role of lipids however is to form a permeability 
barrier, whereas proteins have an important functional role. They guarantee the 
transport of molecules and information across the membrane. For example, 
membrane proteins permit the cell to sense its environment, to transport ions across 
the membrane or to produce energy. 
Based on the nature of their interactions with the membrane, the membrane-proteins 
can be divided into two categories: the integral membrane-proteins (intrinsic) and the 
peripheral membrane-proteins (extrinsic). Intrinsic proteins extensively interact with 
the hydrocarbon chains of the membrane. One or more segments are embedded into 
the hydrophobic core, generally spanning the entire bilayer. These transmembrane 
domains are formed by one or more #-helices or multiple !-strands. The #-helical 
transmembrane domains compose the predominant category. The single pass 
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proteins can be classified as type I and type II transmembrane proteins, depending if 
the cytoplasmic tail is the C- or N-terminus, respectively. The !-strand 
transmembrane domains bind in an antiparallel arrangement, forming a hollow 
cylinder called a !-barrel. Thus far, they have only been found in bacteria and in 
some organelles such as mitochondria and chloroplasts. Certain membrane proteins 
do not enter the bilayer, but are anchored to a leaflet by a covalently linked 
hydrocarbon chain. An example is protein palmitoylation, where a palmitic acid is 
covalently attached to a cysteine or less frequently to a serine or threonine. The 
extrinsic proteins do not enter the hydrophobic core of the membrane. Instead, they 
bind electrostatically and by hydrogen-bond interactions to integral membrane 
proteins or with the head groups of the lipids. 
Recent studies have highlighted how the biological membrane has a highly dynamic 
organization, where lipids and proteins can diffuse rapidly and are mutually 
dependent on one another. However, the fluid nature of the membrane coupled with 
the limited resolution of even state-of-the-art experimental techniques in vitro and 
particularly in vivo (e.g., high speed AFM), hinders a detailed molecular 
understanding of the fine interplay among lipids, small molecules, and proteins 
interacting at different levels with the membrane. Due to their location at the cellular 
envelope and their essential role in numerous physiological functions, the membrane 
proteins constitute preferential targets for drug development. An understanding of the 
dynamical and functional properties of membrane proteins, as well as the 
characteristics of the surrounding membrane is therefore crucial for improving or 
developing novel drugs. 
1.2 Molecular modeling of biological systems 
Earlier views of proteins and membranes as rigid structures have been progressively 
replaced by dynamic models in which internal motions and the resulting 
conformational changes play an essential role in their function. In recent years, 
molecular modeling and simulation have proven to be a valuable complement to 
conventional wet experiments to gain insight into biomolecular structure and 
dynamics. They provide an unmatched resolution able to reach the atomistic level. 
Moreover, the increase in computational power over the past two decades has had a 
great impact on extending the boundaries of molecular simulations. Originally limited 
to small proteins, at present they can be used to investigate large and heterogeneous 
biological systems at biologically relevant timescales.  
A widely used molecular modeling technique applied to biological systems is 
Molecular Dynamics (MD). Given the structure of a biomolecule, all-atom MD 
simulations can be used to interpret experimental data and predict their functional 
properties. Processes can be modeled or reproduced at an atomistic level that 
carefully mimick physiological conditions, thus providing access to an accurate 
thermodynamic description of the system. The gain in computing power and MD code 
scalability permits studying larger systems (up to several million atoms), greater 
conformational changes and longer time scales (up to a %s). At present, molecular 
dynamics is beginning to bridge simulated microscopic length and time scales to 
macroscopic experimental measurements. The application of MD simulations to 
biomolecular systems, integrated and guided by experimental data, has therefore 
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become an important and routine approach for better understanding the physical 
basis of emerging biological functions. In particular, the complexity of the membrane 
environment can now be finer modeled, allowing for a more detailed investigation of 
membrane-embedded proteins under physiological like conditions.  
The accuracy of current force fields and the sampling of the phase-space are still two 
limitations in molecular simulations. First, parameterized models have to reproduce 
as closely as possible the real behavior of the considered system. Second, the 
accumulated sampling over biologically relevant timescales has to be carried out 
within a reasonable period of time. It appears that the precision of all-atom force 
fields is unexpectedly high and robust. Recipes have been developed to derive 
models for any cellular component. However, for many relevant systems, the 
time/length scale gap between computational and experimental methods is great and 
beyond the reach of current of all-atom MD simulations.  
A possible strategy to overcome this limitation is to reduce the number of degrees of 
freedom in the system, which consequently decreases the algorithm complexity. 
Therefore, United-Atom (UA) and Coarse-Grained (CG) models have been 
developed, where fine intra- and intermolecular interactions are neglected in favor of 
a larger speed-up of simulations. When these approximations are not appropriate for 
the investigation of a biological system, enhanced sampling techniques can be 
coupled to MD simulations in order to explore more quickly the conformational space. 
In this case, the chemically-detailed representation is conserved, while the 
accessible timescales are largely amplified. Among these techniques, local elevation 
and metadynamics have shown to be valuable tools for simulating rare events in 
biomolecular systems, and thus reconstructing their associated free energy 
landscape.  
1.3 Objectives of the thesis 
At present, the experimental determination of high-resolution membrane protein 
structures is difficult. Combined with in vitro data, molecular modeling is therefore a 
valuable tool for the structural determination at near-atomistic resolution of this class 
of proteins. In this thesis, in close collaboration with several experimental groups, two 
transmembrane systems, linked to human pathogenesis, were mainly investigated 
using a dry/wet integrated approach: (i) the bacterial chemoreceptor PhoQ and (ii) 
the Amyloid Precursor Protein (APP) in eukaryotic cells.  
Two-component system PhoQ from E. coli. Bacterial infections are one of the 
most frequent diseases in humans and animals, representing the second-leading 
cause of death worldwide. Basic research is therefore necessary to gain insight into 
the molecular function of bacteria. The first section of this thesis will focus on 
modeling the chemo-sensing protein PhoQ which is involved in the host recognition 
mechanism of bacteria. The PhoQ receptor plays a major role in the interaction of 
bacteria with their environment. It detects millimolar concentrations of divalent 
cations. The transduction of environmental changes across the biological membrane 
is essential for the survival of the organism. A modeling protocol based on a united-
atom membrane mimic was used to assemble a model of the PhoQ transmembrane 
domain, and was cross-validated using experimental cross-linking data. The 
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implications of its structural and dynamic determinants are discussed to better 
rationalize the signal transduction mechanism. In a second phase, the 
parameterization of cardiolipin, a key anionic lipid species present at the bacterial 
membrane that plays an important role in PhoQ activity, was carried out. Cardiolipin 
microdomains were also assembled producing a model of the E. coli polar region. 
This more accurate bacterial membrane model will contribute to the investigation of 
membrane related processes, such as interactions with anti-microbial peptides, and 
lipid-mediated regulation of membrane proteins. 
Amyloid Precursor Protein (APP). The Amyloid Precursor Protein is a type I 
transmembrane protein abundantly expressed in the human brain. A change of its 
proteolytic pathways plays a key role in the development of Alzheimer"s disease 
(AD), the most common cause of dementia among elderly people. An exhaustive 
characterization of APP properties and interactions in the membrane are therefore 
required to advance the understanding of the molecular bases of Alzheimer"s 
pathogenesis. Starting from recently reported NMR structures, molecular dynamics 
simulations were extensively carried out on the APP-TM to characterize its dynamics 
properties. APP-TM was inserted into diverse lipid environments. The effects of 
several different experimental setups were also investigated. The structural and 
dynamical features of each system were extracted and compared to the available 
Nuclear Magnetic Resonance (NMR) and Electron Paramagnetic Resonance (EPR) 
data. The MD simulations were crucial for the interpretation and rationalization of the 
experimental data. 
This thesis is structured as follows: Chapter 2 presents the theoretical framework of 
the methods used for this work. Chapter 3 gives a description of the modeling and 
simulations performed for the investigation of the two-component system PhoQ from 
E. coli. and Chapter 4 details the work carried out on the Amyloid Precursor Protein. 
The conclusions and perspectives of the thesis are then presented and in the Annexe 
additional publications and studies related to this thesis are included. 
 

Chapter 2 
 
Molecular Modeling of Membrane Embedded Proteins 
 
13 
 
2 Methods 
Biologically relevant molecular systems are composed of thousands to millions of 
atoms. Such systems cannot be studied using first principles quantum mechanic 
calculations due to current theoretical and computational limitations. Therefore, 
classical molecular dynamics (MD) simulations are commonly used, because they 
are accurate enough to study the conformational space of biomolecules and are 
computationally efficient. They allow computing the time-dependent evolution of a 
molecular system at the atomistic scale. This chapter will present the theoretical 
framework of all-atom MD simulations, that were applied throughout this thesis 
project.  
2.1 Molecular mechanics 
Molecular mechanics is a classical mechanical technique for computing energies and 
selected properties of molecular systems. In an all-atomic molecular representation, 
the electronic motion is ignored and each atom is defined as a single particle. The 
potential energy of the system is calculated as a function of the nuclear position using 
a force field. Force fields are empirical models, designed to reproduce primarily the 
structural properties of molecules. They define the functional form and parameters 
describing the interactions between the atoms. Most atomic force fields have a 
similar functional form that is a compromise between accuracy and computational 
efficiency. 
The basic molecular mechanics functional form describes the interactions between 
the atoms as a summation of bonded and non-bonded terms (eq. 1). The bonded 
terms are computed for the atoms covalently linked and the non-bonded terms are 
computed for all pairs of atoms that are at least separated by three bonds. The 
potential U(r N) depends on all the positions r of the N atoms composing the system 
(eq. 1), 
 
 
(1) 
 
 
The bonded terms are computed for all bonds, angles and torsional angles present in 
the molecule. The non-bonded terms model the electrostatic and van der Waals 
interactions between all pairs of atoms, i.e., i and j.  
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2.1.1 Bonded interactions 
The bonded interactions are used to model all the intra-molecular bonded 
interactions. They account for the interaction of pairs to quartets of bonded atoms. 
Bond stretching  
The Ubond models the potential energy for the bond stretching between covalently 
bonded atoms. Since the forces between bonded atoms is very strong, it is rare that 
the distance between the atoms deviate significantly from its equilibrium position. In 
molecular mechanics, Ubond is often approximated by a harmonic oscillator (eq. 2), 
 
 (2) 
 
In this case, the potential energy varies with the square of the displacement form the 
reference bond length r0 (Hooke"s law). Bond stretching is a strong interaction, e.g. a 
deviation of 0.2 Å from the reference in a C – C bond increases the system energy by 
~12 kcal/mol. 
Angle bending 
The Uangle models the interaction between valence angles, i.e. three consecutive 
bonded atoms. It has also been described using Hooke"s law (eq. 3), 
 
 (3) 
 
Each angle is defined by the spring constant ki and a reference angle !0. Less energy 
is required for distorting than for the bond-stretching term.  
Torsional terms 
Since substantial energy is required to cause deformation for the bond-stretching and 
the angle-bending terms, most of the conformational changes in a molecule are due 
to the interactions between the torsional and non-bonded contributions. Utorsion 
models the interaction between a bonded quartet of atoms. The torsional potential is 
almost always a periodic potential cosine series expansion (eq. 4), 
 
 (4) 
 
The value of kd is a quantitative indication of the barrier height to rotation. The phase 
factor "0 defines where the energy minimum are. The multiplicity term n determines 
the number of minima. 
Improper torsions 
To accurately model the planarity and stereochemistry of chiral centers, an out-of-
plane bending term Uimproper is often added to the force field (eq. 5), 
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 (5) 
 
The Uimproper considers the “improper” torsion angle composed of four consecutive 
bonded atoms not in their sequence. It is commonly modeled as a harmonic 
potential, where ki represents the spring force constant and "0 the equilibrium angle. 
 
2.1.2 Non-bonded interactions 
The molecular structures are not only determined by the intra-molecular bonded 
interactions, but are also strongly dependent on the non-bonded forces between the 
atoms. In most force fields, the non-bonded terms are divided into two types: (i) the 
electrostatic and (ii) the van der Waals interactions. 
 
Electrostatic interactions 
An unequal distribution of charge in a molecule arises due to the difference in the 
electronegativity of its different constituting atoms. The electronegative atoms attract 
more the electrons and acquire a small negative charge. In an all-atom force field, 
each particle will have a specific partial atomic charge, designed to reproduce the 
quantum mechanic electrostatic properties of the molecules. Coulomb"s law is used 
to compute the electrostatic interaction as a sum of interactions between pairs of 
atoms (eq. 6), 
 
 (6) 
 
qi and qj are the partial charges of two atoms and #0 is the permittivity of free space. 
The electrostatic contribution is commonly ignored in the force fields of the bonded 
pair and triplet of atoms, since the stretching (1 – 2) and bending (1 – 3) terms 
already account for the interactions among atoms. For the atoms composing the 
torsional angle (1 – 4), the electrostatic interactions are either scaled down or 
ignored. The computation of electrostatic contributions between all the atoms of a 
system is expensive, i.e. it scales as N2, where N is the total number of atoms. 
Therefore, it is common to introduce a cut-off distance beyond which the electrostatic 
interactions are not calculated. However, for highly polar systems, this cut-off will 
lead to important errors due to the entry and exit of charged particles from the 
exclusion area. To reduce these errors, the Particle Mesh Ewald (PME) method is 
often used (1). Based on an Ewald summation, the electrostatic potential is 
separated into two terms: (i) a short-range potential, whose summation is efficiently 
carried out in the real space and (ii) a long-range potential carried out in the Fourier 
space. The use of the reciprocal space requires periodic symmetry for the system. 
Therefore the systems are required to be neutrally charged, typically by adding 
counter ions. 
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Van der Waals interactions 
The Dutch scientist Johannes Diderik van der Waals observed and quantified 
deviations in the behavior of rare gas compared to ideal gas behavior. His fundings 
suggested the presence of interactions different from electrostatic ones, since the 
multipole moments of these atoms are zero. The van der Waals interactions arise 
from a balance between attractive forces at long-range and repulsive forces at short 
distances and passes through a minimum at around 2.5 – 4 Å (e.g. 3.8 Å for argon). 
These forces are due to two quantum effects: (i) attractive London forces and (ii) 
repulsive forces derived from the Pauli principle. The fluctuations in the electron 
clouds create instantaneous dipole in an atom, which in turn induces a dipole in the 
neighboring atoms. This creates an attractive induction effect, called the London or 
dispersive force. The Pauli principle prohibits two electrons in a system from having 
the same quantum number, resulting in a repulsive force (exchange force). This 
effect decays exponentially and explains the minimum observed for the van der 
Waals interactions.  
The computation of these forces are complicated at the quantum level. Therefore in 
order to model this effect at the classic level, the best known van der Waals potential 
is the Lennard-Jones 12 – 6 function (eq. 7), 
 
(7) 
 
 
The Lennard-Jones potential is characterized by a single minimum of depth &, and 
converges to zero at infinity. The parameter ' defines the collision diameter, i.e. the 
separation at which the energy is zero. The determination of the van der Waals 
parameters ' and & for all pair of atom-types would be very time consuming. To 
overcome this problem, they are commonly obtained from the parameters of mono-
atomic species using the Lorentz-Berthelot mixing rule. The collision diameter !ii is 
computed as the arithmetic mean of each atom (eq. 8). The well depth is equal to the 
geometric mean (eq. 9), 
 
(8) 
 
(9) 
 
To decrease the computational cost for the van der Waals interactions, a cut-off and 
a switching distance are commonly defined. The interactions of pairs of atoms 
beyond the cut-off distance are ignored. To avoid a discontinuity in the potential due 
to the cut-off, ULJ is scaled at the switching distance so that it equals zero at the cut-
off distance. 
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2.2 Classical Molecular dynamics 
Based on molecular mechanics force fields, classical molecular dynamics (MD) aims 
at predicting the dynamical behavior of a molecular system. The successive 
conformations of the system are obtained by integrating Newton"s second law 
(equation of motion) to determine the acceleration of each atom (eq. 10). This set of 
time-dependent configurations is called a trajectory. 
Newton"s equation of motion states that force F applied to an ensemble of atoms at 
time t and position X(t) is equal to the negative gradient of the potential U 
experienced by the set of atoms,  
 
(10) 
 
The force on each atom will therefore change whenever the atom changes its 
position. To solve this equation, an iterative procedure is commonly used. The 
molecular dynamics trajectories are generated based on finite difference techniques, 
breaking down the integration into multiple steps separated by "t in time. The forces 
on each atom are determined at each time step based on its interactions with the 
other atoms. The acceleration is combined with the position and velocity of the atom 
at time t, allowing to calculate the new position and velocity at time t + "t. The forces 
are assumed to be constant during the time step. 
Several integration algorithms have been proposed for molecular dynamics 
calculations and approximate the positions and dynamic properties of a molecular 
system as Taylor series expansions. At present, the Verlet integration algorithm is 
widely used for molecular dynamics simulations. The position of an atom at time t + 
"t is computed based on its positions X at times t and t – "t and on its acceleration A 
at time t (eq. 11). The Verlet integration algorithm does not explicitly consider the 
velocities, but they can be calculated from the derivative of the positions (eq. 12), 
 
(11) 
 
(12) 
 
 
As for any finite difference technique, a time step (t has to be defined for the Verlet 
algorithm. Unfortunately, there is not direct method to determine the correct time 
step. To guarantee the stability of a system, the Nyquist-Shannon sampling theorem 
states that the sampling frequency has to be at least two times faster than the fastest 
event of the system. In an all-atom molecular dynamics simulation, the C–H covalent 
bond vibrates with the highest frequency and has a repeat period of approximately 10 
fs. A rule of thumb is to choose a time step ten times faster, and thus "t = 1 fs is 
commonly used for classical MD simulations. This time step can be increased to 2 fs, 
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by using an constraint algorithm, e.g. SHAKE (2) or LINCS (3) which constrain the 
bond length. 
Since many experimental studies of biological molecules are carried out under 
conditions of constant temperature and pressure, a control of the temperature (300 – 
310 K) and of the pressure of the system (~ 1 atmosphere) of the MD simulations is 
required.  
The temperature can be directly related to the kinetic energy of the unconstrained 
system as follows:  
 
 (13) 
 
 
where the moment pi  of N atoms is proportional to temperature scaled by the total 
number of degrees of freedom of the system. To control the temperature, thermostats 
are used to modify the velocities of the atoms, either by scaling them (Berendsen and 
Nose-Hoover thermostats) or via additional forces (Langevin), 
 
In molecular dynamics simulation, the pressure of a system fluctuates much more 
than other quantities, such as the total energy or temperature. The virial theorem is 
used to calculate the internal pressure of the system (eq. 14).  
 
 
 (14) 
 
The internal pressure of the system is proportional to the kinetic energy minus the 
virial term, i.e. the sum of the products of the coordinates rij of the atoms and the 
forces fij acting on them. The pressure control is achieved by using barostats that 
modify the positions of the atoms. 
 
2.2.1 Setting up and running a simulation 
In order to perform a molecular dynamics simulation, an initial configuration of the 
system has to be assembled. This is a key step for all MD simulations and is often 
critical for the success or failure of the simulations. Since the simulations are carried 
out at equilibrium, the initial configuration should be as close as possible to the 
equilibrium state. Therefore, the X-ray or NMR structures of the proteins are used as 
an initial configuration for biological systems.  
Most MD simulations are carried out with periodic boundary conditions, to avoid 
boundary effects, since the system is of a finite size and use the PME algorithm 
calculate the electrostatic interaction. It is thus necessary to correctly set up the unit-
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cell. First, it has to be big enough to avoid that the same atom interacts directly with a 
neighboring atom and its periodic image, but sufficiently small not to be too 
computationally demanding. For a biological system, a 12-15 Å (which is 
approximately similar to the short-range interaction cut-off, padding water box is 
commonly used to solvate a protein and defines the size of the unit-cell. In addition, 
MD simulations of the membrane protein require modeling the lipid environment. The 
protein is inserted into a membrane bilayer composed of the near-physiological 
mixture of different concentrations of phospholipids. Although most unit-cells are 
cubic, other geometries such as the hexagonal prism, truncated octahedron can be 
used. Second, the system is neutralized by adding counter ions, e.g. NaCl at near-
physiological conditions (i.e., 150 mM). 
All molecular dynamics simulations first start with a minimization of the system, in 
order to bring it to a local minimum of the potential energy surface. This is required to 
guarantee the stability of the system. Once minimized, it is necessary to assign initial 
velocities to the atoms, before starting the molecular dynamic simulation. The 
velocities can be randomly selected from a Maxwell-Boltzmann distribution at the 
temperature of interest (eq. 15). 
 
 
(15) 
 
This Gaussian distribution defines the probability p that an atom i of mass m has a 
velocity v in direction x. The initial velocities are often adjusted to ensure a zero 
momentum of the system. Having set up the initial configuration of the system and 
the corresponding velocities, the molecular dynamic simulation can be started. Since 
the diffusion of lipids is one order of magnitude higher than water, a longer 
equilibration is required for such systems. 
 
Currently, molecular dynamics simulation are performed for systems composed of up 
to several millions of atoms. The computation can be carried out on standard 
workstations, for small systems (less than 10"000 atoms). However, for larger 
systems, a supercomputer with several tens of thousands of processor is required. 
The D. E. Shaw Research group has designed and built a massively parallel 
supercomputer specifically for molecular dynamics simulations (4). 
2.3 Enhanced sampling techniques 
At present, the computational power allows simulating large and complex 
biomolecules. However several phenomena of interest take place at time-scales of 
an order of magnitude higher than simulated time-scales and are not accessible 
using conventional molecular dynamics simulations. Enhanced sampling techniques 
such as local elevation (5), conformational flooding (6) or metadynamics (7) have 
proven to be essential to efficiently explore the conformational space of molecular 
dynamics simulations. These algorithms add a memory-dependant potential to the 
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simulation Hamiltonian, in order to force it to sample unexplored conformations of the 
system. 
In this thesis project, metadynamics simulations were used to characterize the 
conformational space of membrane-embedded proteins. Metadynamics simulations 
were extensively used to study systems described at the classical (8,9) and quantum 
level (10,11). These simulations allow reconstructing the free energy landscape and 
accelerating rare events. This algorithm assumes that a small set of degrees of 
freedom, called collective variables are sufficient to describe the process of interest. 
The simplest type of collective variable is related to the geometry of the system, e.g. 
distances, angles or dihedrals. They can be applied to single atoms or to the center 
of mass of a group of atoms. Such variables are suitable to describe the 
conformational changes of biological systems, which are usually slow events. The 
reliability of metadynamics simulations depends on the correct choice of the 
collective variables. However, the optimal set is difficult, if not impossible, to 
determine a priori. For all practical applications, the collective variables have to 
satisfy at least the following three main properties: (i) Their value should significantly 
differ for the initial, intermediate and final states. (ii) The set should be small, i.e. two 
to three collective variables. Otherwise it becomes computationally too expensive to 
fill the free energy surface, and (iii) All the slow variables defining the phenomena of 
interest have to be included. Neglecting a relevant collective variable will lead to the 
overfilling a local minimum and the metadynamics simulation will never reach the free 
diffusion of the collective variable. Since no theoretical framework exists for choosing 
the correct collective variables, they rely on the chemical or physical intuition of the 
user and often have to be selected by a trial-and-error procedure. Several trial-and-
error steps are usually required with different combinations of variables. A hysteretic 
behavior in the free energy always indicates that one or more relevant collective 
variables have been neglected. Metadynamics simulations have to be preformed 
starting from a fully equilibrated molecular dynamics simulation. When setting-up the 
collective variables, it is useful to monitor them during the unbiased molecular 
dynamics, in order to gain important insight into their behavior. This will allow to 
better tune the collective variables during the metadynamics simulations. 
Based on a set of collective variables s(x), describing the phenomena of interest, a 
history-dependant potential is added to the classical MD Hamiltonian (eq. 16),  
 
(16) 
 
During the metadynamics simulation, the position of the system in the collective 
variable space is determined and a Gaussian-shaped potential is added to the total 
potential. The added Gaussian potentials sum-up during the simulation and 
discourage the system to go back to already explored states until the system 
explores freely the collective variable conformation space. The free energy is finally 
recovered by the opposite sum of the added Gaussian. The metadynamics potential 
depends on three parameters: w and "s defining the height and width of the 
Gaussian and t' = n), n ! *. ) is the frequency at which the Gaussians are added. 
! 
U
G
s(x), t( ) = w  exp  "
s x( ) " s x(t ')( )
2
2#s2
$ 
% 
& 
& 
' 
( 
) 
) 
t '= 0
t
*
Molecular Modeling of Membrane Embedded Proteins 21 
Currently, no theoretical frame-work has been defined for choosing these 
parameters. As an initial guess for all-atom metadynamics simulations, Gaussians 
with a height w of 0.3 and a width "s of 0.4 are added every 300 steps. These values 
are then tuned after several trail-and-error steps. The width and height of the 
Gaussian determine the accuracy of the reconstructed free energy landscape. 
Increasing the height of the Gaussian is commonly used to quickly explore the 
conformation of the region of interest. This however leads to greater errors in 
computing of free-energy landscape. The error in the free energy landscape can be 
reduced by performing multiple metadynamics simulations and arithmetically 
averaging the resulting free-energy profiles. 
In conclusion, metadynamics is a powerful tool for exploring the conformational 
space of a molecular system and for retrieving information about the corresponding 
free energy surface. However, it requires the user to choose (i) relevant collective 
variables, (ii) optimal metadynamics parameters, and (iii) to control the convergence 
and errors of the algorithm. The study of certain biological systems requires too many 
relevant degrees of freedom to allow the use of metadynamics. To overcome this 
problem, several new methodologies that combine a number of simultaneous replica 
of the system, were proposed, e.g. multiple walkers (12), parallel tempering 
metadynamics (13) and bias exchange (14). 
 
In this thesis project metadynamics simulations were used to characterize the 
conformation space of the PhoQ (Chapter 3.2) and APP (Chapter 4.1) 
transmembrane domain.  
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3 Two-component system PhoPQ 
from E. coli
3.1 Introduction 
The increasing emergence of bacterial drug resistance is becoming one of the most 
significant challenges to human health. The effectiveness of the available weaponry 
against these pathogens is progressively lowered by the constant insurgence of 
single- or multi-drug resistant bacterial strains. Antimicrobial peptides (AMPs), which 
are produced by many tissues and cell types as part of their innate immune system, 
have attracted considerable interest as alternative antibiotics [1,2]. Unlike 
conventional antibiotics, AMPs operate via a non-specific mechanism. They target 
the bacterial cell membrane. This has the advantage of low bacterial resistance 
development [3]. Despite a large sequence diversity, AMPs are characterized by a 
cationic amphiphilic structure. They interact with the negatively charged membranes, 
disrupting the phospholipid membrane of the target cells. These types of 
antimicrobial peptides are known to mainly attack Gram-negative bacteria and only a 
few gram-positive bacteria [4].  
Unfortunately, these peptides are complex molecules and suffer from proteolytic 
degradation. For a pharmacological use, it is necessary to capture the essential 
properties of the AMP as in an easy-to-synthesize molecule. However, a resistance 
to antimicrobial peptides is typically acquired by modification of the bacterial cell 
membrane, such as inserting lipopolysaccharides. Therefore, an optimal use of 
AMPs requires a complete understanding of the bacterial sensory systems and 
membrane. It has been proposed that the bacterial selectivity of AMPs is driven by 
the complementarity of their cationic nature with the anionic nature of the bacterial 
membrane. Thus, the bilayer composition is an essential determinant for AMP 
selectivity. The underlying mechanism is however not fully understood. A fine-tuned 
balance between several structural determinants in antimicrobial peptides is 
essential. 
In bacteria, “two-component” systems (TCSs) detect the environmental changes via a 
sensor kinase at the periplasmic level, which leads to a phospho-relay cascade 
mediating specific gene transcriptions. They allow the bacteria to recognize and 
transduce the characteristics of extracellular environments [5]. Only a limited number 
of two-component proteins are found in a few eukaryotes, such as plants. They 
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appear to be absent in animals [6]. Therefore, this could be an ideal target for 
antimicrobial development. 
Among the broad repertoire of TCSs, PhoPQ detects and responds to divalent 
cations, antimicrobial peptides [7] and low pH [8,9,10]. It is a major sensory system, 
regulating as much as 1% of the gene in certain Gram-negative bacteria [7]. PhoPQ 
belongs to a large family of membrane-associated protein kinases that undergo 
autophosphorylation and subsequently transfer the phosphate to the response 
regulatory domain (RR) (Figure 2). PhoPQ is composed of the histidine kinase PhoQ 
and the response regulator PhoP. In vivo, PhoQ forms a multidomain 
transmembrane homodimer, which molecular structure is largely unresolved. 
Consequently, the mechanism underlying PhoQ response to stimuli is not fully 
understood. A significant obstacle is the absence of structural information for the TM 
domain, which connects the structure of the periplasmic sensor domain to the 
cytosolic catalytic portion. Several mechanisms have been proposed to describe 
signaling transmission across the bacterial membrane, including piston shift, helix 
rotation and unwinding of a coiled coil [11,12]. Piston motion is thought to be the 
most efficient way to transmit the signal across the membrane [13,14], and is 
characterized by the displacement of the helix along its main axis perpendicular to 
the membrane"s plane. 
 
Figure 2: PhoPQ Phosphotransfer. For low concentration of Mg2+, acidic pH or in the 
presence of anti-microbial peptides, PhoQ is activated by phosphorylating H277 (1). The 
phosphoryl group is transfered to PhoP (2), which regulates gene expression. Finally PhoP is 
hydrolyzed, releasing the phosphoryl group (3). 
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Knowledge of these key membrane embedded systems is however not sufficient to 
understand the complex interplay between AMPs, and bacteria and their sensory 
systems. The lipid composition of the bacterial membrane is known to be essential 
for the function and modulation of the membrane protein. In the case of PhoQ, a 
large acidic cluster (148—EDDDDAE—154) at the sensor domain was originally 
proposed to be involved in the sensing of electrostatic variations at the bacterial 
membrane surface [15]. When the concentration of Mg2+ or Ca2+ cations is high (> 1 
mM), cations can bind to the acidic cluster, forming a metal-mediated bridge with the 
negatively charged membrane of bacteria. Two major anionic constituents of the 
bacterial membrane are phosphophatidylglycerols (PGs) and cardiolipins (CLs). It is 
noteworthy that cardiolipins are absent in mammalian cytoplasmic bilayer and are 
only found in the mitochondrial membrane. As such, cardiolipins could play a major 
role in AMP selectivity. 
In bacteria, cardiolipins represent a small component ranging from 10 – 20% of the 
molar concentration and are not uniformly distributed in the membrane. The septal 
and pole regions of the bacteria are in fact enriched in CL up to 4-fold at the expense 
of PG moieties [16]. The bacterial membrane curvature is therefore influenced by the 
high local cardiolipin concentration. Furthermore, prokaryotes accumulate cardiolipins 
only under specific conditions, such as during stationary growth and environmental 
stress. The lack of CL reduces growth and function depending on oxidative 
processes. PG and CL deficient mutants are therefore not viable. In addition, 
cardiolipins act as a switch for protein interaction with cations, for example, as in the 
case of the EpsE system that is involved in the export of cholera toxin in Vibrio 
cholerae [17].  
The first section of this chapter presents the modeling of the PhoQ TM domain. A 
novel scheme combining experimental cross-linking data and computational 
techniques was developed. The TM structural model allows the formulation of 
hypotheses concerning the transduction of the chemical signal and the computation 
of the corresponding free energy landscape. By combining the obtained TM model 
and homologous domains of the histidine kinase, an initial atomistic model of the 
PhoQ chemoreceptor will be proposed. The second section describes a novel 
parameterization of the cardiolipin, considering its different protonation states and its 
impact on the organization of the membrane. Interactions of mono and divalent 
cations were also investigated. A model of cardiolipin-rich domain characteristic of 
the polar region of E. coli is then presented. 
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3.2 Assembly of the transmembrane domain of E. coli 
PhoQ histidine kinase 
Published as the following paper: 
“Assembly of the transmembrane domain of E. coli PhoQ histidine kinase: 
implications for signal transduction from molecular simulations” 
Lemmin T., Soto C. S., Clinthorne G., DeGrado W. F., and Dal Peraro M., PLoS 
Computational Biology, 2013 
 
3.2.1 Introduction 
Two-component systems (TCS) are protein signaling complexes present in most 
species of bacteria and are used to sense a wide range of environmental stimuli and 
couple them to adaptive responses [18]. The structure of a prototypical TCS consists 
of a membrane-spanning histidine kinase sensor, that senses the stimuli at the 
periplasmic region, and activates a cytoplasmic response regulator. The PhoQP TCS 
is reported to play a role in the defensive and virulence mechanism for certain Gram-
negative bacteria [19,20]. External stimuli, such as the presence of antimicrobial 
peptides at the periplasmic surface, lead to the auto-phosphorylation of the PhoQ 
histidine kinase core, and to the subsequent transfer of the phosphoryl group to the 
response regulator, which elicits the regulatory response (kinase activity). The 
phosphorylated PhoP promotes the transcription of genes which leads to the 
modification of the outer membrane. These modifications increase the synthesis of 
enzymes that deacylate, almitoylate, palmitoylate, hydroxylate, and attach 
aminoarabinose to lipid A, thus promoting bacterial resistance to antimicrobial 
peptides (AMP) and reducing the host recognition of lipid A [21]. Only a limited 
number of two-component systems are found in a few eukaryotes [22]. Thus, apart 
from the basic understanding of the fundamental signaling mechanism, PhoQP TCS 
is a promising target for the development of synthetic antimicrobial drugs.   
PhoQ forms a multidomain transmembrane homodimer, whose complete molecular 
structure is largely unresolved (Figure 1). Consequently, the mechanism underlying 
the PhoQ response to stimuli is not fully understood, and several mechanisms have 
been proposed to account for signaling transmission across the bacterial membrane, 
including piston shift, helix rotation and unwinding of a coiled-coil domain [11,12]. A 
major obstacle to elucidating the signal transduction mechanism of the PhoQP TCS 
is the lack of a full atomistic structure of PhoQ. The following four different regions 
can be defined and appear to have distinct functions (Figure 1): (i) The periplasmic 
region consists of a sensor domain (SD) that detects changes in the periplasmic 
environment. Two opposing crystal structures have been solved (1YAX [15] and 
3BQ8 [23]); Goldberg et al. [24] have recently showed that the most probable 
physiological arrangement is described by the 3BQ8 x-ray structure. This is 
consistent with disulfide scanning experiments, and can explain the topology and 
connectivity of the SD with the remaining domains of PhoQ.  (ii) Two membrane-
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spanning antiparallel helices (called hereinafter TM1 and TM2) constitute the 
transmembrane (TM) region of PhoQ (Figure 3). (iii) Emerging from the cytoplasmic-
facing membrane is a small signaling domain composed of a helix-loop-helix 
structure known as the HAMP region, and is thought to play an important role in 
transmitting the signal to the catalytic domain [25]. Finally, (iv) the catalytic or 
histidine kinase (HK) domain regulates the phosphoryl-state, and ultimately leads to 
PhoQ"s function mainly as a kinase, or phosphatase during PhoP dephosphorylation. 
The phosphotransfer cycle between PhoQ and PhoP ensures, therefore, a robust 
and efficient genetic switch [26] (Figure 3). 
 
 
Figure 3: Schematic representation of the PhoQ histidine kinase in two-component 
systems. (a) The sequence topology of PhoQ is related to its (b) 3D homo-dimer schematic 
arrangement. The following available structures are used to model the global PhoQ structure: 
the sensor domain solved from E. coli (PDB code 3BQ8 [23]); the cytoplasmic HAMP NMR 
structure from Archaeoglobus fulgidus (PDB code 2L7H [27]), and the histidine kinase crystal 
structure from Thermotoga maritima (PDB code 2C2A [28]). The sensor domain harbors 
several acidic residues (148—EDDDDAE—154, shown in space-filled representation). They 
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have been proposed to be involved in the sensing of divalent cations and AMP at the 
membrane surface. The ADP and the phosphorylation site (His277) are highlighted in space-
filled representation. During the phosphor-transfer reaction, the phosphate group is 
transferred from His277 to the PhoP aspartic acid (Asp51) (green arrow). 
In this study, we focus on the structural characterization of the transmembrane 
portion of PhoQ from E. coli. Difficulties in solving high-resolution x-ray structures of 
properly folded membrane proteins continue to be a significant barrier to determining 
structures at the atomic level and thus alternative, lower-resolution modeling 
strategies are often used as a proxy to obtain structural and functional information for 
membrane proteins [29,30,31,32,33]. Such strategies combined with computational 
methods can produce near-atomistic models; for example, replica exchange 
molecular dynamics (MD) was used to generate structural models for YycG sensor 
kinase consistent with mutagenesis studies [5]. The PhoQ protein might be a 
particularly good target for MD simulations since they are intrinsically well suited for 
studying the structures that are in dynamic equilibrium. When PhoQ activity is 
measured using transcriptional reporters, there is only a 2.5 to 3.5-fold difference in 
its activity in saturating Mg2+ concentration with respect to the basal state. This 
suggests a very small energetic difference in the two states, in the order of a single 
kcal/mol, assuming that the level of transcription reflects the fraction of the protein in 
the kinase mode.  It is likely that multiple conformations observed by MD might be 
related to kinase or phosphatase activity. Thus, we used MD simulations to 
investigate the assembly of the PhoQ TM domain and the formation of a stable 
tetrameric bundle. MD simulations were guided and the resulting models validated by 
experimental cross-linking data. The TM domain connects with known, existing 
structures of the SD periplasmic domain as well as with the cytoplasmic HAMP 
domain. Therefore, the characterization of TM will provide insights into how 
conformational changes at the periplasmic SD might be transmitted to the 
cytoplasmic HAMP. 
In order to test the validity of the models, we simulated point mutations involving the 
polar residue Asn202 [34], which appears to be relevant for the solvation and 
signaling function of the TM domain. PhoQ exists in equilibrium between 
phosphatase-active and kinase-active conformations, and mutations of this residue 
strongly influence the signaling ability of the protein. This probably supports a water-
filled pocket, as also seen in TM domains of another HK structure, HTRII from 
bacteriorhodopsin [35]. We found that Asn202 is indeed crucial for the hydration of 
the PhoQ TM bundle. Importantly, this feature was found to directly trigger a 
combined scissoring movement and ~20 degree rotation of the TM helices that is 
propagated to the cytoplasmic side. This reveals the key role of the TM region in 
transmitting and modulating the signal through the bacterial inner membrane. 
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3.2.2 Results 
The tetrameric assembly of the TM domain reveals an Asn202 inter-
helical lock 
Recently, disulfide cross-linking scanning was used to determine pairs of residues in 
close proximity in the PhoQ sensor domain [24]. The quantification of intermolecular 
disulfide formation showed a distinct periodic arrangement, fluctuating from almost 
100% at peak efficiency to nearly zero at the lowest points, and guiding the modeling 
of the most biologically relevant sensor domain arrangement. The topology of the 
PhoQ homodimer indicates that four segments span the bacterial membrane (Figure 
3). Therefore, by using the same procedure as for the sensor domain, disulfide cross-
linking scanning experiments were performed for the TM region. Maxima occurred at 
residue positions 32, 35-36, 39-40 in TM1 and 199, 201-202, 205 in TM2, 
corresponding to the outer two-thirds of the TM domains (Figure S1 and Text S1).  
No significant cross-linking was observed near the cytoplasmic end of TM1, and the 
cross-linking was weak at this region of TM2, before gaining in intensity as the helix 
transitioned from the membrane and entered the cytoplasmic HAMP domain. The #-
helical periodicity of the cross-linking results strongly suggested that the TM domain 
would assemble as a helical bundle, with the cross-linked residues facing towards 
the bundle core. These initial results along with available structural arrangements of 
domains connected to the TM (i.e. HAMP and sensor domain) strongly suggest a 
tetrameric helix assembly of the TM domain. We therefore modeled the TM1 and 
TM2 segments as ideal #-helices, and investigated their mutual interactions ab initio 
using MD simulations of the protein embedded in a lipid membrane bilayer; the 
disulfide cross-linking data was then used to validate the resulting models.  
MD-refined models for TM1 (Thr21 to Val42) and TM2 (Phe195 to Trp215) showed 
only marginal fluctuations of the secondary structure (population RMSD = 1.4 ± 0.3 
Å) (Figure 4a). This supports the predicted initial helical conformation and matches 
with the membrane hydrophobic core. The presence of a glycine (Gly33) in TM1 and 
a proline (Pro208) in TM2 are important characteristics of these helices. In fact, 
proline residues are known to induce distortions as large as 25 degrees with respect 
to the direction of the helix axis [36,37,38,39]; glycine may also create milder kinks in 
the helices [40,41]. Pro208 formed a kink in TM2 (28 ± 7 deg) as did Gly33 in TM1, 
but to a smaller extent (19 ± 5 deg) (Figure 4a). We expect that both kinks might 
favor the presence of a coiled coil-like helical assembly for the tetrameric TM1-TM2 
complex. These equilibrated helices were used as initial atomistic models to study 
the assembly of the TM complex.   
The homo- and hetero-dimer assembly of TM1 and TM2 helices were analyzed with 
MD simulations. In this case, the predictions of MD simulations can be directly 
compared to available disulfide scanning experiments, that have probed the mutual 
interactions of the TM1-TM1" and TM2-TM2" homo-dimers, and to a smaller extent 
the TM1-TM2 hetero-dimers, within the PhoQ TM complex. This set of simulations 
was conducted with a high concentration of TM segments in a united-atom lipid 
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bilayer to increase the conformational sampling (see Experimental procedures 
section). TM1 helices showed a strong tendency to form stable homo-dimers (60% of 
the total population, RMSD 2.1 ± 0.4 Å). In all TM1 dimers, hydrophilic residues 
(Thr21, Ser29, Tyr32, Tyr40) face the dimer interface (Figure 4b). Self-assembly of 
TM2 helices also produced a stable cluster of dimers (RMSD 2.7 ± 0.7 Å). The 
distortion caused by Pro208 led to a coiled coil-like assembly for TM2 dimers (Figure 
4b). Asn202 plays a central role for the stability of the TM2 dimer. The Asn202 pair 
consistently forms two hydrogen bonds between their side chains. If only a single 
hydrogen bond is formed, then the dimer disassembles during the simulation. As 
previously reported [34], Asn202 is highly conserved in the transmembrane domain 
of TCS"s and our models point to a structural role during dimer assembly. Moreover, 
experimental data indicate that the PhoQ function is impaired when Asn202 is 
mutated (e.g. during cross-linking), in agreement with this model, thus indicating a 
functional role of this residue in signaling conduction. 
 
Figure 4: Assembly of the TM domain. (a) Models of individual TM1 and TM2 helices 
equilibrated in an all-atom membrane bilayer. Gly32 and Pro208 produce a kink in TM1 and 
TM2, respectively. (b) Stable TM dimers as obtained from MD in a united-atom membrane 
bilayer. (c) Tetrameric TM model structure produced using TM dimers, MD simulations and 
cross-linking spatial restraints. From left to right, the model is presented embedded in the 
membrane from the periplasmic top view, and with a focus on the H-bond network formed by 
residues Tyr32 and Asn202, which contributes to stabilize the bundle. 
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We also used experimental cross-linking data to validate the helix-helix interface of 
the dimer models produced by MD simulations. All residues showing high cross-
linking efficiencies for TM1 and TM2 (TM1: Tyr32, Val35 Ala36, Tyr40; TM2: Leu199, 
Ala201 Asn202, Leu205) are in close proximity in the dimer models (Figure S2), thus 
providing a solid basis for further investigating the tetrameric assembly. We also 
probed the interactions along the TM1-TM2 interface: TM1 and TM2 domains 
associate in the membrane, forming oligomers. Two-thirds of the oligomers assemble 
in a conformation where Tyr32 interacts with Asn202 (Figure 4b). Moreover, these 
structures were in agreement with the cross-linking we were able to observe for the 
TM1-TM2 interface, where Ile207 was in close proximity to Val25 and Leu26 (Figure 
S3).  
The TM1/TM2 homo/hetero-dimer structures were used to form a tetrameric 
conformation, and available cross-linking efficiency data were converted into semi-
harmonic spatial restraints and applied during the first 10 ns of MD to equilibrate 
several initial tetrameric conditions. MD simulations were carried out afterward 
without any applied restraints on the bundle and converged to a stable conformation 
for the TM domain during ~80 ns of MD. The final structural ensemble of the TM 
domain is characterized by an approximate 2-fold symmetry (Figure 4c); TM2 helices 
are more tightly packed than to TM1 and this is consistent with the overall stronger 
cross-linking efficiency reported for TM2 (Figure S1). The coiled-coil TM1 and TM2 
dimer is within a 1-Å RMSD of a Crick-ideal backbone [42,43]. All polar residues of 
TM1 (e.g. Thr21, Ser29, Tyr32, Tyr40) face the interface of the assembly. This final 
TM assembly is compatible with experimental cross-linking data, as shown by the 
correlation between the cross-linking efficiency and C# contact maps calculated from 
MD simulations (Figure 5). The periodicity remains in close agreement with the 
predicted interface from cysteine-cross-linking mutagenesis. The predominant bundle 
conformation is stabilized by extensive van der Waals interactions throughout the 
bundle. Additionally, hydrogen-bonded interactions involving Asn202 and Tyr32 may 
contribute to stability. These polar amino acids formed a hydrogen-bonded network in 
many conformations, mainly involving the hydroxyl group from Tyr32 and the amide 
of Asn202 (Figure 4c).  Previous studies showed that Tyr32 is not essential for 
signaling, and that various residues of different size, shape and hydrogen-bond 
donors and acceptors complementarity can replace Asn202 [34]. Thus, the specific 
hydrogen-bond network seen in the model may not be required for attaining the 
kinase-active conformation. Instead, it could be representative of structures formed in 
the resting phosphatase-active state. 
 
Connections between the TM bundle and neighboring domains 
The minimal TM structure was extended to help model the connections to the 
domains outside the lipid bilayer surface. N-terminus to TM1 is a 20-residue 
sequence with a high potential to form a surface-seeking amphiphilic helix [44], 
hereafter referred to as the cytoplasmic N-terminal amphiphilic helix (Figure 4c). At 
the C-terminus of TM1 we also included residues 43–50, corresponding to a portion 
of the helix that forms the dimer interface of the neighboring periplasmic sensor 
domain. We also extended the TM2 helix from its C-terminus to include its connection 
 Chapter 3: Two-component system PhoPQ from E. coli 32 
to the HAMP domain. The additional segments were appended in a helical 
conformation to the TM structure, inserted in an all-atom membrane, and simulated 
over 150 ns of MD (population RMSD = 1.9 ± 0.3 Å). The TM bundle was stable 
during this timescale and maintained the same core interactions as described above 
(Figure 4c).  
The N-terminal cytoplasmic helix folded onto the membrane in a surface orientation, 
as expected. The presence of a proline at position 10 induced a kink that bent the 
helix back making it parallel to the membrane surface in a rivet-like conformation 
(Figure 4c). This arrangement is also consistent with the amphipathic nature of the 
Met1 – Pro10 segment, and might be required for the anchoring and signal 
transduction through the membrane. The distance between TM2 C-termini is 
consistent with the NMR [27] and X-ray [45] structures of HAMP, and the periplasmic 
side of TM1 is well positioned to connect to the SD domain (namely pdb 3BQ8 [15]). 
 
 
Figure 5: TM structural validation using disulfide cross-linking scanning. MD-averaged 
contact maps for (a) TM1 and (b) TM2 interfaces within the assembled TM domain. A direct 
comparison with cross-linking efficiency of (a) TM1 and (b) TM2 is reported in the inset, and 
shows a strong correlation between the cross-linking (1-efficiency) (black) and the MD-
averaged C" distance measured for the TM model structure (red). The cross-linking efficiency 
for the whole TM1 and TM2 regions is reported in Figure S1. 
 
Asn202 is crucial for the solvation of the TM domain  
Recently, Goldberg et al. [34] showed that Asn202 in TM2 is critical for signal 
transduction. When Asn202 is mutated to non-polar residues, the transcription of 
PhoPQ-regulated genes is impaired. Thus, it was proposed that the polarity of 
Asn202 and the possibility to accommodate a water pocket at the TM core could 
potentially play an important role for kinase activity and signal transduction. Using the 
assembled model for TM, we further investigated the solvation of the bundle and 
monitored the structural determinants of Asn202 and other polar residues within the 
bundle (i.e. Tyr40, Ser43, Lys46, Thr47, Arg50, Lys186, Ser193, Tyr197, Ser200). 
Their arrangement forms a “hydrophilic ladder”, and allows water molecules to diffuse 
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into the membrane only from the periplasmic side. They progress discretely from 
residue-to-residue, by either interacting with the hydrophilic side chains or with the 
backbone. During MD, we observed transient solvation of the TM bundle. Lys46, 
Arg50 and Lys186, due to their long aliphatic chain and polar head, enhance water 
permeation in the membrane. Water molecules then access the membrane"s 
hydrophilic core by interacting with Ser193, Thr47 or Ser43, before finally entering 
the bundle"s center at the Asn202 position (Figure S4).  
The presence of water in the middle of the bundle is consistent with the water-
containing cavity hypothesis [34]. We introduced selected mutations in our model, 
namely N202A, N202R and N202H, to test their effect on the solvation of the bundle. 
In vitro experiments showed that N202A mutation fully impaired the kinase function of 
PhoQ. In MD, N202A resulted in an important rearrangement of the tetramer 
hydrogen bond network. The hydrogen bond network, observed for the wild-type TM 
bundle, is totally disrupted, and Tyr32 formed hydrogen bonds with the backbone of 
Ala202. Furthermore, the mutation prevented the water molecules from completely 
entering the bundle (Figure 6). In vitro experiments involving N202R and N202H 
showed increased kinase activity compared to the wild-type [34]. During the 
simulation, the N202R mutation, which was also the most “activating” mutation, had 
the greatest effect on hydration and structure. The Arg202 side chain stretched 
towards the periplasmic side of the membrane interface and attracted water 
molecules into the bundle (Figure 6). The core of the TM bundle remained solvated 
throughout the entire simulation. The snorkeling of Arg202 prevents Tyr32 from 
engaging in the same interactions as in the wild-type. The N202H mutant preserved 
the H-bond network: A single water molecule remained trapped in the hydrophilic 
cavity throughout the entire simulation (Figure 6). Our analysis seems to indicate that 
His202 is more efficient in keeping the cavity solvated. When the center of the bundle 
is solvated, TM1 bends towards the center of the tetramer for both mutations, 
reducing the inter-helical distance to approximately 17 Å. Thus, the electrostatic 
features and the general structure of our TM model allow for the solvation of the 
bundle. This fully supports the water-cavity hypothesis previously proposed and 
points to the crucial role of water for easing the mechanism involved in signal 
transmission defined by TM1 and TM2 segments (see following sections).  
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Figure 6: Effects of Asn202 mutation on the solvation of the TM domain. The kernel 
density estimation of water molecules for MD simulations of the wild-type TM bundle, and 
three relevant Asn202 mutants: N202A, N202H, and H202R. Residue 202 is localized in the 
middle of the membrane (at 0 Å). Conservative mutations preserve the hydration of the TM 
core, while substitution with alanine prevents water from entering the bundle. Distribution is 
calculated along the axis orthogonal to the membrane bilayer, and the transmembrane portion 
is schematically indicated by the grey area defined by the MD-averaged distance between 
bilayer polar heads (namely, phosphorus atoms). 
 
Solvation triggers the conformational rearrangement of the TM domain 
The transition between a solvated and non-solvated state observed in MD is 
associated with a conformational change in the wild-type bundle, i.e. a scissoring 
movement at the periplasmic surface of the membrane characterized by TM1 helices 
bending towards the center of the bundle, thus causing TM2 to spread apart. This 
scissoring movement, however, does not seem to propagate fully to the TM2 C-
termini. To further characterize this conformational change, a principal component 
analysis (PCA) was performed based on the positions of the C# atoms during the MD 
simulation. PCA has been shown to be an effective tool to remove thermal noise and 
retrieve significant movements of a system [46]. The main principal components were 
computed and used as a new coordinate system for the projection of the position of 
the TM bundle"s C# atoms. The rotation around the helix main axis was then 
extracted for TM2 (Figure 7a). The corresponding angle distribution has three modes 
that can be described using three Gaussians (Figure 7a).  
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Figure 7: Solvation-dependent dynamic features of the TM domain. (a) The rotation of 
the C" atoms around the TM2 helix main axis is computed based on a principal component 
analysis, and the angle distribution is characterized by three major modes that can be fitted 
using three Gaussians, (b) MD time series of the TM2 residue state corresponding to the 
angle distribution. The system is initially in a metastable state (black), before switching to a 
solvated state where the TM1-TM1 interface is tighter (grey). After ~30 ns, the system, 
passing through to a metastable state, shifts to a stable state characterized by a larger TM1-
TM1 distance (light grey). (c) The rotation per residue related to the switch between the 2 
most relevant states in MD (b) is calculated. TM2 Pro208 acts like a hinge, and transforms the 
large movement of the N-terminus into a mild rotation (~20 degrees) of the TM2 residue at the 
cytoplasmic interface. 
 
Three centroids were defined by using the k-means clustering method, each 
representing a distinct state. In each frame of the simulation, the position of the C# 
was classified in one of the three states. When plotted against time, each cluster 
corresponds to a well-defined conformational state in the simulation (Figure 7b). 
During the transition state, a minor (~10 deg) rotation of TM1 C-termini allows water 
molecules to enter the membrane and eventually solvate the center of the bundle. 
The solvation of this cavity triggers the previously described conformational change. 
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The scissoring movement of TM1 imposes a rotation of TM2 that is propagated to its 
C-terminus. It is interesting to note that Pro208 acts like a hinge, transforming a large 
TM2 rotation (> 45 degrees) coupled to a scissoring movement (6 Å) at the 
periplasmic side into a pure TM2 rotation at the cytosolic side (Figure 7c). Cross-
linking experiments showed that even though PhoQ was still functional, mutating 
Pro208 decreased the activity of PhoQ. This is consistent with sequence analysis 
using BLAST [47,48], where we found that proline at position 208 is highly 
conserved, thus supporting its functional role. The final rotation of TM2 C-termini is 
approximately 20 degrees. The helical conformation of the TM region also induces a 
minor coupled piston-like translation of TM2 (0.8 ± 0.1 Å). This could influence the 
stability of HAMP and trigger the signal transduction [49]. Furthermore, the amplitude 
of the piston movement is in agreement with the experimental observation of the 
nitrate-sensing protein (NarX) structure [50]. This complex dynamic rearrangement 
was not observed for the N202A mutant that consistently remained locked in a rigid 
conformation with the lack of solvation of the bundle. Instead, the activating 
mutations (N202H and N202R) were able to explore the wild-type conformation 
characterized by a large solvation of the bundle, and are expected to readily adapt to 
conformational changes of the periplasmic SD to modulate the HAMP domain during 
PhoQ kinase activated state.  
 
A coupled TM movement provides insight into the signal transduction 
mechanism 
Unrestrained MD provided us with useful information about solvation and atomistic 
features of the bundle, including a possible coupled movement of TM1 and TM2. 
However, we were unable to exhaustively sample the large conformational space 
associated with TM dynamics, especially for higher energy states that could be 
relevant for the different kinase/phosphatase states of PhoQ. For this reason, we 
used enhanced sampling techniques to explore the dynamic determinants of the TM 
domain. Among those methods, metadynamics has been shown to be a valuable tool 
in simulating rare events and reconstructing the free energy landscape of 
biomolecules [51]. In order to characterize the free energy landscape associated with 
TM conformational changes, we used the distances between TM1 C-termini and TM2 
N-termini as main collective variables. They appear to describe the major large-scale 
fluctuation of the TM domain in free MD. They allowed the sampling of the opening 
and closing movements taking place at the periplasmic side of the membrane. 
Metadynamics confirmed the equilibrium configuration ensemble (F0) found in free 
MD characterized by an inter-helical distance of ~20 Å for TM1 and ~14 Å for TM2 ( 
Figure 8). It is interesting to note that the free energy landscape associated with TM1 
and TM2 movement showed a broad valley (~5 kcal/mol higher with respect to the F0 
equilibrium conformations), that extends to shorter TM1 (~16 Å) and larger TM2 (~19 
Å) distances, thus capturing a second alternative conformation state (F1), already 
transiently sampled during free MD simulations. Moreover, as in previous unbiased 
MD simulations, the conformational change along the valley is coupled with a ~20 
degrees rotation of TM2 C-termini. This slightly higher energy region found in multiple 
metadynamics runs is probably representative of conformations sampled by TM 
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during signal propagation. In fact, given the small energy difference between the two 
states, which might be comparable or lower than the effect of changing the 
phospholipids composition of the bacterial membrane (event that is likely to happen 
during sensing of cationic species at the perisplasmic side), we assume that both 
states might be representative of equilibrium-like configurations of either the kinase-
active or phosphatase-active states.  
 
 
Figure 8: Free energy landscape for the TM conformational change. The free energy 
landscape defined by sampling inter-helical distances between TM1 C-termini and TM2 N-
termini is reported. The conformational change observed in the unbiased MD simulations 
(orange points) occurs along a free energy valley, that connects a main equilibrium state (F0) 
and a high-energy conformation, and can be associated with relevant states during the 
signaling process (F1, ~5 kcal/mol higher in free energy). 
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3.2.3 Discussion 
Currently, no soluble NMR or X-ray crystal structure has been solved for the PhoQ 
transmembrane domain, thus hindering a thorough understanding of the signal 
transduction mechanism from the periplasmic sensor to the cytoplasmic kinase 
domain. In this study, we have combined all-atom molecular dynamics simulations 
with experimental cross-linking disulfide scanning data to build a four helical bundle 
model for the E. coli PhoQ TM region. Experimental cross-linking data provided a set 
of low-resolution spatial restraints for TM packing, thus validating a structural 
ensemble of the TM domain generated by MD simulations. The accuracy of the 
proposed structural ensemble might be limited by the absence of the adjacent PhoQ 
domains during the modeling and by the current sampling limitations of MD methods. 
However, the ensemble appears to recapitulate much of the experimental data 
observed for PhoQ. As discussed in more detail below, we see agreement with the 
experiments and find insights into the signaling of histidine kinases. First, the 
simulations provide an ensemble of molecular models that are consistent with the 
disulfide cross-linking data, particularly over the regions where strong cross-linking is 
observed. Secondly, they demonstrate the essential role of Pro208, which causes a 
bend in the TM2 helix. This bending provides a mechanism to modulate the 
amplitude and combination of motions in the TM domain. Finally, simulations of 
several mutants are compared to the experimental activity measurements, leading to 
a correlation between the degree of hydration of the bundle"s core and the 
conformational changes of the TM domain.  
Cross-linking data support a four-helix bundle for the PhoQ transmembrane domain 
(Figure S1). During MD, the packing of the side chains formed a stable coiled-coil 
tetrameric arrangement (within 1 Å RMSD of a Crick-ideal backbone), characterized 
by an approximate 2-fold symmetry. Moreover, we identify an N-terminal cytoplasmic 
amphiphilic helix lying along the membrane surface. This could help anchor TM to a 
specific location in the membrane bilayer and in turn, may favor the signaling 
transmission. Furthermore, the tetramer assembly is fully consistent with disulfide 
scanning data. The registration and packing of the helices in this structure is fully 
compatible with our model (RMSD 2.1 Å), and the structural difference between the 
two models is consistent with the resolution that is characteristic of the approach 
used to model the TM region. Although some aspects of the disulfide cross-linking 
studies are well explained by the model, others would appear more difficult to 
rationalize. For example, experimentally one observes very low cross-linking 
efficiency for TM1 and TM2 at the cytoplasmic interface (Figure S1). On one hand, 
the tight packing of this region, as observed in our model, could preclude the diffusion 
of reagents needed to induce disulfide formation. On the other hand, the diagonal 
helices of the TM bundle might also explore more distant conformations during 
signaling, as observed in the related TM bundle of HtrII, where the helices are under-
packed in this region of the structure [35].  
Despite this discrepancy, the topology of the bundle is consistent with the available 
structures of the periplasmic (SD) and cytoplasmic (HAMP) domains. At the 
periplasmic membrane surface, when the bundle is solvated, TM1 helices can easily 
connect to the biologically-validated dimeric conformation of the sensor domain (pdb: 
3BQ8 [23]) (Figure 9). On the cytoplasmic surface of the membrane, the TM2 C-
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terminal helices can be extended to merge with the two currently available structures 
of the HAMP domain (Figure 9). Furthermore, we observed that the kink induced by 
Pro10 at the PhoQ N-terminal amphiphilic helix is functional, thus helping to avoid 
steric clashes with the helical structure of the HAMP domain (Figure 5).  
 
 
Figure 9: TM connectivity and implications for signaling mechanism. The panels (a) and 
(b) indicate the projection for the F0 and F1 states, respectively, on the periplasmic (top) and 
cytoplasmic (bottom) surface of the membrane of the helical termini of the TM model. The 
contour lines represent the position of TM1 and TM2 during MD, and the dots represent the 
position of SD and HAMP available structures at the same section surface. (Central panel) At 
high mM concentration of Mg2+ and Ca2+ cations, metal bridges are formed between the SD 
acidic cluster and the negatively charged membrane. This conformation can be associated to 
the F0 state of our model and to a kinase-dominant state (K+). When the concentration 
decreases, the metal ion bridges are disrupted, leading to repulsion between the membrane 
and SD active site. This triggers a conformational change of the TM domain (F1 state 
associated to a phosphatase-dominant conformation, P+), and results in a rotation of TM2 at 
the cytoplasmic interface, that is then transmitted to the linked HAMP domain.  
 
MD simulations of this structural ensemble showed that the polar nature of Asn202 is 
crucial for the assembly and proper solvation of the TM domain. In the proposed 
model, Asn202 forms a hydrogen-bonded network with water and other residues in 
the lumen of the TM region. Furthermore, the proximity of other polar residues at the 
periplasmic end allows water molecules to enter the bundle and reach its core. We 
showed that the removal of this polar residue in the N202A mutant (for which in vitro 
the kinase activity is completely impaired [34]) prevents the solvation of the TM core, 
thus locking the domain into a rigid one-state conformation. Mutations to histidine or 
arginine partially preserve the electrostatic nature of the native Asn202. This 
produces a similar hydration of the TM core and indicates a more flexible 
conformation of the TM domain. Consistently, the kinase activity of these mutants is 
conserved and is even higher than the wild-type [34]. Therefore, the degree of 
solvation of the TM domain appears to be strongly correlated with the kinase activity 
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of PhoQ. This points to the key role of polar residues located within the bundle and 
water molecules in facilitating signaling through the membrane.  
It is interesting to see how this model can help elucidate the mechanism of signaling, 
and how its structure and dynamics relate to the SD and HAMP domains. The SD X-
ray structure (3BQ8 [23]) can optimally be connected to the TM state observed during 
MD where the TM1 helices are closer together (F1 in  
Figure 8). Therefore, the F0 state, featuring the opening of TM1 helices, could be 
associated with the yet uncharacterized SD conformation. The stimuli (e.g. change in 
the concentration of cations) could drive the rearrangement of the SD dimer, causing 
it to pivot around its inter-helical dimeric interface (Figure 9). This scissoring 
movement would change the angle and inter-helical distance at which TM1 helices 
enter the membrane, thus promoting a concerted rearrangement of TM1 and TM2 
helices, as observed in our simulations. Clearly, further studies are needed to unveil 
the dynamic features of the SD-TM coupling. Nonetheless, several experimental 
studies have shown that the TM helices undergo a structural rearrangement during 
signaling [52,53,54], and that a sensor domain-independent mechanism also exists 
[55]. Therefore, the complex interplay between scissoring and rotational movements 
at the periplasmic side of the membrane results, as revealed by our model, in a 
simple clockwise rotation of the TM2 helices at the cytoplasmic side (~20 degrees, 
Figure 7 and Figure 9). This is consistent with the cogwheel mechanism proposed for 
the HAMP domain [27] (Figure 9). Therefore, we conclude that the two relevant 
conformations observed in MD for the TM domain might be representative of the two 
main states of PhoQ, i.e. kinase and phosphatase active. And, the interconversion 
between these two states modulates the rotation of the cytoplasmic HAMP domain 
and, eventually, the phosphorylation and dephosphorylation ability of the histidine 
kinase domain (Figure 9).  
Finally, this study shows how molecular simulations combined with low-resolution 
spatial restraints extracted from experimental cross-linking data can be used to 
investigate the structure and assembly of transmembrane proteins. Although full 
coarse-grained MD approaches can correctly assemble helix oligomers in 
membranes [56,57,58], we adopted here an atomistic representation to better 
describe the helical kinks and the important solvation effects at the PhoQ TM 
domain. This protocol is of general applicability and can easily be extended to study 
other transmembrane protein complexes. In this case, the characterization of the 
PhoQ TM domain, not only sheds new structural light on two-component system 
signal transduction across membranes, but also can be exploited for the design of 
specific drugs or peptidomimetics capable of impairing PhoQ assembly and function. 
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3.2.4 Materials and Methods 
 
Structural models. No structural data exist for TM1 and TM2. Thus, we modeled 
their structures ab initio. We combined hieght topology prediction algorithms to 
isolate the transmembrane domain (TM) of PhoQ (Table S1). The transmembrane 
portion of TM1 was roughly identified from residue Thr21 to Val42, and TM2 from 
Phe195 to Trp215. Both transmembrane domains were modeled as ideal "-helices 
based on the combined results of secondary prediction tools such as HNN [59], 
Jpred [60,61], NetSurfP [62], PSIpred [63], ProteinPredict [64]. These initial 
predictions were used to build the atomistic models of TM1 and TM2 embedded in 
the lipid bilayer. The MD simulations were then used to equilibrate them and to find 
the correct match with the membrane hydrophobic environment. 
 
Molecular dynamics simulations of the assembly. We used molecular dynamics 
(MD) simulations to further characterize the assembly of the TM domain. In a first 
step, the ideal helical TM models were each separately inserted and equilibrated in a 
60 x 60 Å2 Palmitoyl Oleoly Phosphatidyl Choline (POPC) membrane patch [65] to 
characterize their isolated structure in a phospholipid bilayer. Then, the self-assembly 
of TM1 and TM2 was studied separately, producing a high-concentration of TM 
proteins in a 100 x 100 Å2 pre-equilibrated patch of united-atom dodecane membrane 
(DODE). The thickness of the DODE membrane is approximately equivalent the 
hydrophobic core of the POPC bilayer. Diffusion in an all-atom membrane model is 
slow and the protein oligomerization may require timescales not easily accessible 
within an all-atom MD. We inserted the equilibrated transmembrane domains TM1 
and TM2 into a united-atom dodecane membrane (DODE) [66]. In a united-atom 
model, groups of atoms are clustered, thus decreasing the computation and diffusion 
time. In a second step, TM1 and TM2 dimer conformations compatible with cross-
linking data were used to assemble a four-helix bundle. The resulting tetramer was 
inserted in a 55 x 55 Å2 DODE membrane bilayer. Since an important rearrangement 
of the side chains is expected, harmonic restraints were also added to C" showing 
high cross-linking efficiency. Only TM2 dimers were restrained, due to the highly 
dynamic nature, i.e. Phe195, Val198, Asn202 and Val206 pairs were subjected to 
semi-harmonic restraints with force constant kf = 100 kcal/Å
2 and the rest point x0 to 
12 Å. The harmonic restraints were removed after a 10 ns simulation. In addition, an 
extended version of the TM1-TM2 tetramer (TM1: Met1 – Arg50, TM2: LYS186 – 
ARG219), and three mutant species (N202A, N202H, N202R) were also tested in a 
70 x 70 Å2 Palmitoyl Oleoly Phosphatidyl Ethanolamine (POPE) membrane. 
All simulations were performed using NAMD [67] engine with the CHARMM27 force 
field [68], including CMAP corrections. We used metadynamics to explore the free 
energy landscape associated with the opening and closing of the TM domain at the 
perisplasmic side. In metadynamics, Gaussians are added to the energy surface and 
force the system to escape from local minima. This technique requires a priori 
knowledge of the degree of freedom relevant to a conformational change. In the 
current system, the observed conformational change was described by means of two 
collective variables representing the distance between the C-termini and N-termini of 
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TM1 and TM2 respectively, and was the most relevant motion from a principal 
component analysis of the unbiased MD simulations. The inter-helical distances were 
defined using the center of mass of residue Ser43 to Thr48 for TM1 and Ser188 to 
Trp192 for TM2. A set of three metadynamics simulations (~30 ns each) was 
performed using the collective variable module of NAMD. Gaussians of width 0.3 and 
weight 0.01 were inserted every 300 fs. The conformational space was sampled from 
15 to 25 Å for TM1 and 10 to 20 Å for TM2 (Figure 8). The obtained free-energy 
profile was visualized as an iso-contour map with a grid spacing of 0.3 Å (Figure 8).  
It should be mentioned that our models and simulations may be affected by several 
approximations: the assembly does not include the complete PhoQ homodimer, but 
only the TM domain and perturbations might be more evident at the protein termini; 
two collective variables may not be able to describe all the degrees of freedom of the 
system, leading to an approximation of the real energy landscape; furthermore, 
sampling can also be an issue to accurately describe solvation of the bundle. 
Therefore, multiple MD simulations were run from different initial conditions to ensure 
the reproducibility of the results. A list of all performed simulations is reported in 
Table 2. 
 
Crosslinking reactions and analysis. Covalent chemical cross-linking has shown 
to be a useful technique to probe protein-protein interactions and provide low-
resolution structural information of the protein-protein reciprocal arrangement [69] 
[24,31,70]. If both cysteine residues are close to each other (< 12 Å between two 
C"), the cross-linking efficiency will be high. The spatial interaction between the 
different amino acids can then be deduced and provides spatial restraints on the 
folding and packing of the PhoQ TM region. In the current study using a procedure 
similar as in [10], we report cross-linking results for the TM1-TM1 and TM2-TM2 
intermolecular interactions for the TM tetrameric bundle (Figures 3 and S1) [71]. We 
also report a limited set of data for the inter TM1-TM2 interactions centered on Ile207 
at TM2 (Figure S3). To crosslink cysteine residues in the transmembrane domain we 
used the oxidative catalyst copper (II) 1,10 phenanthroline (Cu(II)Phenanthroline), a 
small membrane permeable reagent that efficiently catalyzes disulfide bond 
formation in the membrane. We treated a 10µL sample of cell envelopes to 10µL of 
buffer containing 2mM or 0.2 mM Cu(II)Phenanthroline for a final concentration of 
either 1mM or 0.1 mM. Reactions were allowed to proceed for 30 minutes at room 
temperature, and then stopped by the addition of 20mM N-Ethyl Maleimide (NEM) 
and 20mM EDTA. Reactions were spun at 16"000 rpm at 4 degrees C to concentrate 
membranes. Suspension in 8M urea LDS loading buffer preceded gel loading. 
Western blotting was used to estimate cross-linking efficiency quantifying the fraction 
of cross-linked dimer to total visible protein (i.e. dimer/dimer + monomer, see details 
in Text S1 and Figure 5, Figure S1 and Figure S3).   
 
3.2.5 Supporting Information  
Molecular dynamics setup.  
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All simulations were performed using NAMD [67] engine, with the CHARMM27 force 
field [68], including CMAP corrections. TIP3P water [72] parameterization was used 
to describe the water molecules. The spatial overlapping of lipid molecules and 
protein were removed and the resulting protein-membrane system was solvated in a 
variable-sized water box, neutralized through the addition of NaCl at a concentration 
of 150 mM. The periodic electrostatic interactions were computed using particle-
mesh Ewald (PME) summation with a grid spacing smaller then 1 Å. All systems 
were first minimized by 2000 conjugate gradient steps. POPE membranes were 
equilibrated for 500 ps at 300 K with a restraint on the proteins, water and ions. Since 
the DODE membrane was already equilibrated, this step was not required. All 
systems were subsequently gradually heated from 0 to 300 K in 800 ps with a 
constraint on the protein backbone scaffold. Finally, the systems were equilibrated for 
3 ns at 300 K. Free molecular dynamics of all equilibrated systems were performed 
with a 2 fs integration time step using the RATTLE algorithm applied to all bonds. 
Constant temperature (300 K) was imposed by using Langevin dynamics [73], with a 
damping coefficient of 1.0 ps. A constant pressure of 1 atm was maintained with a 
Langevin piston dynamics [74],  200 fs decay period and  50 fs time constant. 
 
Crosslinking reactions, Western blotting and analysis. Oxidized membranes 
were reconstituted in 20uL of loading buffer (Invitorgen LDS buffer plus 8M urea and 
0.5M NEM) and heated for 10 minutes at 70 degrees C. 5uL of sample were loaded 
onto either a 7% or 3-8% gradient Tris Actetate gel (NuPage, Invitrogen). Proteins 
were separated by molecular weight with application of 150V for 60 minutes. Proteins 
were transferred to a nitrocellulose membrane by electrophoresis (iBlot, Invitrogen). 
Membranes were washed with Tbst (10mM tris pH 7.5, 2.5 mM EDTA, 50 mM NaCl, 
0.1% Tween 20) and blocked with 3% BSA in Tbst. PhoQ* was probed using Qiagen 
penta-his antibody. His antibody was probed with HRP conjugated sheep anti mouse 
IgG. Proteins were visualized by exposure to ECL reagent (Amersham, GE health 
sciences) for 1 minute and exposure to film for 30 – 60 seconds. Pixel density 
histograms were generated using the ImageJ software, freely available from NIH 
(http://rsbweb.nih.gov/ij/), and crosslinking efficiency was determined using the 
fraction of cross-linked dimer to total visible protein (dimer/dimer+monomer).  
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!
Figure S1: Fractional cross-linking of PhoQ TM residues. The black curve represents the 
cross-linking efficiency of (a) TM1 and (b) TM2. The data can be fitted with a sine wave 
(dashed orange). N202 was excluded for the fit, since it is an inactivating mutation. The 
reported periodicity (# = 3.62 and # = 3.3 respectively) strongly suggested that the TM 
domain would assemble as a helical bundle. These data are used to validate our results for 
TM assembly and are compared with MD results in Figure 5 of the main text (see Supporing 
materials and methods section). 
Figure S2: TM homodimer validation and selection via disulfide cross-linking 
scanning. MD-averaged contact maps for (a) TM1 and (b) TM2 dimer interfaces. A direct 
comparison with cross-linking efficiency (Figure S1) of (a) TM1 and (b) TM2 is reported in the 
insets and shows a strong correlation between the cross-linking (1-efficiency) (in black) and 
the MD-averaged C" distance measured for the TM model structure (in red). 
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Figure S3: Inter-TM crosslinking for Ile207. Results of inter-TM crosslinking experiment 
between residue 207 on TM2 and a window of TM1 residues between 23 and 27. Error bars 
represent two independent experiments. 
 
 
 
Figure S4: Water distribution around the TM bundle. (Top) The water molecules in 
contact with the TM bundle for wild type (WT), and three mutants: N202H, N202R and N202A 
are displayed with red spheres (see also Figure 4 in the main text). (Bottom) The focus on the 
N-terminal helix extended from TM1 illustrates its amphiphilic nature in our model. The 
hydrophobic residues are displayed in white, the polar and positively charged residue in green 
and blue, respectively. 
0
0.2
0.4
0.6
0.8
1
F
ra
c
ti
o
n
 o
f 
c
ro
s
s
li
n
k
in
g
Val24Leu25Val26Val27 Ala23
Inter-TM crosslinking of Ile207
Pro10
N-ter
Pro10 hydrophobic
positive
polar
N-ter
WT N202H N202R N202A
Asn202 His202
Arg202
Ala202
 Chapter 3: Two-component system PhoPQ from E. coli 46 
Table 1: Transmembrane domain predictions. The transmembrane domain considered for 
the modeling is highlighted in grey as a consensus obtained from the following programs: 
SPOCTOPUS [75], OCTOPUS [76], PSIpred [63], TMHMM [77], HMMTOP [78], TMpred [79], 
topcons single [80], and DAS [81]. 
 
 
Table 2: List of performed simulations 
 
             FIYVLSANLLLVIPLLWVAAW      uniprot
VWSWFIYVLSANLLLVIPLLWVAA          HMMTOP
         WFIYVLSANLLLVIPLLWVAAWW   TMHMM
             FIYVLSANLLLVIPLLWVAAW       TMpred 
      SWFIYVLSANLLLVIPLLWVA              Octopus    
      SWFIYVLSANLLLVIPLLWVA              Soctopus
            FIYVLSANLLLVIPLLWVAAW        psipred  
            FIYVLSANLLLVIPLLWVAAWW    topcons single
            FIYVLSANLLLVIPLLWVA               DAS
FLLATAAVVLVLSLAYGMVAL             uniprot
FLLATAAVVLVLSLAYGMVALIG         HMMTOP
       ATAAVVLVLSLAYGMVALIGYSV  TMHMM 
FLLATAAVVLVLSLAYGMVALIGY       TMpred
FLLATAAVVLVLSLAYGMVALIG          Octopus
FLLATAAVVLVLSLAYGMV                   Soctopus
FLLATAAVVLVLSLAYGMVALIGY        psired
FLLATAAVVLVLSLAYGMVAL               topcons single
FLLATAAVVLVLSLAYGMVAL               DAS
TM
2
TM
1
195 215
21 42
System Membrane Number of 
atoms 
Simulation time 
TM1 monomer POPC 27,333 50 ns 
TM2 monomer POPC 27,956 50 ns 
Dimerization TM1 DODE 40,700 100 ns 
Dimerization TM2 DODE 40,700 100 ns 
Dimerization TM1-
TM2 
DODE 40,700 100 ns 
Initial tetramer DODE 40,000 60 ns 
Initial tetramer POPE 47,300 80 ns 
Extended tetramer  POPE 51,200 150 ns 
N202A POPE 51,200 100 ns 
N202H POPE 51,200 100 ns 
N202R POPE 51,200 100 ns 
Metadynamics POPE 51,200 3x30ns 
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3.3 Near-atomistic model of the complete PhoQ histidine 
kinase 
The cytoplasmic domain of PhoQ is largely unsolved. MODELLER, a comparative 
modeling software for three-dimensional protein structures, was used to assemble 
the complete atomistic model of the PhoQ homodimer [1]. The crystal structure of the 
sensor (PDB: 3bq8, [2]) and catalytic (PDB: 1id0, [3]) domain have been solved for E. 
coli. The histidine kinase (PDB: 2C2A , identity: 22.9%, [4]) and HAMP (PDB: 2l7h, 
identity: 31.8%, [5]) domains of, respectively, Thermotoga maritima  and 
Archaeoglobus fulgidus were used as templates for the cytoplasmic domain. The 
preserved residues are mostly located in the helical domains, supporting a probable 
functional importance. The TM domain was taken from cross-linking guided models 
produced by using MD simulations (see Section 3.2). 
 
 
Figure 10: Atomistic model of PhoQ. The acid cluster and H277 are highlighted in licorice 
representation. 
In the final model, the large acidic cluster (148—EDDDDAE—154) of the sensor 
domain (SD), involved in sensing divalent cations and AMP, lies very close to the 
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membrane surface (Figure 10). It was proposed that the SD senses the electrostatic 
variation at the bacterial membrane surface [6]. When the concentration of Mg2+ or 
Ca2+ cations is high (> 1 mM), cations can bind to the acidic cluster, forming a metal-
mediated bridge with the negatively-charged membrane of bacteria. Based on this 
assumption and consistent with the proposed model, each SD acidic cluster could 
closely interact with the membrane surface [6]. The repulsion or attraction of the 
acidic cluster may lead to a scissoring movement at the SD interface. Such a 
movement could induce a conformational change of the transmembrane domain, 
consistent with the one observed in MD. Finally, the resulting rearrangement of the 
HAMP and histidine kinase domains would trigger the phosphorylation of the His277 
and a phosphotransfer to PhoP. 
!
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3.4 Modeling of cardiolipin species 
Published as the following paper: 
“Cardiolipin models for molecular simulations of bacterial and mitochondrial 
membranes”,  
Lemmin T., Bovigny C., Lançon D., and Dal Peraro M., Journal of Chemical Theory 
and Computation, 2012, 9 (1), pp 670–678 
3.4.1 INTRODUCTION 
The biological membrane constitutes an essential barrier for all living organisms. It is 
composed of a complex mixture of lipids and embedded proteins, forming a 
heterogeneous liquid-crystalline structure, organized into rafts of local association of 
lipids, with specific physicochemical properties [1]. Over the past years, it has been 
established that lipids do not constitute a simple structural support for proteins, but 
interact, modify and regulate their function [2,3]. Cells invest a substantial amount of 
energy to synthesize a large repertoire of different specific lipids, and nearly 5% of 
genes are involved in this synthesis [4].  
The composition of cell membranes in archaea, eukaryotes and bacteria differ 
significantly. In particular, cardiolipins (CLs) are anionic phospholipids found in Gram-
negative and Gram-positive bacteria, as well as in mitochondria and chloroplast inner 
membranes of eukaryotes. CLs are composed of two phosphatidyglycerols moieties 
connected by a single glycerol molecule (Figure 11). This dimeric structure is unique 
among phospholipids, and confers an important role in the structural stabilization and 
activation membrane-dependent processes [5,6]. CLs can potentially carry two 
negative charges, one on each phosphate group (Figure 11c). Despite the apparent 
symmetry of the head group, the ionization of the phosphate groups occurs at 
different acidity levels (pK1 ~ 2.8 and pK2 ~ 7.5 – 9.5) [7]. Under physiological 
conditions, CLs may therefore carry one negative charge. However, depending on 
the local pH and CL concentration, the deprotonation of both head groups cannot be 
excluded [8]. Importantly, cardiolipins have the tendency to produce high membrane 
curvature due to their large hydrophobic region and small charged head. Moreover, 
their bilayer and non-bilayer lipid properties are strongly modulated by the presence 
of divalent cations, namely Mg2+ and Ca2+ ions. 
Despite the importance of CLs in bacterial and mitochondrial membrane composition 
and their key role in cell division [9], energy metabolism and pathologies [10], there 
are to date few molecular, biophysical, and biochemical characterizations thoroughly 
describing their properties and specific interactions with other lipid species and 
protein complexes.  
Molecular simulations, at different levels of resolution, have contributed in many 
respects to describe the structural and kinetic properties of biological membranes in 
the last two decades [11,12,13]. Coarse-grained and united-atom models for 
cardiolipins have been parameterized [14,15,16,17]. These models provided useful 
mechanistic insights into phase transitions and aggregate geometries, but the lack of 
atomistic details inherent to a coarse-grained approach prevents a full molecular 
understanding of their properties. Similarly, united-atom models may suffer from the 
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same limitations [14]. Rog et al. proposed [18] the first all-atom OPLS-based model 
for the study of the mitochondrial inner membrane. Only the doubly charged 
protonation state was modeled in this case and the partial charges were directly 
derived from Murzyn et al. and adapted from the OPLS force field [19]. They 
observed that the effect of CLs on the membrane properties is strongly dependent on 
the membrane composition and cannot be easily predicted. The interaction with 
cations, which is known to influence CL properties, however, has not yet been 
described. Recently, Aguayo et al. [16] proposed a new hybrid set of parameters for 
the doubly charged cardiolipins in the united-atom CHARMM27-UA and all-atom 
CHARMM36 framework. They reported the effect of cardiolipins on the order of the 
acyl chains and membrane thickness, which can be associated to mitochondrial 
membrane activity.  
To date, atomistic models of all the possible protonation states of CLs have not yet 
been parameterized for classical molecular dynamics (MD) simulations consistent 
with the commonly used AMBER or CHARMM force fields. Therefore, we propose in 
this work an ab initio parameterization of CL models with different physiological 
protonation states, in which the phosphate groups can either be unprotonated or 
singly protonated. In the singly protonated CL, a proton is trapped in the bicyclic 
resonance structure formed by the two phosphate and hydroxyl groups (Figure 11c), 
for which an energy barrier as low as 4 – 5 kcal/mol has been estimated for the 
proton exchange between the phosphates [20].  
We used and tested these initial models to characterize CL-rich membrane patches 
and the interaction of CLs with monovalent and divalent cations. Our results were 
consistently validated a posteriori by quantum mechanics calculations and available 
experimental data, such as X-ray structures of proteins co-crystallized with cardiolipin 
molecules.  
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3.4.2 RESULTS 
CL structure and parameterization were obtained following the procedure given in the 
Material and Methods section. This set of parameters is the result of an extensive 
conformational search of CL head group space, from which the most representative 
structures were clustered and optimized to produce a novel and consistent set of 
partial atomic charges. Since the pK2 of cardiolipins (>7.5) is of the same order as 
the physiological pH, this would imply the coexistence of different protonation states 
of the phosphate groups. Thus, two protonation states for cardiolipin head groups 
were considered in this study: CLs with unprotonated phosphate groups (uCL) and a 
singly protonated phosphate group (pCL) (Figure 11c). To characterize the effect of 
the protonation, three cardiolipin bilayers were assembled. The first two systems 
were exclusively composed of uCL or pCL molecules. The third system was a 
uniform mixture of both kinds of cardiolipins. Molecular dynamics simulations were 
carried out for all three systems using CL parameterization consistent with the 
CHARMM and AMBER force fields. The subscripts “a” and “c” will be used to 
differentiate simulations carried out with the AMBER and CHARMM force fields, 
respectively (e.g. uCLa: unprotonated CL with AMBER force field). CL refers to the 
cardiolipin independent of its protonation state.  
 
 
Figure 11: Cardiolipin structure and protonation states. Cardiolipin (CL) chemical 
structure (a) and 3D model (b). The cardiolipin forms a unique dimeric phospholipid 
composed of four acyl tails. (c) CLs can be unprotonated  (uCL) or singly protonated (pCL) 
depending on the protonation state of the OA3 oxygen atom, highlighted in blue. Relevant 
atom names composing CL head group are shown on the 3D structure, consistently with the 
topology and parameter files reported in Supporting Informations. 
Biophysical characterization of the cardiolipin bilayer 
Experimental data showed that the cardiolipin phase transition temperature is 
significantly higher than those corresponding to similar diacyl phospholipids [21]. 
Consistent with these results, a membrane patch composed exclusively of 
cardiolipins arranges in a gel phase conformation. To test our models, we quantified 
the order parameter (SCD), which represents a measure of the orientation mobility of 
carbon-deuterium bonds that can be observed in the 2H NMR experiments (Figure 
12a). The computed SCD profiles are in good agreement with the experimental data 
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for the hydrophobic region of the phospholipid membrane [22]. The protonation of the 
phosphate group slightly affects SCD; in pCL systems the order parameter is 
systematically higher. The higher order parameter for CLa indicates that the acyl 
chains are more parallel to the bilayer normal when using the AMBER 
parameterization. Mixing cardiolipins with different protonation states only marginally 
affected the order parameter, which remains comparable to the uniform CL patches. 
 
 
Figure 12: Biophysical properties of CL-rich membrane patches. (a) SCD order 
parameters for pCL and uCL for both the AMBER and CHARMM parameterization. (b) Side 
view MD snapshots of the CL membrane systems for pCL and uCL simulated using the 
CHARMM force field. 
 
Another consequence of the difference between the two parameterizations is seen by 
the thickness of the membranes. Membranes simulated with the AMBER force field 
are thicker compared to the CHARMM simulations, ~ 45 Å and ~ 42 Å, respectively 
(Table 1). At 35o C, the thickness measured by x-ray diffraction was estimated to be 
~ 43 Å [23]. The acyl tails are more extended and vertical in the simulation performed 
with the AMBER force field and explains this difference. It was observed that MD 
simulations of a membrane using AMBER parameters have a tendency to favor gel 
over liquid crystal phase. This may be due to the still limited testing of the force field 
parameters for lipids [11,12]. 
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Table 1. Biophysical properties of cardiolipin membrane patches simulated in this study.  
Thickness Area per lipid† Volume per lipid System Force field 
[!] [!"]  [!#] 
Diffusion coefficient          
[10-8 cm2/s] 
CDL Na+ CHARMM 41.46 ± 1.52 90.81 ± 0.20 
(30.25) 
1825.43 ± 12.68 4.85 ± 0.15 
CHARMM 39.53 ± 2.81 100.03 ± 0.21 
(27.41) 
1789.59 ± 12.41 4.65 ± 0.25 CDL Mg2+ 
AMBER 43.26 ± 2.6 86.45 ± 0.18 
(16.16) 
1859.77 ± 15.78 2.46 ± 013 
CLP  Na+ CHARMM 42.67 ± 2.29 86.97 ± 0.17 
(25.46) 
1808.66 ± 11.54 5.26 ± 0.46 
CHARMM 40.93 ± 2.63 92.83 ± 0.19 
(28.16) 
1795.58 ± 12.60 5.11 ± 0.18 CLP Mg2+ 
AMBER 44.18 ± 2.95 82.93 ± 0.14 
(21.48) 
1872.08 ± 16.97 2.67 ± 0.24 
mixed  Na+ CHARMM 41.60 ± 2.56 90.28 ± 0.18 
(24.40) 
1818.10 ± 13.12 5.02 ± 0.08 
CHARMM 41.42 ± 2.42 92.74 ± 0.20 
(35.50) 
1784.01 ± 12.70 4.54 ± 0.45 mixed Mg2+ 
AMBER 44.74 ± 2.96 82.54 ± 0.16 
(20.61) 
1833.82 ± 17.62 2.12 ± 0.11 
†
The value in parenthesis indicates the standard deviation measured for the patch.  
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In order to estimate the variation within the membrane patch, the area per lipid was 
estimated using a Voronoi decomposition applied to the position of the pairs of CL 
phosphorus atoms [24]. The order parameters would correspond to bilayer in the gel 
phase, whereas the CL area per lipid is close to the one measured in liquid crystal 
phase (83 Å2 at 35o C) [23]. A similar difference has been observed for the recently 
reported united-atom parameterization of cardiolipins [16]. The pCLs is significantly 
packed tighter than uCLs. The lipids are more tightly packed for the simulations 
carried out with the AMBER force field independent of the protonation state. These 
values are in good agreement with the ones reported by Aguayo et al.[16], which are 
the closest models reported in the literature to our parameterization. On the other 
hand, when mixing different protonation states, the area per lipid is comparable to the 
pure uCL patch. The variation of the area per lipid within a patch remained 
comparable for all the systems.  
The diffusion coefficient of CLc is in good agreement with the expected values for 
lipids from the experimental data (~ 4*10-8 cm2/s) [25]. The pCLc diffuse faster than 
the unprotonated cardiolipins (Table 1). The CLa diffuses slower (1.38 ± 0.01 10
-8 
cm2/s), which is consistent with the more significant gel-like conformation adopted by 
the acyl tails.  
Exploring the conformational space of the cardiolipin polar heads 
Experimental data point to a predominant functional role of cardiolipins in several 
crucial cellular mechanisms, such as protein regulation, energy metabolism and 
structural membrane organization. Accurately reproducing the conformation space of 
the polar heads is therefore essential. Currently, only limited information is available 
for CL head group geometries. 
 
 
Figure 13: Conformational flexibility of the CL head groups. (a) The inter-phosphate 
distance d(PA1-PB2) and (b) phosphate-hydroxyl angle !(PA1-O1-PB2) of the polar heads 
are shown. Since the protonation state did not affect these variables, the simulations are 
averaged depending on the force field used. The relative quantities extracted from CL 
crystallized in the PDB structures are shown with dashed lines (see SI for the exhaustive list 
of the protein complexes used for this analysis). 
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We therefore decided to characterize these properties based on our models and 
compare and validate the various conformers extracted from the MD simulations with 
the crystallographic structures of CL from PDB data, as proposed by Dahlberg et al. 
[14]. These structures were co-crystallized with proteins and are therefore not per se 
fully representative of a membrane bilayer. We expected however that they would 
sample the head group conformational space to some extent. A total of 91 structures 
formed the set of crystal structures (see Table S1 in the Supporting Material section). 
The head group geometry was characterized based on the inter-phosphate distance 
d(PA1—PB2) and the phosphate-hydroxyl angle !(PA1—O1—PB2) (Figure 13). These two 
variables reduce the degrees of freedom of the conformational space and describe 
global characteristics of the head group geometry.  
The PDB inter-phosphate distance is characterized by a bimodal distribution, with a 
first maximum at 5.9 Å and the other at 7.0 Å (Figure 13a). In the molecular dynamics 
simulations, the maximum is situated at 6.8 Å and 6.7 Å for AMBER and CHARMM, 
respectively. The maximum for both force fields is closer to the second experimental 
maximum (7.0 Å). CHARMM covers more uniformly the conformational space. 
Despite this shift, the conformation space explored by both models is in good 
agreement with these experimental data, even though the PDB structures do not 
represent bilayer structures. The protonation state does not significantly influence 
these distributions. The angle distribution is also bimodal (maxima at 78 and 128 
degrees). CHARMM-based models show a single mode distribution, which largely 
overlaps the PDB global maxima. The principal mode for the AMBER force field is 
shifted (95 degrees), but the distribution is bimodal with a second mode closer to 
PDB (132 degrees; Figure 13b).   
In order to further quantify the accuracy of the atomic partial charges and dihedral 
parameters derived for the head group, a hybrid quantum mechanics/molecular 
mechanics (QM/MM) geometry optimization was carried out. A set of 50 membrane 
bilayer structures was extracted from the MD simulations. Single CL molecules in the 
patch were randomly selected to be geometrically optimized at the QM/MM level. The 
refined structures were in good agreement with the MD head group conformation 
(RMSD 0.13 ± 0.03 Å). The inter-phosphate distance and phosphate-hydroxyl angle 
varied only slightly (0.08 ± 0.13 Å and 0.39 ± 3.00 degrees, respectively). The angles 
and dihedrals of the bonded atoms of the head group remained constant between the 
MM and QM structures with a variation under 10%.  
Therefore, the reasonably good conformational overlap with available crystallized 
structures of CLs, and the limited variation of CL geometries relaxed at a higher level 
of theory support the structural robustness of the force field parameters derived here 
for MD simulations.  
Cardiolipin interactions with cations 
Cations are known to be crucial for the structural and functional integrity of cell 
membranes. The anionic nature of cardiolipins makes them a major binding site for 
cations, or positively charged species (e.g. AMPs). We therefore analyzed the 
distribution along the z-axis normal to the membrane surface and the radial 
distribution function of Na+ and Mg2+ with respect to CL lipids (Figure 14 and Figure 
15). A larger patch (200 x 200 Å2) was also used to study the combined effect of Na+ 
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and Mg2+. Since at this stage, the CHARMM model seems to better capture the 
physical properties of the membrane, the results for this model will be presented in 
more detail (additional results for AMBER models are reported in the Supporting 
Information section).  
 
Figure 14: Cardiolipin interactions with sodium. (a) Distribution of Na
+
 (orange) and water 
molecules (red) along the z-axis normal to the membrane surface. From left to right, data for 
the uCL, pCL and CL (mixed uCL/pCL) systems are reported for the CHARMM force field. (b) 
Radial distribution function g(r) and coordination number n(r) (orange) for Na
+
 with respect to 
CL phosphate oxygen atoms for simulations carried out with CHARMM force field. 
 
Figure 15: Cardiolipin interactions with magnesium. (a) Distribution of Mg
2+
 (purple) and 
water molecules (red) along the z-axis normal to the membrane surface. From left to right, 
data for the uCL, pCL and CL (mixed uCL/pCL) systems are reported for the CHARMM force 
field. (b) Radial distribution function g(r) and coordination number n(r) (purple) for Mg
2+
 with 
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respect to phosphate oxygen atoms for simulations carried out with CHARMM force field (see 
results for AMBER force field in SI section). 
In the unprotonated system, 90% of the Na+ and 85% of the Mg2+ are localized within 
4 Å from the membrane surface (Figure 14a and Figure 15a, respectively). The 
protonation leads to a broadening of the distribution, reducing to 55% the number of 
Na+ and 76% the number of Mg2+ within 4 Å from the surface. It is of interest to note 
that this proportion increases to ~ 89% for both cations when interacting with the 
mixed protonation state bilayer. Consistent with the experimental data, the phosphate 
groups constitute the main binding site for cations. On one hand, Na+ cations are 
partially buried in to the membrane (Figure 14a). These cations interact directly with 
the CL phosphate oxygen atoms (i.e. OA3 and OB4), corresponding to the first peak 
in the radial distribution function (Figure 14b). Several Na+ cations interact with a 
single cardiolipin molecule (Figure S6, for a representative CL – Na+ conformation). 
On the other hand, despite a few Mg2+ cations form direct interactions with the CL 
phosphate oxygen atoms, the main solvation structure indicates that CL – divalent 
cation interactions are water mediated. The most relevant peak found at ~ 4 Å 
corresponds to Mg2+ surrounded by their first solvation shell in an octahedral 
conformation, with water hydrogen atoms pointing towards the phosphate group or 
the bulk. The peak at ~ 6 Å mainly represents the other phosphate group of a 
cardiolipin, which interacts with a cation (see Figure S6 for a representative CL – 
Mg2+ conformation). For the unprotonated systems (uCL), each phosphate is able to 
interact globally with one cation in the first shell, whereas when one phosphate is 
protonated (pCL systems), the cation occupancy is nearly half (pCL system in Figure 
15 and Figure S5b). When the uCL and pCL moieties are mixed, the phosphate-
cation interactions are mixed as well, showing an improved ability, as compared to 
the pCL system, to globally attract cations close to the membrane surface. The area 
per lipid decreases significantly in presence of Na+ in the pure protonated or 
unprotonated cardiolipin patches (Table 1). The order parameters, however, are not 
modified and therefore do not contribute to this difference in the area per lipid. The 
effect of cations on the area per lipid is only marginal in the mixed protonated CL 
bilayer.  
The different CL protonation states produce a different electrostatic signature for the 
membrane surface, which is directly related to the CL ability to interact with cations 
and possibly other proteins and/or phospholipids. As expected, the uCL membrane 
surface displays a distinct strong negative charge, whereas the surface for pCL is 
less charged. This is consistent with the normal distribution of cations at the 
membrane surface (Figure 16). Cations are localized in contact with the most highly 
charged regions. Complex and intricate networks involving several cardiolipins were 
observed. In presence of monovalent cations, the cardiolipins form a very tight 
network trapping up to three Na+ per CL (Figure S6). In contrast, the cardiolipins form 
pockets composed of up to three lipids that are able to trap a Mg2+ cation (Figure S6).  
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Figure 16: Electrostatic properties of the CL-rich membrane surface. The electrostatic 
potential of the cardiolipin membrane surface was computed with APBS [26] and plotted on 
the molecular surface of the CL membrane. For sake of clarity, the uCL molecules are 
topologically identified with gray balls representing the phosphorus atoms connected by 
sticks. Similarly, pCL moieties are in blue. Na+ and Mg2+ cations are shown as orange and 
purple spheres, respectively. 
 
When Na+ and Mg2+ cations are both present in a mixed protonated CL bilayer, more 
cations are simultaneously interacting with at least one protonated and one 
unprotonated cardiolipin.  There is up to twice as many Na+ than Mg2+ interacting only 
with uCL molecules and at the interface of the protonated and unprotonated 
cardiolipins (Figure 17a).  In contrast, the pCL interacts almost equally with both 
cations. The radial distribution of Mg2+ within 6 Å of the membrane surface 
corresponds to the one expected for molecules which do not interact (Figure 17b). 
This indicates a random distribution of Mg2+ on the membrane surface. In contrast, 
Mg2+ radial distribution function with respect to Na+ shows a clear peak at 5 Å, which 
corresponds to Mg2+ and Na+ cations interacting simultaneously with the same 
cardiolipin molecules. The cardiolipins impose a structural order to the Na+ cations, 
via its direct interaction with the phosphate group. The interaction with the Na+ packs 
the CL head groups tighter, allowing a Mg2+ cation to be trapped above the Na+ 
(Figure S6). On the average, such an interaction involves a single Mg2+ and Na+ 
cation and represents ~ 5% of Mg2+ localized close to the membrane surface. 
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Figure 17: Cardiolipins in the presence of sodium and magnesium cations. (a) Number 
of cations interacting with only uCL molecules, pCL molecules and with at least one uCL and 
one pCL molecule (interface), and (b) Radial distribution function g(r) for Mg
2+
 with respect to 
Mg
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 and Na
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3.4.3 DISCUSSION  
Cardiolipins represent a unique anionic lipid species, which is only present in 
bacterial and mitochondrial membranes, and plays a key role in several cellular 
functions. To date only limited information concerning CL physicochemical properties 
is available. We therefore built and parameterized cardiolipin models for the 
commonly used AMBER and CHARMM force fields, to allow a further investigation of 
their fundamental role through molecular dynamics simulations. Since the pK2 of CLs 
is close to the physiological pH, two protonation states for the phosphate groups are 
likely to be present under normal conditions (an unprotonated (uCL) and the singly 
protonated (pCL) CL conformation); their properties, mutual interactions and 
interactions with cations are characterized for the first time in this study.  
Our model accurately reproduces the lateral diffusion coefficient and the area per 
lipid expected for lipid bilayers, with the CHARMM parameterization better capturing 
the physical properties of the membrane. This difference can be explained by the fact 
that AMBER acyl parameters have not yet been extensively tested and optimized for 
lipid bilayers. Recently, a new set of parameters for the acyl chains has been 
proposed [27]. Coupling these new parameters to our AMBER models of the head 
group can be a good starting point for further development.  
The asymmetry created by the protonation of the phosphate groups leads to a 
modification of the area per lipid (Table 1). Consistent with our observations, Khalifat 
et al. studied the effect of pH on the packing of cardiolipin-containing bilayer [28], and 
proposed that the change in area per lipid is the driving force for membrane shape 
instability. Moreover, the presence of cardiolipin domains and their pH-dependent 
packing could function as a proton sink. It has been suggested in fact that 
cardiolipins stabilize the proton gradient across the membrane necessary for ATP 
synthesis [29]. Since cardiolipins are also associated to the proton uptake pathway in 
the cytochrome bc1 complex, they may play a role in proton conduction [30]. The 
proposed models will therefore allow investigating the effect of CL protonation on 
these systems at the molecular mechanics level.  
A PDB data-mining was used to characterize the conformation space of cardiolipins. 
Event though, cardiolipins present in the PDB co-crystallized with proteins have a low 
statistical weight, and are not entirely representative of a bilayer conformation, the 
inter-phosphate distance and hydroxyl-phosphate angle measured from MD 
simulations nicely overlap with this distribution. This implies that the conformational 
space accessible to CL molecules forming a bilayer is greater, but largely overlaps 
with the one representing the interaction of CL with protein complexes. CLs thus can 
smoothly transition from the membrane phase to interacting with proteins without a 
specific contrasting conformational rearrangement. The higher CL binding affinity for 
specific protein regions would therefore be the only main driving force for CL-protein 
interactions. 
 
It is known that cations, especially divalent, influence the physicochemical properties 
of cardiolipins (e.g. transition temperature, non-lamellar macroscopic phases) [21]. 
The CL surface displays a net negative charge attracting the cations to the 
membrane surface. Consistent with experimental evidence, we observe that cations 
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interact primarily with CL phosphate groups [31,32,33]. Although the monovalent 
cations interact directly with the oxygen atoms, only few divalent cations are trapped 
in the first solvation shell of the phosphate. Their main mode of interaction is through 
water-mediated bridges with CL phosphates. Nonetheless, CL-rich membranes are 
able to attract a high concentration of cations from the bulk. The cations neutralize up 
to 96% of the membrane surface charge. Thus, the binding of the cations could 
modify the membrane surface electrostatic potential. Using NMR, Macdonald et al. 
[34] showed that the binding of Ca2+ is predominantly due to electrostatic effects, 
rather than to the intrinsic affinity with CLs. Furthermore, in addition to the screening 
effect, interactions with cations shape the complex network of cardiolipins, which 
form negatively charged cavities where the Na+ and Mg2+ cations are trapped. 
In a bacteria membrane, phosphatidylglycerol (PG) and CL are the major contributors 
to the membrane surface negative charge. Antimicrobial peptides (AMPs) are part of 
the immune system, and are characterized by a cationic amphiphilic nature, mirroring 
the properties of the bacterial membrane. During critical phases of an infection, such 
as cell division, the bacterial membranes are enriched in cardiolipins at the expense 
of PG [35]. Cardiolipins with their mixed protonation conformations could therefore 
constitute a key target for the AMPs. It has been shown in fact that cardiolipins and 
divalent cations modulate the binding of antimicrobial peptides to Gram-positive 
bacteria [36].  
In conclusion, the proposed models of cardiolipins have shown to be reliable and 
robust, and can reproduce the biophysical properties of cardiolipin-rich membrane 
portions. The availability of parameterized models accounting for multiple protonation 
states under physiological conditions will permit to build more realistic systems 
representative of the bacterial and mitochondrial membrane. This will allow gaining 
insight, through molecular simulations, into the biophysical properties of different 
membrane mixtures exposed to different environmental conditions, such as cation 
concentrations, AMP stress, and protein complexes interactions.  
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3.4.4 MATERIALS AND METHODS 
Structural models and parameterization of the cardiolipin polar heads 
The cardiolipin head group possesses two phosphate groups and can therefore carry 
up to two negative charges. CL pK2 (>7.5) is of the order of the physiological pH, 
therefore two protonation states for the cardiolipin head group were considered for 
building the initial models: CLs with unprotonated phosphate groups (uCL) and a 
singly protonated phosphate group (pCL) (Figure 11). Ideal head groups were initially 
built considering atoms between the phosphate groups (from atoms OA2 to OB2 in 
Figure 11c). Two methyl molecules were used to cap the head group, replacing atom 
CA3 and CB3 as shown in Figure 11c. 
An extensive search of the CL head group conformational space was carried out 
using Maestro[37]. A set of 991 conformers was generated. After minimization, 298 
structures were clustered and ranked according to the OPLS force field [38] based 
energy function. The twenty most representative structures were finally extracted and 
an ab initio geometry optimization was performed with Gaussian09 [39] at the 
B3LYP/6-311+G**[40] level of theory. For the CHARMM-consistent parameterization, 
the partial atomic charges were computed at RHF/6-31G* level of theory and 
optimized to reproduce the water interaction using the Force Field Toolkit plug-in[41]. 
For the AMBER models, the partial atomic charges were instead extracted and 
averaged from single point calculations at the HF/6-31G* level of theory. 
Finally, the atom types and bonded force constants were extracted directly from 
CHARMM36 [42] and general AMBER force field (GAFF) [43] parameter sets, 
respectively. This strategy ensures an optimal compatibility with both of the existing 
parameterizations. We completed the CL head models using the existing 
CHARMM36 parameterization for the acyl chains. The AMBER acyl parameters were 
instead extracted from the GLYCAM06 set [44]. These parameters, however, have 
not yet been finely tuned to reproduce the characteristics of acyl chains of 
phospholipids. The formatted topology and parameter files for MD simulations with 
the AMBER and CHARMM force fields are available in the Supporting Material. 
Molecular dynamics simulations 
We used molecular dynamics (MD) simulations to characterize the structural and 
dynamical properties of cardiolipin bilayers. In particular, tetramyristoyl cardiolipins 
were used for this study (Figure 11). Cardiolipins were assembled into a 60 x 60 Å2 
membrane patch composed of 50 lipids. The systems were then solvated in a 60 x 
60 x 80 Å3 water box.  
Na+ and Mg2+ were used to investigate the effect of monovalent and divalent cations 
on CL. Mg2+ is an abundant cation in nature and plays a central role in several 
biological processes. For example, Mg2+ is essential for the maintenance of the 
bacterial membrane and is required for the synthesis of cardiolipins [45]. Cardiolipins 
are also responsible for the Mg2+ inhibition of SecA [46]. NaCl or MgCl2 salts were 
added at a concentration of ~150 mM. A larger 200 x 200 Å2 cardiolipin patch 
composed of 450 lipids was assembled to study the ions interactions with CL when 
NaCl or MgCl2 are mixed at a concentration of ~150 mM.  
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All simulations were performed using NAMD [47] engine, with the CHARMM36 or 
AMBER ff99SB force fields [48]. TIP3P water [49] parameterization was used to 
describe the water molecules. The periodic electrostatic interactions were computed 
using the particle-mesh Ewald (PME) summation with a grid spacing smaller than 1 
Å. For the simulations performed with the CHARMM force field, the Van der Waals 
interaction with the cations was modified to correct the excessive binding (NBFIX) 
[50,51]. All systems were first minimized by 2000 conjugate gradient steps, and then 
equilibrated by using a linear temperature gradient that heated the system from 0 to 
300 K in 5 ns. All systems then were equilibrated for 10 ns at 300 K. Free molecular 
dynamics of all equilibrated systems were performed with a 2 fs integration time step 
using the RATTLE algorithm applied to all bonds. Constant temperature (300 K) was 
imposed by using Langevin dynamics [52], with a damping coefficient of 1.0 ps. A 
constant pressure of 1 atm was maintained with a Langevin piston dynamics [53], 
200 fs decay period and 50 fs time constant.  Each simulation was run up to 300 ns 
after the equilibration step (Table 1). Throughout the simulations, we monitored the 
order parameter, the area per lipid and the diffusion coefficient. We assumed that 
convergence was achieved, when the average and the standard deviation, computed 
on a 20 ns sliding window, reached a plateau (i.e. always within the first 100 ns of 
simulation). The analyses were performed on the last 150 ns of each simulation. 
A posteriori validation of the cardiolipin parameterization  
NWChem was used to carry out a quantum mechanics/molecular mechanics 
(QM/MM) microiteration-based geometry optimization [54]. A set of 50 representative 
bilayer structures was extracted from CHARMM and AMBER all-atom MD 
simulations. Head-groups (the glycerol and both phosphate groups) were then 
randomly selected and optimized at the QM level. The defined QM and MM regions 
were treated with a DFT/B3LYP [55] functional using 6-31G* [40] basis set and 
Amber ff99SB force field [43], respectively. The DFT convergence was set at 10-7 
Hartree. The MM charges were excluded for linked MM and QM atoms. A set of 300 
cycles with 500 QM and 10!000 MM iterations was performed to reach a 10-6 
convergence.  
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3.4.5 Supporting Information 
!
Figure S5: Cardiolipin interactions with divalent cations for CL models compatible with 
the AMBER force field. (a) Distribution of Mg2+ (purple) and water molecules (red) along the 
z-axis normal to the membrane surface. From left to right, data for the uCL, pCL and CL 
(mixed uCL/pCL) systems are reported when using the CHARMM force field. (b) Radial 
distribution function g(r) and coordination number n(r) (orange) of Mg2+ around phosphate 
oxygen atoms for simulations carried out with AMBER force field. 
!
!
Figure S6: Coordination of cations around CL molecules. (Left) A single cardiolipin 
molecule interacts with up to three Na+ cations (orange). The cation interacts directly with the 
phosphate group (see Figures 4 and 6 of the main text). (Middle) Four cardiolipins (in cyan) 
trap a Mg2+ cation (purple) with its first solvation shell. The phosphate groups interact directly 
with the solvation shell are localized at ~4 Å from the cation, whereas the second phosphate 
group is localized at ~6 Å. (see Figures 5 and 6 of the main text). (Right) Na+ cations bring the 
CL head group closer allowing it to trap a Mg2+ cation. 
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3.5 Lipid Builder for membrane models 
The physicochemical properties of the different lipid species are essential for the 
structural and functional organization of the biological membrane. They play a key 
role in the segregation of membrane domains, the formation of non-bilayer structures, 
and the interactions with proteins. The lipid head groups are not the only important 
determinants of a membrane. The nature of the lipid acyl chains strongly influences 
membrane properties. They define the membrane thickness and fluidity, and 
consequently the orientation of the membrane proteins. Unsaturation changes the 
packing of the lipids and creates defects in the bilayer, which affect the insertion of 
molecules and peptides. Due to the increase in computational power, it is now 
possible to simulate large membrane systems composed of a complex mixture of 
lipids.  
To facilitate the creation of templates and topology files, a VMD plug-in based on the 
CHARMM force field was implemented. Based on the SMILE structure of the acyl 
chains, the creation of the corresponding phospholipid is fully automatized. First, the 
lipid!s topology is created by combining the selected phospholipid head groups, 
extracted from a built-in library of structures and the provided acyl chains. Since the 
acyl chains have been parameterized based on a “plug and play” philosophy in the 
CHARMM force field, the acyl chains are generated by linking a series of alkanes. 
Three different classes of hydrocarbons have been defined: saturated, unsaturated 
and cyclopropane. We used the refined QM-based parameters to better describe the 
cyclopropane ring [1]. This cyclic moiety has frequently been neglected in the MD 
simulations of bacterial membranes. They are however present in many species of 
bacteria and increase the lipid surface area. Finally, the psfgen algorithm and the 
generated topology file were combined to build the template PDB and PSF files of the 
phospholipids [2]. 
Using this plug-in, a realistic bacterial membrane composed of the 20 main species 
of E. coli phospholipids was assembled. The bilayer is a model of the pole region 
characterized by a cardiolipin rich domain. It is composed of 50% cardiolipins, 35% 
PE and 15% PG (Figure 18). We combined the results of two mass spectrometry 
experiments to define the acyl chain composition of the lipids [3,4]. The analysis of 
this membrane model using MD will be important for better understanding the 
biophysical properties of the bacterial membrane and for guiding the rational design 
of novel antibiotics mimicking the AMP mechanism of action. 
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Figure 18: LipidBuilder. (a) The graphical user interface of LipidBuilder, and (b) the 
membrane bilayer of a cardiolipin-rich domain. Each lipid type is displayed in a different color. 
!
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3.6 Conclusions and Perspectives 
!
The pharmacological use of antimicrobial peptides represents a promising alternative 
to conventional drugs. Their use and future development however require a better 
knowledge of bacterial sensory systems and membrane response. Therefore, this 
thesis work focused on producing accurate models of the bacterial chemosensor 
PhoQ and membrane constituents. 
PhoPQ TCS senses the host environment via antimicrobial peptides and acidic pH. 
Since two-component systems appear to be absent in the animal cell, they also 
represent a promising target for the development of synthetic antimicrobial drugs. A 
significant obstacle in the understanding of signal transduction is the lack of a full 
atomistic model for the signaling TCS machine. Therefore, the assembly of an 
atomistic model of the PhoQ TCS was carried out in this thesis project. The 
structures of certain domains of the PhoQ have already been solved, and others 
were produced by comparative modeling here. A structural model of the 
transmembrane region is crucial for understanding signal transduction across the 
membrane. However, no structure or homology-model is available and its modeling 
represents a major challenge. The final PhoQ model produced by linking these 
different sub-domains (Figure 10) supports a transduction mechanism consistent with 
available mutagenesis studies and could help to rationalize the sensing of 
antimicrobial peptides and the design of antimicrobial drugs. PhoQ plays a key role in 
the sensing the host environment and the regulation of the transcription of genes 
promoting bacterial resistance to antimicrobial peptides. Therefore the inhibition of 
PhoQ could impair the virulence of some species of bacteria (e.g. Salmonellla 
typhimurium) and improve the efficiency of  current antimicrobial peptides. 
Antibiotic selectivity is based on fundamental biochemical differences between 
microbial and mammalian cells. Membrane composition appears to highly affect the 
selectivity of AMPs. Models for a realistic bacterial membrane whose composition is 
as close as possible to cellular conditions are therefore desirable. In this context, 
cardiolipin species, which are key components of the bacterial membrane, were 
successfully parameterized and characterized. Using these models, the investigation 
of a large system representative of the bacterial membrane at the pole region is 
currently being carried out (Figure 18), with the hope of better analyzing and 
understanding the distinctive anionic features relevant for antibiotic resistance. 
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4 Amyloid Precursor Protein
4.1 The flexibility of the transmembrane domain of the 
amyloid precursor protein  
Submitted as the following paper:  
“The amyloid precursor protein APP-TM is highly flexible and adapts to the lipid 
environment ”, 
Lemmin T., Dimitrov M., Fraering P. C., and Dal Peraro M. 
 
4.1.1 Introduction 
The aggregation of amyloid-! (A!) peptides and the formation of extracellular A! 
plaques in brain tissue have been associated to the neuropathological process of 
Alzheimer"s disease (AD). A! is a 38 – 42 amino acid long peptide (#!38 – 42) 
contained within the C-terminal fragment of the Amyloid Precursor Protein (APP), a 
type-I transmembrane glycoprotein. A! is produced by the sequential cleavage of 
APP by !- and $-secretases. The !-secretase first cleaves the extracellular domain 
of APP, producing a 99 amino acid long transmembrane protein, referred to as APP-
C99. Then, the proteolytic cleavage of APP-C99 by $-secretase occurs within the 
transmembrane domain, releasing A! peptides.  
The neurotoxicity of A! depends on the peptide length and therefore on the position 
within APP-C99 of the $-secretase cleavage site. In Alzheimer"s patients, the ratio of 
A!42 versus A!40 is significantly increased. Effort has therefore been invested into 
characterizing the structure and dynamics of APP-C99 and how this substrate would 
interact with $-secretase. Mutations in or adjacent to the transmembrane region have 
a drastic effect on cleavage at the $-site. More than half of the mutations in APP 
causing early-onset familial AD are found in its transmembrane domain (TM) (3). 
Moreover, the interaction of the APP-TM with the membrane environment, in 
particular with cholesterol, Cu2+ and Zn2+ metal ions, alter the structural and 
dynamical properties of the protein (4, 5). 
Until recently, only a theoretical structure existed for the APP transmembrane 
domain. Miyashita et al. (6) used molecular dynamics simulation (MD) in implicit 
solvent to build and study a first atomistic model of the APP transmembrane domain. 
They observed that G708 and G709 play an important role in the flexibility of the 
helix. This mechanism can stabilize the TM domain in the membrane, allowing it to 
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adapt to the fluctuations of the membrane thickness. These residues are close to the 
!-site and may directly influence cleavage. The APP-TM contains two GXXXG motifs 
(Figure S7), which are believed to mediate dimerization in transmembrane proteins 
(7). Mutations of the GXXXG motif also lead to a drastic decrease in the secretion of 
A"42 (8-10). Molecular dynamics simulations in implicit solvent showed that these 
mutations shifted the position of the !-site in the membrane (11). Recently, two NMR 
structural ensembles have been solved. Nadezhdin et al. (2) determined the structure 
of APP-TM (Q686 – K726) in  dodecylphosphocholine (DPC) detergent micelles 
(PDB code: 2LLM, Figure 1a). The structure features a short N-terminus juxta-
membrane helix (K687 – D694) and a 24 amino acid transmembrane helix (G700 – 
L723). A minor bend (~16 degrees) is observed at residues G708 – G709. These 
residues, located in the middle of the TM, can act as a hinge to compensate for the 
fluctuation of the membrane thickness.  
Barrett et al. (1) solved the NMR structure for the helical domain of APP-C99 (V683 – 
Y728) in lysomyristoylphosphatidylglycerol (LMPG) detergent micelles (PDB code: 
2LP1, Figure 19a). The N- and C- termini are mostly unstructured, except for a short 
C-terminus helix, whereas the transmembrane domain is characterized by a highly 
curved !-helix (~115 degrees at G708 – G709). To validate the biological relevance 
of this kink, double electron-electron resonance (DEER) spectroscopy was used to 
estimate the distance between the ends of the TM domain in lipid bilayers. 
Methanethiosulfonate (MTSL) spin labels were attached to residues G700 and L723, 
mutated beforehand to cysteines. The distance measured in the micelles and lipid 
vesicles were nearly identical, thus providing indirect evidence that APP would also 
be curved in lipid bilayers.  
In order to explain the existence of these divergent structures (Figure 19a) and to 
obtain detailed insights into the dynamic properties of APPs, we used molecular 
dynamics simulations to understand the effect of the different experimental conditions 
on the APP transmembrane conformations. We show that the kink observed in the 
APP NMR structures is largely reduced when inserted into a more physiological lipid 
bilayer environment. The relative conformational space of APP is strongly influenced 
by the size of the micelles and by perturbations introduced by specific mutations and 
spin labels. Taken together our results support a conformation for the APP 
transmembrane domain that is mainly populated by straight #-helical structures when 
embedded in a membrane bilayer. This conformation however shows a significant 
flexibility at the G708 – G709 region, which explains the multiple conformations that 
have been observed. This flexibility may have functional implications for !-secretase 
presentation during proteolytic processing.  
4.1.2 Results 
We carried out an extensive set of MD simulations of APP-TM structures considering 
their embedment into a palmitoyloleolyphosphatidylcholine (POPC) lipid bilayer and 
LMPG micelles. We compared and validated our results with available experimental 
data (namely, NMR and EPR (1)). We also tested the effect of the experimental 
protocols; such as those produced by spin labeling of APPs. MD simulations of 
proteins in the membrane might require a long simulation time to reach equilibrium. 
We therefore used enhanced sampling techniques such as metadynamics to explore 
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the dynamic determinants of the APP-TM domain and to reconstruct the 
corresponding free energy landscape under relevant external conditions (12). 
The APP-TM domain has a predominantly straight helical conformation 
in a membrane bilayer. 
We used molecular dynamics (MD) to study the structural and dynamic properties of 
the APP transmembrane domain. We considered the two available NMR structural 
ensembles  (PDB codes 2LLM and 2LP1), referred to hereinafter as APP2LP1 and 
APP2LLM, respectively. APP2LLM is solved as a mostly straight !-helix with a small 
concavity near G708 – G709, whereas the APP2LP1 structure is characterized by an 
important kink at this region. To characterize these structures in a physiological-like 
environment, we inserted them into a 60 x 60 Å2 membrane bilayer formed by 
phosphatidylcholine (POPC), which is a major lipid constituent of the synaptic plasma 
membrane (13). The MD simulations were carried out under physiological-like 
conditions (e.g., pH ~7, 1 atm and 300 K, Figure 19b). 
When inserted into the POPC bilayer, the secondary structure of both APP NMR 
structures fluctuates only marginally and preserves an !-helical conformation. The 
transmembrane domain of APP2LLM remains very close to the initial NMR structure 
(RMSD 1.86 ± 0.19 Å). The important bend observed in the APP2LP1 initial structure 
straightens within the first 20 ns of simulation and remains straight throughout the 
rest of the simulation (>300 ns, Table S1). The final structures for the transmembrane 
domain, starting from both initial conformations, are nearly identical (RMSD 1.26 ± 
0.14 Å) and are characterized by a straight TM !-helix with a small kink at the paired 
residues G708 – G709 (Figure 19b). The APP2LLM TM helix tilts slightly less with 
respect to the membrane surface compared to APP2LP1 (~20 ± 7 and ~36 ± 5 
degrees, respectively). We also observe a different behavior of the N-terminus 
domain. Consistent with the NMR observations and theoretical models, the APP2LP1 
N-terminus amphiphilic helix (Q686 – N698) lies on the membrane surface, and a 
lysine belt (K687, K699, K724 – 726) anchors the TM and N-terminus helices, 
respectively, in and onto the membrane. In the APP2LLM, an extra turn forms at the N-
terminus of the TM domain (S697 – K699), hindering the interaction of the N-terminus 
helix with the membrane surface. This is however consistent with the NMR 
ensembles, where this terminal helix is flexible and explored a broad spectrum of 
conformation (angles ranging from 75º – 180º with respect to the TM domain). 
The water molecules interact mostly with residues close to the membrane interface 
(G700, A701, L720 and L721), and a small solvation is observed in the core of the 
TM domain, where water molecules interact with G708 or G709 (Figure 19c). The 
water molecules access the TM core from the N-terminus by interacting with the 
G29XXXGXXXG37, or from the C-terminus by interacting with the residue T719 side 
chain (Figure S1).  
In order to characterize the free energy landscape associated with the helix bending 
in a membrane bilayer, we defined the two dihedral angles " and #, respectively 
connecting the backbone nitrogen atoms of G708 to G709 and G709 to V710. 
Consistent with the unbiased MD simulations, the metadynamics trajectories showed 
that the POPC bilayer presence strongly confines the APP-TM structure to a well-
defined straight helical conformation (minimum at [-35º; -43.5º], Figure 19d). The free 
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energy penalty needed to explore bent conformations similar to the APP2LP1 NMR 
structures is as high as 6-7 kcal/mol, suggesting that in the membrane environment, 
a straight conformation is more populated than the curved one. 
 
 
Figure 19: APP-TM under physiological conditions. (a) The NMR structures of the APP-
TM domain (PDB code: 2LLM (2) and 2LP1 (1)). The hypothetical micelle sizes inscribing the 
protein are displayed with transparent spheres and are based on the experimental setup 
reported in (1, 2), (b) Representative MD snapshots of the NMR 2LLM (left) and 2LP1 (right) 
structures after 200 ns in a POPC bilayer, (c) The relative level of solvation of each APP-TM 
residue for the two systems in the bilayer and (d) Free energy landscape associated to ! and 
" dihedral angles connecting the nitrogen atoms of G708 to G709 and G709 to V710, 
respectively, as calculated by metadynamics MD. The average NMR conformations relative to 
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the straight 2LLM [-41º; -46º] and bent 2LP1 [-1º; 13º] ensembles are reported by green 
asterisks. 
The APP-TM domain explores !-helical kinked conformations in 
detergent micelles. 
Since both NMR structural ensembles were solved in detergent micelles and not in a 
lipid bilayer, we used MD simulations to study the behavior of APP when embedded 
in micelles having properties mimicking the experimental setup. The APP2LP1 NMR 
ensemble was used as starting structures in order to investigate if its tertiary 
structure could be stabilized by the micelle. The micelles inscribing the APP2LP1 and 
APP2LLM NMR structures are reported to have different sizes (Figure 19a) due to the 
different lipid detergents used in the experiments. Two systems containing the juxta-
membrane and TM helices (residues V683–Y728) embedded into different micelles 
were therefore assembled. As in Barrett et al. (1), a 35-Å diameter micelle was 
considered for the first system (M35), whereas a larger micelle (i.e. 45 Å diameter) 
was used in the second system (M45) to study the dependence of the APP 
conformation on micelle size. Each micelle was first equilibrated separately in a water 
box. The micelle assembly converged and remained stable after 50 ns. The protein 
was then inserted into the micelle and the simulations were extended for at least an 
extra 150 ns. Since the NMR spectra were measured at 45 oC, we performed 
simulations under physiological conditions  (300 K) and at a higher temperature (318 
K) consistent with the experimental setup (Table S1). 
The M35 micelle severely affects the structure of APP. The size of this micelle is too 
small to fully accommodate the TM helix, thus exposing the helical interface that 
encloses the G29XXXGXXXG37 motif to the solvent (Figure 20a). The T714 and T719 
hydroxyl groups and the G700, G704, G708 and V711 backbone atoms participate 
the most in the interaction with water molecules (Figure 20b). The TM helix is highly 
curved, kinking either between residues G708 and G709, which is consistent with the 
NMR, or more rarely between residues G709 and V710. The larger M45 micelle can 
better accommodate the transmembrane domain (Figure 20a). The structure 
alternates between a curved and straight structure, with a preference for the latter 
one. Similar to M35, but to a lesser extent, the threonine side chains and glycine 
backbone interact with water molecules (Figure 20b). The solvation of the TM domain 
therefore seems to be the major driving force producing a kink in the APP-TM 
domain. Since only one interface is exposed to the solvent, solvation is observed with 
the same periodicity as the helical motif (Figure 20b). Consistent with the NMR 
structure, the amphiphilic N-terminus helix lies on the surface of the micelles. Heating 
of the system to 318 K, as in the experimental setup, only marginally affected the 
APP structure. The ensemble of conformers remained comparable to the one at 300 
K (population RMSD 2.86 ± 0.69 Å and 3.01 ± 0.39 Å, respectively).  
The NMR APP2LP1 structural ensemble however is characterized by a single 
conformation of the TM backbone. In order to explain the discrepancy between our 
observations and the NMR results, we decided to back-compute the residual dipolar 
couplings (RDCs). The RDCs provide long-range structural information and can be 
used to estimate the fold of proteins. They have been shown to be in good 
agreement with the results of MD simulations (14). Since the exact characteristics 
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and composition of the NMR sample cannot be defined, we used a genetic algorithm 
(GA) to select an ensemble of conformers that would best fit the experimental RDCs. 
A set of 3000 structures was first extracted from the MD simulations performed in 
both M35 and M45 (similar results were obtained by a separate analysis of the M35 
and M45 systems). For each structure, the backbone N–H vector was defined and 
the alignment tensor was computed using singular value decomposition (SVD). 
Based on several runs of the GA, on the average, a set of 500 structures was able to 
best fit the experimental RDCs. The correlation of these back-calculated RDCs 
extracted from the MD trajectories was comparable to the one calculated for the NMR 
ensemble (Q-factor 0.23 and 0.31, respectively, Figure S8a). The selected structures 
were finally grouped into 33 structures composed of straight and bent helices 
obtained from the M35 and M45 simulations (Figure S8b). This provided a solid 
indication that APP is able to explore a larger and more heterogeneous set of 
conformations in the micelle environment, as documented by MD simulations. 
Finally, metadynamics simulations in M35 and M45 micelles were used to more 
exhaustively explore the conformational space of APP (Figure 20c). The free energy 
landscape for both micelles validated the unbiased simulations where the structures 
inserted into a micelle could freely explore the bent and straight conformations on a 
multi-nanosecond timescale. The barrier to pass from the straight helix minimum 
(slightly more populated) to a bent structure is in fact in the order of ~3 kcal/mol, and 
it is thus accessible via thermal fluctuations (Figure 20c). Consistent with our 
simulations, the conformational space associated with this transition is expected to 
be sampled on a ~102 ns time scale. 
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Figure 20: APP-TM in a water-micelle environment. (a) Representative MD snapshots of 
the APP2LP1 TM domain embedded into LMPG micelles of different sizes (35 and 45 Å, 
called respectively, M35 and M45) are shown. Glycine and threonine residues shown in blue 
are mainly exposed to the solvent. A focus of the G708-G709 region exposed to water 
molecules is reported in the inset, (b) The distribution of the water molecules solvating the 
TM-APP tract is reported for the M45 and M35 systems and (c) Free energy landscape 
associated to ! and " dihedral angles as calculated by metadynamics MD on the M45 
system (similar results obtained for M35 are shown in Figure S9). The green asterisk 
indicates the average NMR conformation relative to the 2LP1 ensembles. 
The APP-TM segment responds to structural perturbations by exploiting 
its flexibility 
Electron paramagnetic resonance (EPR) power saturation methods can be used to 
measure the membrane depth of a protein. By monitoring the collision rate of a spin 
label with a paramagnetic relaxation agent, the solvent accessibility of the label can 
be estimated. Methanethiosulfonate (MTSL) is a commonly used nitroxide spin label, 
covalently bonded to genetically engineered cysteines in the protein (Figure 21a). 
The depth parameter is determined by the ratio of the collision rate of two different 
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probes (e.g. oxygen and Cr(C2O4)
3-) with the label and can be defined as a function 
of the distance of the label from the phosphate group (15, 16). EPR double electron-
electron resonance (DEER) has become a popular method for measuring the 
distance distributions between paramagnetic spin labels in proteins (17) when two 
MTSL labels are bonded to cysteines. The DEER technique has the advantage that it 
neither requires the crystallization of the protein complex nor is it limited by the 
complex size. Distances in the range of 18 Å to 60 Å can be measured in 
biomolecules (18-20).  
We used the EPR data reported by Barrett et al. (1) to clarify and rationalize our MD 
observations for the APP structure in the membrane bilayer. We also performed 
several point mutations in the APP-TM in order to characterize their impact on the 
tertiary structure. !wo mutation sites (G700 and L723) used for the insertion of the 
MTSL spin labels in the DEER EPR were considered. First the single and the double 
mutants (G700C, L723C and G700C/L723C) were inserted into a POPC membrane 
and simulated under physiological conditions. The mutation on the G700 site 
significantly affected the structure and the dynamics of the APP. The position of the 
N-terminus helix on the membrane significantly differed from the wild-type (Figure 
S10). This mutation changes the flexibility of the loop connecting the juxta-membrane 
helix to the TM domain. The solvation of the APP-TM core is therefore also affected 
(Figure S11). In contrast, the L723C mutation did not significantly alter the structure 
of the APP. The tilting and position of the juxta-membrane helix remained similar to 
the WT.  
For all three mutants, we attached a MTSL spin label to each cysteine (G700CM, 
L723CM and G700CM/L723CM). Again, the G700 mutations perturb the APP 
structure the most, with the TM helix remaining strongly curved and the N-terminus 
helix rearranging itself on the top of the membrane. The helix started to slowly 
straighten after 130 ns of simulation (Figure S10). The G700CM/L723CM system was 
therefore extended to 300 ns during which time the helix remained fully straight. As 
observed previously, the L723CM single mutant only marginally affected the APP 
structure, with the transmembrane domain remaining straight, as in the wild-type 
conformation. 
The depth parameter of APP inserted in the lipid bilayer was computed for the 
straight and curved structures of the G700CM/L723CM mutant, respectively (Figure 
21b). A representative population composed of 500 structures (over 50 ns) was 
extracted for each conformation. The power saturation profile of the straight structure 
better matches the experimental values than the curved one (correlation coefficient 
0.96 and 0.88, respectively). Consistent with the experimental data, the most buried 
residues are located at around V711 for the straight structure. This maximum shifts 
from V711 to I716 for the bent structure. The profile of the bent helix for the flexible 
domain (G700 – G709) better matches the experimental values. As observed during 
simulations, this region is easily perturbed by the experimental protocol and bent 
when spin labels were attached. 
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Figure 21: Effects of spin-labeled probes in EPR experiments. (a) Cysteine thiol side 
chain reacts with the MTSL spin label and produces a spin-labeled side chain, (b) The 
membrane depth parameter measured experimentally (1) (shown in green) is compared to the 
corresponding value computed from MD simulations for the straight and curved spin-labeled 
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TM conformation in black and red, respectively. Positive values indicate burial into the 
membrane, (c) Representative MD snapshots of the MTSL spin labels attached to the curved 
(left) and straight (right) APP (a solid line indicates the average position of the membrane 
bilayer). The black circles outline the possible conformational space accessible to the MTSL 
in solution; due to the hydrophobic nature of the MTSL tag, the membrane restricts this 
conformational space (highlighted in grey), (d) The MTSL distance distributions are compared 
as reported from DEER experiments (1) (in green), as predicted by using MMM for the MD 
ensembles of curved and straight conformations (in red and black dashed lines, other 
predictions are reported in Table S2), and as measured from unbiased and metadynamics 
MD simulations of the G700CM/L723CM system (in blue) and (e) Free energy landscape 
associated to ! and " dihedral angles as calculated by metadynamics MD for the 
G700CM/L723CM system. The average curved [0º; -20º] and straight [-40º; -37º] 
conformations shown in (c) are indicated by green asterisks.  
The predicted distance distribution calculated using three different DEER prediction 
algorithms (MMM (21), mtsslWizard (22), and Pronox (23)) were compared for the 
straight and curved helical conformations extracted from MD simulations. All three 
algorithms predicted a similar distance and on the average, the distance for a bent 
helix was 31.3 ± 3.7 Å, and 38.9 ± 4.4 Å for the straight helix (Figure 21d for MMM 
prediction, and Table S2). When compared with the experimental distribution, these 
predictions support a more curved helical conformation. However, the straight 
conformation cannot be excluded, since these algorithms are parameterized to 
predict the distance of proteins in solution (17). The presence of the membrane 
would limit the flexibility of the probes and, most importantly, can strongly trap their 
hydrophobic regions. We therefore decided to extract the position of the N–O bond 
from the MTSL tags during MD simulations and compute the corresponding distance 
distribution (Figure S12). As expected, the distributions systematically shift towards 
shorter distances in comparison to DEER prediction algorithms. This difference is 
well pronounced for the straight helix distribution, and is comparable to the bent helix 
distribution. Due to the hydrophobic nature of the spin labels, they are buried deep 
into the membrane, thus limiting the conformational space of their rotational degrees 
of freedom (Figure S13). Furthermore, the presence of this anchor allows the TM 
helix to explore a bent conformation in the membrane bilayer. 
Metadynamics simulations confirmed that by adding MTSL labels to APP at positions 
700 and 723, the structure acquired an increased flexibility compared to the wild-
type, and was able to explore more curved structures, as was observed in the micelle 
environment. A straight conformer is however slightly more preferred by ~1 kcal/mol 
over a bent conformation (Figure 21e). This is consistent with the observation in free 
dynamics, where the bent helix straightens. Since the ! dihedral explores more freely 
its conformational space, G708 may confer more flexibility to the APP-TM domain. 
Based on the free energy landscape, we built an ensemble of conformers that follow 
a Boltzmann distribution. The distance distribution computed for this ensemble allows 
to better account for the broad distribution observed experimentally (Figure 21d), and 
strongly hints to a heterogeneous population alternating between straight and bent 
APP conformations. 
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4.1.3 Discussion 
The alteration in the proteolytic cleavage of the APP transmembrane domain has 
been linked to the pathogenesis of Alzheimer!s disease. The absence of direct 
structural information on the APP/"-secretase complex currently hinders a complete 
understanding of the enzymatic mechanism and its pathogenic implications. 
Recently, two structures of the APP transmembrane domain were solved using NMR 
(PDB code: 2LLM and 2LP1), thus providing new insights into the instrinic properties 
of APP. In the first structural ensemble, the APP-TM is mainly defined by a straight 
helical conformation, whereas an important bend is observed at residues G708 – 
G709 for the second reported NMR ensemble. Since these structural ensembles 
have been solved in detergent micelles, they are not fully representative of the APP 
embedded into its natural environment. In this study, we used molecular dynamics 
simulations coupled to NMR and EPR data to dissect the structural and dynamical 
properties of the transmembrane domain of APP when inserted into micelles and into 
a membrane bilayer that is more representative of the neuronal synaptic envelop.  
We found that once inserted into a lipid bilayer, the transmembrane domain of the 
APP mainly adopts a straight helix conformation that is consistent with the 2LLM 
structural ensemble. The TM domain is characterized by a dynamic structure, in 
which the paired residues G708–G709 confer flexibility to the transmembrane domain 
and allow it to adapt to the fluctuations of the membrane thickness. To rationalize the 
origin of the discrepancy between the structure of APP in a bilayer and in micelles, 
we modeled as closely as possible the experimental conditions. We first inserted 
APP into micelles of different sizes, and observed that the curvature of the TM 
domain is enforced by smaller micelle sizes (~ 35 Å). The driving force for the 
formation of the bend is the solvation of the G29XXXGXXXG37 motif, which is largely 
exposed to the bulk solvent. The APP-TM is less exposed to the solvent in the larger 
micelles (~ 45 Å), favoring the straighter conformer. Since different surfactants (DPC 
and LMPG, respectively) composed the micelles used for the NMR spectroscopy, the 
APP2LLM structure was probably embedded into larger micelles, producing a much 
straighter conformation. The exact characteristics of the NMR samples however are 
difficult to determine. In order to gain insight into their composition, we compared the 
experimental and back-calculated MD RDCs. The RDC measurements provide long-
range orientation restraints and are therefore widely used for NMR structure 
determination. A genetic algorithm was used to extract an ensemble of structure 
correctly reproducing the experimental results. A heterogeneous population of 
straight and bent helices was obtained, suggesting as observed in MD simulations, 
that the APP-TM backbone can adopt several different conformations. These results 
are also consistent with the free energy landscape of APP in micelles, where we 
observed that APP could explore almost freely the conformational space associated 
to the TM bending. 
To give further support to our model, we compared it to the EPR power saturation 
and DEER experiments used to analyze the structural characteristics of APP-C99 in 
the POPC liposome (1). EPR power saturation allowed estimating the burial of each 
residue in the membrane. Based on the MD simulations performed in the POPC 
membrane, a straight transmembrane helix model better matches the reported EPR 
power saturation profile (Figure 21b). By enforcing a bend as observed in the APP2LP1 
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structure, the most buried amino acid shifted by 5 residues. The length of the 
transmembrane domain was measured by the EPR DEER experiments.  Cysteine 
mutations were performed at positions G700 and L723, in order to covalently bind 
MTSL spin labels. The MD simulations showed that mutations of G700 significantly 
affected the dynamical behavior of APP. G700 is the last residue of the loop 
connecting the juxta-membrane domain to the TM domain. Therefore, perturbing this 
region directly affects the APP backbone flexibility, causing the juxta-membrane 
domain to rearrange itself (Figure S10). This increases the solvation of the TM N-
terminus, and in turn perturbs the entire TM domain. When the MTSL spin labels are 
bound to G700C, we observed that the dynamical properties of the TM domain are 
even more dramatically affected. The curved and straight conformations of the TM 
helix were observed in the POPC bilayer, with a slight preference for the latter one. 
The deep burial of the MTSL spin label into the membrane surface forces the APP 
helix to bend. The MTSL spin labels have shown a preference for hydrophobic 
cavities (17, 24). In the presence of a membrane, these markers have a tendency to 
bury themselves into the hydrophobic core of the membrane. The differences 
observed between the predicted distance distribution and the one extracted from MD 
simulation could be explained by the fact that the rotamer libraries used for the MTSL 
prediction algorithms are based on long simulations in solution (17). They are 
therefore not able to consider the effect of the hydrophobic environment of the 
membrane. Once buried into the membrane, the spin labels can no longer explore 
the full conformation space, biasing the expected simulated distance towards shorter 
distances. The broad distance distribution observed experimentally is caused by the 
simultaneous presence of the straight and kinked helices, as documented by MD 
simulations. The Boltzmann distribution of structures derived from the measured free 
energy landscape, matched the most accurately the experimental results. Consistent 
with experimental findings, the free energy landscape also confirmed that G708 
confers more flexibility to the APP-TM (1). By mutating this residue, the flexibility is 
reduced, thereby biasing the structure towards a straighter helix. This produces a 
much sharper DEER distance distribution. 
In conclusion, APP appears to be a highly dynamic structure that can easily adapt to 
changes in the lipid environment. In this context, the atomistic interpretation of 
experimental data accessible by enhanced sampling molecular dynamics simulations 
was fundamental in discovering that APP, while having preferential conformers under 
different conditions, is better described by a dynamic ensemble of conformations that 
explore the intrinsic flexibility encoded in the G708-G709 motif. Alterations in the 
membrane composition, especially the concentration of cholesterol, have been linked 
to AD. It is hypothesized that they affect the formation and insertion of the plaques 
(25-27). Since a change in the concentration of cholesterol would also affect the 
flexibility and thickness of the membrane (28), the structure of the APP-TM domain 
would probably also be affected. In addition, the mutations causing familial AD might 
affect the flexibility of the TM domain and therefore alter the cleavage profile of the 
APP. The low-resolution cryo-EM map of !-secretase suggests a possible 
arrangement of the "-helical binding site, which might favor a curved structure of the 
APP substrate (29, 30). Therefore, the curved APP2LP1 structure observed in micelles 
could be better accommodated and bind to the !-secretase  active site (1). The 
observed flexibility of APP could play two key roles in !-secretase-mediated 
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proteolysis. First, the induced shift would be essential for exposing the consecutive 
cleavage sites to the !-secretase. Second, the bending could recruit, as in micelles, 
water molecules required for catalytic cleavage at the hydrophobic core of the 
membrane.  
 
4.1.4 Material and Methods 
Molecular dynamics (MD) simulations were used to characterize the structure of APP 
in micelles and membrane bilayers, under the effect of different experimental 
conditions. The NMR structure (PDB code 2LP1, (1)) was inserted and equilibrated in 
35 Å and 45 Å lyso myristoyl phosphatidyl glycerol (LMPG) micelles and in a 60 x 60 
Å2 palmitoy loleoly phosphatidyl choline (POPC) patch (31). To test the effect of the 
spin labels used for DEER spectroscopy, we performed cysteine or MTSL bound to 
cysteine (CM) point mutations on the APP. In total, seven APP mutants (5 single 
mutations (G700C, G700CM, G700C, G700CM and G700W) and 2 double mutations 
(G700C/L723C and G700CM/L723CM) were inserted into a 60 x 60 Å2 POPE 
membrane. All systems were solvated in a 15 Å padding water box, neutralized by 
the addition of NaCl at a concentration of 150 mM (Table S1). 
All simulations were performed using NAMD 2.8 (32) engine, with the CHARMM27 
force field (33), including CMAP corrections for the protein and CHARMM36 for the 
POPC membrane (34). The parameters of the MTSL spin label were extracted from 
the work of Sezer et al. (9). TIP3P water (35) parameterization was used to describe 
the water molecules. The periodic electrostatic interactions were computed using 
particle-mesh Ewald (PME) summation with a grid spacing smaller then 1 Å. 
Constant temperature (300 or 318 K) was imposed by using Langevin dynamics (36) 
with a damping coefficient of 1.0 ps. Constant pressure of 1 atm was maintained with  
Langevin piston dynamics (37), 200 fs decay period and 50 fs time constant. All 
systems were equilibrated for 20 ns at 300 K. Free molecular dynamics were 
performed up to hundreds of ns timescale with a 2 fs integration time step using the 
RATTLE algorithm applied to all bonds. The list of simulations is reported in Table S1 
for a cumulative simulation time of 2 "s. 
Metadynamics is used to enhance the sampling of the conformational space and to 
retrieve the associated free energy landscape. Gaussians are added to the energy 
surface and force the system to escape from local minima. This technique requires a 
priori knowledge of the degrees of freedom relevant to a conformational change. In 
the current systems, the observed conformational change was described by means 
of two collective variables representing the dihedral angles # and $, which connect 
the nitrogen atoms of G708 to G709 and G709 to V710. These angles allow the 
sampling of the different kinked conformations observed for the TM domain in the 
NMR structures. A set of three metadynamics simulations (~30 ns each, Table S1) 
was performed using the collective variable module of NAMD. Gaussians of width 0.3 
and weight 0.01 were inserted every 300 fs. The conformational space was sampled 
from -75 to 10 degrees for # and $ (Figure 19d, Figure 20d, Figure 21e). 
The residual dipole couplings (RDCs) were back calculated based on the orientation 
of the backbone N–H bond vector. A singular value decomposition (SVD) was used 
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to compute the alignment tensor, which would best map the experimental RDCs. 
First, the N–H vector was extracted from the APP2LP1 ensemble and then back 
computed the RDCs. A set of structures was then extracted from the MD trajectories 
performed for the two micelle systems. The structures that would best fit the 
experimental RDCs were selected with a genetic algorithm. We finally clustered them 
using the Jarvis-Patrick clustering algorithm (38) (Figure S8). 
Three different EPR DEER prediction algorithms were considered in order to 
estimate the distance distribution profile for the tagged APP-TM domain, namely 
MMM (21), mtsslWizzard (22), and Pronox (23). The DEER signal was computed for 
the straight structure equilibrated in a POPC bilayer and the curved NMR structure. A 
modified version of MMM was used to estimate the distance distribution based on the 
MTSL coordinates extracted from the MD and metadynamics simulations (Figure 21d 
and Figure S12). 
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4.1.5 Supporting Material 
 
 
Figure S7: Solvation of the APP-TM. The water molecules access the TM core via the N-
terminus (left) or C-terminus (right). The membrane surface is indicated with gold lines. 
 
 
 
Figure S8: Residual dipole coupling analysis. (a) The correlation of residual dipole 
coupling (RDC) was back calculated from the NMR ensemble of structures (green) and MD 
simulations performed in both micelles; M45 and M35 (grey), and (b) The four major 
conformers are reported with their RMSD with respect to the APP2LP1 NMR structures. 
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!
Figure S9: APP Free energy landscape. The free energy landscape associated to dihedral 
angles ! and " as calculated by metadynamics MD on the M35 system. The green asterisk 
indicates the average NMR conformation relative to the 2LP1 ensembles. 
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!
Figure S10: Structural model of APP mutants and spin labled. The wild type and three 
relevant mutants, namely G700C, [G700CM/L723CM] and G700W, were inserted in a POPC 
membrane bilayer and simulated with MD. 
!
!
!
WT G700C
G700CM / L723CM G700W
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Figure S11: Solvation of APP-TM. The relative level of solvation of  APP-TM for two G700 
mutations. 
!
!
!
 
Figure S12: DEER distance distribution. The experimental distance distribution (1) (green) 
is compared to the predicted distance distribution using MMM (dashed lines) and the 
distribution measured for MD with MTSL tags (solid lines). 
G7
08
V7
11
723
G7
04
700 residue number
1.8
1.0
0.0
1.5
0.5
G700CM/L723CM
G700C/L723C
nu
m
be
r o
f w
at
er
 m
ol
ec
ul
es
0
0.01
0.02
0.03
0.04
0.05
0.06
Pr
ob
ab
ili
ty
 
distance [Å]
20 25 30 35 40 45 50
straight
curved
experimental 
 Molecular Modeling of Membrane Embedded Proteins 99 
!
Figure S13: Spin labeled transmembrane domain. Lipids interacting with the MTSL spin 
label are highlighted in blue. 
Table S1. List of performed simulations 
system name lipid type # of atoms free MD  metadynamics 
WT 2LP1 POPC 40,000 200 ns 100 ns 
WT 2LLM POPC 40,000 200 ns - 
M35 LMPG 65,000 150 ns 30 ns 
M35 @ 318K LMPG 65,000 100 ns - 
M45 LMPG 65,000 150 ns 30 ns 
M45 @ 318K LMPG 65,000 100 ns - 
G700C POPC 40,000 100 ns - 
L723C POPC 40,000 100 ns - 
G700C/L723C POPC 40,000 120 ns - 
G700CM POPC 40,000 180 ns 30 ns 
L723CM POPC 40,000 100 ns - 
G700CM/L723CM POPC 40,000 300 ns 2 x 60 ns 
G700W POPC 40,000 130 ns - 
Table S2. DEER distance prediction  
system MMM [Å] MTSSLWizard [Å] Pronox [Å] 
straight helix 38.9 ± 4.4 40.61 39.9 ± 4.3 
bent helix 31.3 ± 3.7 25.61 30.1 ± 4.3 
MTSL
C700
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4.2 Alzheimer!s disease mutations in the Amyloid 
precursor protein 
Revised excerpt from the following paper:  
“Early-onset Alzheimer!s disease mutations in APP, but not "-secretase modulators, 
affect epsilon-cleavage-dependent AICD production”  
Dimitrov M., Alattia J., Lemmin T., Rajwinder L., Fligier A., Houacine J., Hussain I., 
Radtke F., Dal Peraro M., Beher D., and Fraering P. C., submitted 
 
4.2.1 Introduction 
The main pathological hallmark of Alzheimer!s disease (AD) is the formation of toxic 
amyloid fibers that progressively accumulate into plaques. Two forms of AD exist: the 
sporadic form and the genetic form. Several inherited mutations causing the genetic 
form, also called Familial Alzheimer!s disease (FAD), are found in the amyloid 
precursor protein (APP). It has been shown that pathological amino acid substitutions 
in the APP and chemical "-secretase modulators (GSMs) affect the processing of the 
APP by the "-secretase complex. The mutations in the transmembrane domain of the 
APP causing aggressive early-onset familial Alzheimer!s disease affect both the "- 
and #-cleavage sites, by increasing the A$42/40 ratio. The #-cleavage site is defined 
as the first step of the processing of APP and the "-site as the last one. 
In this study, three different FAD mutants were considered (T714I, V715A and 
V717F). These mutations were chosen because they either affect both the "- and #-
cleavage sites (T714I, V715A), or only the #-site (V717F). The mutations T714I and 
V715A increased the A$42/40 and A$38/40 ratios. In contrast, for V717F, these 
profiles were comparable to those obtained with wild type (WT) APP. Two #-cleavage 
sites were observed in the WT: Leu49 and Val50. For all FAD mutants, only the 
Leu49 site is present. To rationalize these findings, we used molecular dynamics 
simulations of the APP-TM segment embedded in the lipid bilayer, and proposed that 
FAD-APP mutants and possibly GSMs affect the "-cleavage site by changing the 
flexibility, tilt angle and position of the substrate in the membrane. The FAD mutants 
also altered the solvation at the #-cleavage site, which can explain the different 
product lines generated after the first step of the processing of APP. 
  
4.2.2 Results 
We used molecular dynamics (MD) simulations to gain insights into the structural and 
dynamic properties of the transmembrane domain (TMD) of wild-type APP and three 
FAD-mutants (T714I, V715A and V717F) in the membrane environment. The TM 
region of the APP-C99 NMR structure (PDB code 2LP1 [1]) was used and inserted 
into a phosphatidylcholine (POPC) lipid bilayer (Figure 22a). MD simulations were 
carried out under physiological-like conditions (i.e., pH ~7, 1 atm, 300 K), mimicking 
as close as possible the conditions of the "-secretase enzymatic assay used to study 
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the cleavage. For all systems, the secondary structure of the APP fluctuated only 
marginally. Consistent with the NMR observations, the N-terminus amphiphilic helix 
(Q686–N698) lies on the membrane surface, whereas a lysine belt (K687, K699, 
K724–726) anchors the TMD and N-terminus helices, respectively, in and onto the 
membrane (Figure 22a). During simulation, the helices tilted with respect to the 
membrane surface. We found that the V717F mutation affected the orientation of the 
TMD the most, tilting it by 45 ± 5 degrees, whereas the wild type and T714I and 
V715A mutants remained more vertical (36 ± 5, 38 ± 3 and 36 ± 3 degrees, 
respectively) (Figure 22a and Figure 23a). These mutations further shifted the TMD 
perpendicularly to the membrane surface. When measuring the position of the A!42 
cleavage site (i.e., I712 – A713 peptide bond), the T714I and V715A mutants shifted 
closer (2.9 ± 1.2 Å and 2.3 ± 0.9 Å, respectively) to the cytoplasmic interface 
compared to the WT, and V717F moved closer (-0.2 ± 1.3 Å) to the extracellular 
membrane layer (Figure 22b).  
 
 
Figure 22: Structural and dynamic models of the TM domain in WT and FAD-causing 
APP mutants. (a) The NMR structure of WT APP (PDB code: 2LP1 [1]) and three FAD-
causing mutants, namely T714I, V715A and V717F, were inserted in a POPC membrane 
bilayer and simulated with molecular dynamics. The "-sites G709, V711 and A713 and #-sites 
L720 and V721 positions are indicated by blue spheres, (b) The spatial distribution of the 
A!42 cleavage site is reported for the four systems. The distribution is calculated along the 
axis orthogonal to the membrane bilayer surface and the reference putative position of the "-
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site in wild-type conditions is highlighted with the light blue area, (c) The local bending of the 
APP helix is computed for the TM domain (with a standard error of 2.8 degrees) and (d) The 
coordination number of water molecules around the relevant residues at the !-site is reported 
for the WT and mutants. 
The combined effect of shifting and tilting perturbations of the APP TMD due to FAD-
mutations probably affects the presentation of the "-cleavage site at position 42 to 
the enzyme. This correlates quantitatively with the changes in the #$42/ A$40 ratio. 
Moreover, the flexibility of the transmembrane domain, that was estimated based on 
the local bending of the helix [2], was much higher for the T714I and V715A mutants, 
specifically at the G29XXXGXXXG37 region (Figure 22c). Molecular docking and 
simulations of the GSM-1 compound suggested that the drug-binding pocket is 
conserved for the wild-type and mutant APPs (Figure 23b). In the drug-binding 
pocket, L701, G704 and G708 had the most direct interactions with GSM-1. Thus, the 
effect of GSM-1 on T714I and V715A FAD mutants might cause an reduction of their 
flexibility close to the "-site. For all three mutants, the hydration of the !-site at 
residue L720 significantly decreased compared to the WT (Figure 22d). In particular, 
for APP-WT, one water molecule is on the average within 3 Å of L720 backbone, the 
water coordination number drops to less than 0.5 Å for V715A, and to nearly zero for 
T714I and V717F. This effect is related to the different water permeation properties of 
the APP C-terminus lysine belt combined with the perturbed helical orientation 
produced by the mutants. In summary, our data support a model in which structural 
changes, in particular, the position of the "-cleavage site relative to the membrane 
surface potentially can modulate #$ production, while the hydration of L720 can 
affect the !-cleavage site and the production of the two amyloid precursor 
protein intracellular domains potentially implicated in signalling pathways and in 
the pathogenesis of AD. 
Figure 23: Molecular docking and MD simulations of GSM-1 bound to APP-C99. (a) 
Different orientations in the membrane of APP WT and mutants TMD, (b) GSM-1 binding to 
WT, T714I, V715A and V717F APP obtained using SWISSDock and BSP-SLIM revealed that 
the compound binds to the G29XXXGXXXG37 motif (in ball representation) with a conserved 
and stable conformation. The wild-type system is equilibrated using MD simulation and 
confirmed a stable pose of GSM-1 compound in dynamics. 
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4.2.3 Discussion 
We propose that the observed effects on A! production can be triggered by 
combined changes in the flexibility, tilting angle, and positioning of both the "- and #-
sites in the membrane, along with the hydration levels at the #-sites. Such structural 
changes might affect the "-secretase cleavage specificity by potentially modifying the 
presentation of the substrates to the enzymatic complex. Consistent with this model, 
the high A!38/40 ratio observed in mutants T714I and V715A can be explained by 
the vertical shift of the helix in the membrane bilayer, with the consequent 
presentation of position 38 instead of 40 to the "-secretase cleavage site. The 
observed vertical shift in mutants (~2.5 Å) is in fact associated with a tilting of half of 
a helix turn (i.e., displacement of 2 amino acids).  
The increased water accessibility to L49 may favor cleavage at this position, or inhibit 
cleavage at V50 by preventing the interaction of APP-C99 at position 50 with the 
hydrophobic transmembrane domain 1 of the "-secretase catalytic. 
To better understand the effect of GSM binding, the GSM-1 compound was docked 
on the ensemble of wild-type and FAD-mutant (T714I, V715A and V717F) 
conformations were generated by MD simulations. GSM-1 strongly binds to the 
WT T714I V715A V717Fa
b
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previously identified G29XXXGXXXG37 motif (Figure 23b), further supporting our 
observation that amino acids close to the !-sites of APP are not required for GSMs 
activity, again underlying the therapeutic potential of these compounds [3]. 
In conclusion, molecular simulations suggest that FAD mutations modulate the 
flexibility of the APP transmembrane domain. The presentation of its !-site and the 
solvation of the "-site are thus modified. 
 
4.2.4 Material and Methods 
Molecular dynamics simulations and molecular docking  
We used molecular dynamics (MD) simulations to characterize the TM domain of WT 
and APP with FAD mutations. In a first step, the NMR structure (PDB code 2LP1[1]) 
was inserted and equilibrated in a 60 x 60 Å2 Palmitoyl Oleoly Phosphatidyl Choline 
(POPC) patch[4] to relax the structure in a phospholipid bilayer. The system was 
solvated in a 60 x 60 x 100 Å2 water box, neutralized through the addition of NaCl at 
a concentration of 150 mM. After 30 ns, the equilibrated structure was used as initial 
seed to build the other three mutants (T714I, V715A and V717F) and WT-ligand 
complex. GSM-1 ligand was parameterized using CGenFF and ParamChem 0.9.6[5]. 
All MD simulations were performed using NAMD 2.8 engine, with the CHARMM27 
force field, including CMAP corrections for the protein and CHARMM36 for the POPC 
membrane [6,7]. TIP3P water parameterization was used to describe the water 
molecules. The periodic electrostatic interactions were computed using the particle-
mesh Ewald (PME) summation with a grid spacing smaller than 1 Å. All systems 
were equilibrated for 30 ns at 300 K. Free molecular dynamics were performed up to 
100 ns with a 2 fs integration time step using the RATTLE algorithm applied to all 
bonds. Constant temperature (300 K) was imposed by using Langevin dynamics, 
with a damping coefficient of 1.0 ps. A constant pressure of 1 atm was maintained 
with Langevin piston dynamics, having a 200 fs decay period and a 50 fs time 
constant.  
GSM-1 was docked on the WT and APP mutants using SWISSDock [8,9] and BSP-
SLIM [10]; independently both approaches produced similar configurations. Since 
these algorithms do not account for the presence of the membrane, we discarded all 
unphysical docking poses, e.g. the GSM-1 hydroxyl was buried in the hydrophobic 
membrane core. The conformation with the lowest energy was then selected for each 
system. 
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5 Conclusions and Perspectives
The biological membrane forms a nearly impermeable barrier, defining the 
boundaries of a living organism. Its lipid composition closely affects the stability and 
mechanism of membrane-embedded proteins, causing a large disparity between the 
understanding of soluble and membrane-proteins. To overcome these issues, 
detergent micelles are often used during protein purification, crystallization and 
functional studies. However, theses experimental setup can strongly influence the 
structural and dynamical determinants of the protein. Moreover, the conformational 
changes essential for the function, the stability or the binding of the protein are 
difficult to deduce from wet experiments. Molecular modeling is therefore an essential 
tool for gaining insight into the structure and function of membrane-proteins. The 
computational power available today allows simulating large and complex systems, 
which are closely mimicking realistic models of protein-membrane complexes. 
This thesis project dealt with the following four important problems related to the 
study of membrane-embedded proteins at the atomistic level and proposed various 
solutions: 
1. The determination of the high-resolution structure of transmembrane proteins is 
difficult. A method for the assembly of transmembrane proteins, combining molecular 
modeling with structural and experimental studies, was proposed. By integrating 
secondary predictions and cross-linking data to molecular dynamics simulations, a 
model of the transmembrane domain of PhoQ was assembled. This model was fully 
consistent with the available adjoining structures and a signal transduction 
mechanism could be formulated. 
2. Fine interactions between the membrane-proteins and their environment are 
difficult to address experimentally. Molecular dynamics simulations were used to 
study the interactions between the membrane and the embedded proteins at the 
atomistic scale. Modeling of a large diversity of lipids is therefore required. Two 
aspects of this problem were dealt with. First, the parameterization of cardiolipin, a 
unique dimeric phospholipid, supplemented the available head group models in the 
CHARMM and AMBER force fields. This anionic lipid is essential for the investigation 
of bacterial and mitochondrial membranes. The assembly of realistic membranes can 
be accelerated by facilitating the creation of an ad hoc mixture of lipids. Based on the 
SMILE sequence of the acyl chain, a software automatically generating the topology 
and template of the required phospholipid was implemented. It is currently being 
ported to a web server, allowing easy access and the establishment of a lipid 
database.  
 Chapter 5: Conclusions and Perspectives 110 
3. Adapting characterization methods for solution proteins to membrane proteins is 
not always straightforward. The lipid bilayer could strongly affect the expected 
measurements. In this thesis project, molecular dynamics simulations were shown to 
be an important complement for the rationalization and refinement of such 
experimental data. The effect of the membrane on different experimental setups was 
investigated at the atomistic scale. The dynamical behavior of the transmembrane 
domain was also deduced by combining MD simulations with the analysis of data 
such as cross-linking, NMR or EPR. 
4. The slow diffusion and conformational properties of the embedded proteins require 
long simulation time. Classical molecular dynamics at present are not able to sample 
the entire conformational space within a reasonable timeframe. Enhanced sampling 
techniques are necessary to more accurately interpret certain experimental data. 
Metadynamics simulations were used to characterize the dynamical properties of 
transmembrane proteins and were essential to accurately explain the corresponding 
in vitro measurements. 
The organization of the biological membrane at the nanometer scale is difficult to 
study experimentally. At present, various techniques permit investigations at the 
molecular scale (e.g. spectroscopy) and at the micrometer scale (e.g. microscopy). 
Molecular modeling has proven to be a valuable tool for bridging these two 
experimental techniques. The work carried out in this thesis project effectively 
integrated MD simulations and experimental data, thus contributing to the 
understanding of membrane-proteins properties. However, membrane-proteins often 
assemble in large complexes and require simulation times that are still beyond the 
reach of today!s computational power. Novel strategies, such as enhanced sampling 
(applied in this thesis) and coarse graining, would be required to study these 
complexes. Moreover, combining molecular dynamics simulations with other 
computational techniques can further improve the sampling. For example, molecular 
modeling based on multistate Bayesian scoring functions has recently proven to be 
an efficient method. It allows combining data available from different experimental 
procedures, thus that molecular dynamics simulations can be integrated to these 
Bayesian strategies in three ways: (i) The dynamic behavior of high-resolution 
structures of subunits composing a molecular assembly can be determined using MD 
and then integrated as extra restraints to the Bayesian modeling, (ii) The properties 
of experimental probes can be significantly altered due to their environment (e.g., 
membrane). By simulating an atomistic model representing the experimental set-up, 
Bayesian models of the experimental data can be improved, and (iii) Initial modeling 
of assemblies is usually performed using a residue-based coarse-grained 
representation. Biased molecular dynamics can be used to reconstruct the all-atom 
representation of these models. For example, Molecular Dynamics Flexible Fitting 
(MDFF) has proven to be an efficient method for fitting an atomic model into a low-
resolution density map. In a similar way, the coarse-grained models produced can be 
used to guide the assembly of a near-atomic model during MD simulations.  
At present, computational methods generate structural models mostly using literature 
data to guide computation. However, modeling the structure and dynamics of 
macromolecular assemblies allows gaining valuable insight into important biological 
functions, interactions and conformational changes. This feedback could be used to 
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stimulate new experiments or, better, to be directly incorporated when designing 
experiments aimed at unveiling the biological function of molecular complexes.
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ABSTRACT  
Pathological amino acid substitutions in the amyloid precursor protein (APP) and chemical !-secretase 
modulators (GSMs) affect the processing of APP by the !-secretase complex, and the production of the 
amyloid-beta peptide A"42, the accumulation of which is considered causative of Alzheimer#s disease. 
We demonstrate here that mutations in the transmembrane domain of APP causing aggressive early-
onset familial Alzheimer#s disease (FAD) affect both !- and $-cleavage sites, by raising the A"42/40 ratio 
and inhibiting the production of AICD50-99, one of the two physiological APP intracellular domains (ICDs). 
This is in sharp contrast to GSMs, which shift A"42 production towards the shorter A"38, but 
unequivocally spare the $-site and APP- and Notch-ICDs production. Molecular simulations suggest that 
FAD mutations modulate the flexibility of the APP transmembrane domain and the presentation of its g-
site, modifying at the same time the solvation of the $-site.  
 
INTRODUCTION  
The main pathological hallmark of Alzheimer#s disease (AD) is the formation of toxic amyloid fibers that 
progressively accumulate into plaques, which leads to degeneration of the neighboring neuronal cells
1
. 
Further biochemical studies identified the main protein component of plaques to be a short fragment of 
APP, the 42 amino acid long peptide A"42
2
. Moreover, dominantly inherited mutations causing Familial 
Alzheimer#s disease (FAD) are found in APP as well as in the PSEN1 and PSEN2
3,4
 genes encoding for 
the catalytic subunit of the !-secretase complex, an intramembrane-cleaving protease which cleaves APP 
in the plasma membrane and generates the A" peptides
5
. Together, these findings clearly demonstrated 
the implication of APP, !-secretase and A" in both the sporadic and genetic forms of AD. They further 
highlighted the !-secretase-dependent APP processing as an attractive target for drug development.  
In addition to APP, !-secretase cleaves various other substrates regulating biological functions including 
development and stem cell differentiation. This unusual proteolytic complex indeed plays an important 
role in cell signaling pathways by processing different type-I transmembrane cell receptors including the 
Notch receptors, the Insulin receptor, and the Growth hormone receptor
6
. In the brain, it maintains 
synaptic contacts by regulating cleavage of neuronal adhesion molecules like Cadherins and 
Neurexins
7,8
. With the continuously growing number of substrates the need for understanding the exact 
molecular mechanism of this particular proteolytic processing arises.  
!-Secretase is composed of four subunits, presenilin (PS), Aph-1, Pen-2 and Nicastrin (NCT). The 
complex contains in total 19 a-helices embedded in the membrane bilayer, which allows the overall 
structure to adopt different conformations upon binding with the substrate or transition-state analog 
inhibitors
9
. Moreover, the catalytic aspartate residues (Asp257/385) in PS1 are buried into the lipid bilayer 
and surrounded by hydrophobic helices and the cryo-electron microscopy density maps suggested the 
existence of two pores in the globular structure of !-secretase, which can explain the entrance of water 
molecules necessary for the hydrolysis of the peptide bond
10
. Yet, a rigorous biochemical characterization 
of !-secretase complexes with FAD mutations revealed that they all represent a loss of enzymatic 
function, but they ultimately lead to altered A" production and elevated A"42/40 ratio
11,12
. Interestingly, 
FAD mutations in APP can show substrate cleavage patterns that differ from those of mutations in !-
secretase. The large extracellular domain of APP is first removed by b-secretase in the vicinity of the 
plasma membrane. Gain-of-function mutations in this b-site cause elevated levels of total Ab
13
.  !-
secretase processes the remaining 99-amino-acid APP-C terminal fragment (APP-C99) at $-sites close to 
inner layer of the membrane, and releases 49- and 50-amino-acid long APP- intracellular domains 
(AICD50-99 and AICD49-99). After this step, !-secretase sequentially continues to trim the residual 
transmembrane stub, finally producing A"42,  A"40 and A"38 peptides
14
. Mutations surrounding the $-
sites either increase the production of A"42,  which is more neurotoxic compared to the shorter and less 
!!
"""!
fibrillogenic A!40, or lead to elevated total amounts of the A! product without affecting A! ratios
12,15
.  
Amino acid substitutions in the g-site lead to high A!42/40 ratios and are characterized by the most 
prominent and earliest phenotypes of FAD
16
. 
Inhibiting the "-secretase activity to reduce A! production became an attractive therapeutic strategy to 
treat AD. However, "-secretase inhibitors (GSIs) tested in clinical trials not only did not meet their initial 
clinical endpoints, but also manifested severe off-target effects due to impaired Notch signaling, leading to 
gastrointestinal bleeding and increased risk of skin cancer
17
. Consequently, a concept of selective 
modulation of the "-secretase activity has emerged. A subset of non-steroidal anti-inflammatory drugs 
(NSAIDs) were the first Notch-sparing small molecules shown to selectively lower A!42 and subsequently 
raise A!38, both in vitro and in vivo
18,19
. These "-secretase modulators (GSMs) were initially shown to 
bind to APP, although some more recent studies demonstrated that they also can target "-secretase
20,21
.  
Although the precise molecular mechanism of action remains poorly understood, a number of these 
molecules have advanced to clinical trials
22
.  
In this report, we demonstrate that second generation GSMs, including the clinically tested E2012, 
effectively lower the production of toxic A!42, without affecting the e-cleavage sites of both APP and 
Notch substrates. In contrast, we show that the T714I, V715A, V717F and L723P FAD-APP mutations in 
the transmembrane (TM) region block the production of AICD50-99, the 49-amino-acid long AICD, without 
affecting the total amount of AICD. Moreover, mutations T714I and V715A elevated the A!42/40 and 
A!38/40 ratios, in contrast to I716V, V717F and L723P for which these profiles were comparable to those 
obtained with wild type APP. GSMs affected all mutants at their "-cleavage site, with the strongest effect 
on the A!38/40 and A!42/40 ratios in T714I and V715A, suggesting that these amino acid substitutions 
are important for the generation of A!42 and A!38 . In addition, we found that GSMs do not reverse the 
loss of AICD50-99 production caused by FAD mutations.  We rationalize these findings using molecular 
dynamics simulations of the APP TM segment embedded in the lipid bilayer, and propose that FAD-APP 
mutants and possibly GSMs affect the "-cleavage site by changing the flexibility, tilt angle and position of 
the substrate in the membrane. GSMs fail to recover e-cleavage, most likely because they affect the 
substrate-enzyme interface at a position which is distant from the #-site and closer to the outer layer of 
the membrane. Finally, FAD mutants had altered solvation at the e-cleavage site, which can explain the 
different product lines generated after the first step of the processing of APP. 
 
RESULTS 
GSMs affect the g- but not the e-cleavage of APP and Notch.  
We first investigated the effect of GSM-1 and E2012, two representative molecules of the two main 
classes of second generation GSMs: NSAID-based phenylpiperidine-type compounds and non-NSAID 
bridged aromatics, respectively (Fig. 1a). Although these compounds have different structures, they both 
modulate  "-secretase activity at low nanomolar concentrations in cells
23
. In enzymatic in vitro assays 
using highly purified "-secretase and recombinant APP-C100-Flag substrate, we first show that 
concentrations several fold higher than the cellular IC50 concentrations of GSM-1 and E2012 do not affect 
the overall amounts of A! and AICD, when compared to control levels (Fig. 1b, upper panels).  We next 
investigated in detail the effect of these molecules on all reaction products. For both compounds tested at 
10 mM, immunoprecipitation with 4G8 anti-A! antibody, combined with MALDI-TOF spectrometry (IP/MS) 
revealed a robust increase in A!38, associated with a decrease in A!42  (Fig.1b, middle panels).  At this 
concentration GSM-1 showed a stronger effect than E2012 on A!42/40  and A!38/40 ratios, while both 
compounds lowered A!43. IP/MS analyses of the C-terminal cleavage products revealed an unchanged 
equimolar production of the two AICDs (Fig. 1b, lower panels). Together, these results clearly 
demonstrate that GSMs affect the APP "-cleavage sites, while completely sparing the #-sites. Because of 
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the clinical relevance of GSMs and the Notch signaling pathway, we further questioned whether GSMs 
could interfere with the Notch intracellular domain (NICD) production. As shown in Figure 1c, GSMs did 
not influence total NICD production and did not affect the NICD cleavage profiles. Our in vitro findings 
were further confirmed in cell-based assays. First, intracellular accumulation of endogenous !-secretase 
substrates APP-C83 and APP-C99, which is a common characteristic among known !-secretase 
substrates in response to !-secretase inhibition, was assessed in HEK293T cells stably overexpressing 
APP with the FAD Swedish mutation KM670/671NL. In contrast to the control GSI, 1 and 10 mM E2012 or 
GSM-1 did not affect the levels of APP- CTFs (Supplementary Fig.1a). Next, treatments with E2012 and 
GSM-1 up to 1 mM in a cell-based luciferase assay in which AICD generation correlates with increased 
luciferase expression and induced luminescence emission, did not result in a significant inhibition of AICD 
release (Supplementary Fig. 1b). Additionally, the GSMs were tested in human lymphocytic leukemia 
SUP-T1 cells constitutively producing NICD. In contrast to the GSI XIX which completely abolished NICD 
production, E2012 and GSM-1 did not affect NICD production at concentrations up to 10 mM 
(Supplementary Fig. 2a). These findings were confirmed in a cellular Notch-based assay in which a 
luciferase reporter system is directly placed under the control of NICD
24
 (Supplementary Fig. 2b), as well 
as in HEK cells overexpressing NotchDE
25
 (Supplementary Fig. 2c). In the latter two assays, E2012 and 
GSM-1 concentrations up to 1 mM did not affect NICD production. At 10 mM, E2012, but not GSM-1, 
significantly reduced NICD production in DL4-Hela/N1-Hela co-cultures by 55% (***p<0.001) 
(Supplementary Fig. 2b). Taken together, we conclude that E2012 and GSM-1 do not alter the Notch and 
APP "-site cleavage at concentrations as high as 10x cellular IC50. At higher concentrations (100x cellular 
IC50), only the non-NSAID-based compound E2012 can inhibit to some extent intracellular signaling of 
Notch and APP in cell-based assays. 
   
APP mutations causing familial Alzheimer!s disease differentially alter g- and "-sites. 
APP mutations causing familial Alzheimer#s disease (FAD) can be grouped based on their localization at 
three different regions: at the b-secretase cleavage site, in close vicinity of the a-secretase cleavage site 
in the A$ region, or in the transmembrane domain (TMD) of APP, between the g- and the "-sites (Fig. 2a, 
left). These mutations differ not only by the onset of the disease (Fig. 2a, right), but also by the molecular 
fingerprint of the produced A$ peptides. Indeed, the vast majority of mutations in the a- and b-sites lead to 
overproduction of total A$ (mutations in the A$ region can also render the A$42 peptide more fibrinogenic 
and prone to aggregation) while mutations in the transmembrane region seem to be linked to an elevated 
A$42/40 ratio
12,26
. Because no information exists about how these mutations affect both the g- and e-
cleavage sites in APP, and because AICD has been suspected to play a role in the pathogenesis of 
Alzheimer#s disease, we analyzed A$ and AICD products generated from purified APP-C99 substrates 
carrying the FAD mutations listed in Figure 2a. All recombinant substrates were processed by purified !-
secretase (Supplementary Fig. 3). IP/MS analyses of the A$ and AICD profiles revealed that amino acid 
substitutions clustered near the a-secretase (A692G, E693G, D694N) apparently do not alter the A$ or 
AICD profiles, when compared to the control WT APP-C99 (Fig. 2b). In striking contrast, T714I and V175A 
mutations close to the transmembrane !-cleavage site lead to drastically increased A$42/40 and A$38/40 
ratios and to a total inhibition of the production of the shortest AICD50-99 (Fig. 2c). Interestingly, 
mutations closer to the e-cleavage sites (I716V, V717F and L723P) are characterized by an intermediate 
phenotype as they do not alter A$ profiles, but clearly lower the production of AICD50-99 (below detection 
levels for V717F and L723P) (Figs. 2b and c). Taken together, our data demonstrate that FAD-causing 
mutations in the transmembrane region of APP, but not close to the a-secretase site, affect both  g- and/or 
"-sites.  
 
GSMs affect the g- but not the e-cleavage of APP with FAD mutations.  
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To better understand the molecular mechanism by which GSMs shift A! production, as well as to verify 
whether GSMs can still lower A!42 and have potential therapeutic benefits in patients with FAD, we 
decided to test GSM-1 on APP-C99 with FAD mutations. GSM-1 was chosen because it was more potent 
in our in vitro "-secretase assay, and also because this compound did not affect e-cleavage in all cell-
based experiments. First, 10 mM GSM-1 did not affect the levels of total cleavage products (compare 
AICD and A! levels in Supplementary Figs. 3a and 3b), providing further evidence that GSMs do not 
modify the overall yield of "-secretase processing. Next, we found that GSM-1 conserved its A!42-
lowering and A!38-raising properties on all tested mutant substrates (Fig. 3a). However, GSM-1 did not 
influence the e-cleavage and none of the mutants tested recovered the wild-type phenotype of nearly 
equimolar production of AICD49-99 and AICD50-99 (compare AICD profiles in Figs. 3b and 2c). Our 
findings provide new evidence that GSMs lower A!42 production by interfering with the g-site in APP 
substrates with FAD mutations, strongly suggesting that none of the substituted amino-acid residues are 
crucial for the GSM-dependent modulation of APP processing by "-secretase. They further demonstrate 
that GSMs fail to reverse the effects on AICD production of FAD-causing mutations in the transmembrane 
domain of APP.  
  
Structural changes in the TM domain of APP with FAD-causing mutations  
To support our results mechanistically, we used molecular dynamics (MD) simulations to further insights 
into the structural and dynamic properties of the transmembrane domain (TMD) of wild-type APP and 
three FAD-mutants (T714I, V715A and V717F) in the membrane environment. These mutations were 
chosen because they either affect both "- and #-cleavage sites (T714I, V715A), or exclusively the #-site 
(V717F). The TM region of the APP-C99 NMR structure (PDB code 2LP127) was used and inserted into a 
phosphatidylcholine (POPC) lipid bilayer (Fig. 4a). MD simulations were carried out under $#%& 
physiological conditions (i.e., pH ~7, 1 atm, 300 K), mimicking as close as possible the conditions of the 
"-secretase enzymatic assay used in our study. For all systems, the secondary structure of APP 
fluctuated only marginally. Consistent with the NMR observations, the N-terminus amphiphilic helix 
(Q686–N698) lies on the membrane surface, and a lysine belt (K687, K699, K724–726) anchors the TMD 
and N-terminus helices, respectively, in and onto the membrane (Fig. 4a). During simulation, the helices 
tilted with respect to the membrane surface. We found that the V717F mutation affected the most the 
orientation of the TMD, tilting it by 45 ± 5 degrees, while the wild type and T714I and V715A mutants 
remained more vertical (36 ± 5, 38 ± 3 and 36 ± 3 degrees, respectively) (Fig. 4a and Supplementary Fig. 
4a). These mutations further shifted the TMD perpendicularly to the membrane surface. When measuring 
the position of the A!42 cleavage site (I712 - A713 peptide bond), T714I and V715A mutants shifted 
closer (2.9 ± 1.2 Å and 2.3 ± 0.9 Å, respectively) to the cytoplasmic interface compared to the WT, 
whereas V717F moved closer (-0.2 ± 1.3 Å) to the extracellular membrane layer (Fig. 4b). The combined 
effect of elevation and tilting perturbations of the APP TMD due to FAD-mutations is probably affecting the 
presentation to the enzyme of the "-cleavage site at position 42, correlating quantitatively with the 
changes in A!42/A!40 ratio (Fig. 2). Moreover, the flexibility of the transmembrane domain, estimated 
based on the local bending of the helix28, resulted to be much higher for T714I and V715A mutants, 
specifically at the G29XXXGXXXG37 region (Fig. 4c). 'olecular docking and simulations of GSM-1 
compound suggested the same region as the conserved drug-binding pocket (L701, G704 and G708 
being the most direct interactions with GSM-1, Supplementary Fig. 4) for both the wild-type and mutant 
APP. Thus, GSM-1 effect on T714I and V715A FAD mutants might cause an attenuation of their flexibility 
close to the g-site. For all three mutants, the hydration of the #-site at residue L720 was significantly 
decreased compared to the WT (Fig. 4d). In particular, for APP-WT one water molecule is in average 
within 3 Å of L720 backbone, while the water coordination number drops to less than 0.5 Å for V715A, 
and to nearly zero for T714I and V717F. This effect can be ascribed to the different water permeation 
properties of the APP C-terminus lysine belt combined with the perturbed helical orientation produced by 
the mutants. Together, our data support a model in which structural changes and, in particular, the 
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position of the !-cleavage site relative to the membrane surface can potentially modulate A" production, 
while the hydration of L720 can affect the e-cleavage site and the production of the two AICDs potentially 
implicated in signalling pathways and in the pathogenesis of AD. 
 
DISCUSSION  
Mutations in APP cause aggressive early-onset Alzheimer#s disease by triggering abnormal production, 
accumulation and aggregation of A" peptides. The most severe pathological phenotype is observed for 
mutations occurring in the transmembrane region and in close vicinity of the A"42 !-cleavage site, 
leading to elevated A"42/40 and A"38/40 ratios (Fig. 2). Small chemical !-secretase modulators (GSMs) 
are known to lower A"42 and raise A"38, without affecting the overall production of the A" peptides. In 
this study, we used second generation GSMs with a strong therapeutic potential (GSM-1 and E2012), in 
combination with APP substrates with FAD-causing mutations, (i) to better understand the molecular 
mechanisms of the !-secretase-dependent, intramembrane and sequential cleavage of the substrate, (ii) 
to identify changes in APP-cleavage profiles, potentially implicated in the pathogenesis of AD, and (iii) to 
further support the therapeutic potential of GSMs to safely treat sporadic as well as early-onset familial 
AD. We further demonstrate here that GSMs represent an attractive scaffold for structure-activity 
relationship design (SAR) of potent disease-modifying drugs against AD. As they do not affect the 
processing of the Notch substrate (Fig. 1), GSMs are expected to circumvent clinical side effects 
observed with GSIs and attributed to impaired Notch processing17. Moreover GSMs do not alter AICD 
production (Fig. 1) and thus are not likely to influence the downstream cell signaling functions of APP, 
again underlying the huge therapeutic potential of these compounds in sporadic AD cases. Additionally, 
our results confirm altered g-site processing in APP-FAD mutations, associated with an increase of A"42 
and A"38 and demonstrate that mutations located in close vicinity to the g-site do impede the production 
of the shorter $-site counterpart AICD50-99. Mutations T714I and V715A display the strongest phenotype 
at both g- and $-sites, with highest A"42/40 and A"38/40 ratios. Moreover, these mutations lead to the 
production of only one detectable AICD, suggesting a putative role of AICD in AD pathogenesis. These 
results might be explained with the sequential cleavage model of APP-CTF, in which the generation of 
A"40 is dependent on the AICD50-99, while A"42/38 is linked to AICD49-9914. Reduced AICD50-99 (as 
observed for some FAD mutants) is expected to be associated with less A"40 and more A"42/38, thus 
increasing the pathogenic ratio of A"42/40. The combination of higher A"42/40 ratio and the loss of 
AICD50-99 can explain the extreme aggressiveness of these APP mutations with regard to the onset of 
the disease. GSMs were still potent at the g-site of mutated APP substrates, but failed to rescue the 
phenotype at the e-cleavage site (Fig. 3). These findings clearly demonstrate that GSMs can be used for 
the treatment of patients with both sporadic and genetic forms of AD. To better understand the effect of 
GSM binding, we docked the GSM-1 compound on the ensemble of wild-type and FAD-mutants (T714I, 
V715A and V717F) conformations generated by MD simulations. GSM-1 strongly binds to the previously 
identified G29XXXGXXXG37 motif (Supplementary Fig.4), further supporting our observation that amino 
acids close to the g-sites of APP are not required for GSMs activity, again underlying the therapeutic 
potential of these compounds20. 
Rationalizing these results with structural models based on molecular simulations of wild type and mutant 
APP substrates, we propose that the observed effects on A" and AICD production can be triggered by 
combined changes in the flexibility, tilting angle, and positioning of both g- and $-sites in the membrane, 
along with the hydration levels at the $-sites. Such structural changes, by potentially modifying the 
presentation of the substrates to the enzymatic complex, might affect the !-secretase cleavage specificity. 
Consistent with this model, the elevated A"38/40 ratio observed in mutants T714I and V715A can be 
explained by the vertical shift of the helix in the membrane bilayer, with the consequent presentation of 
position 38  instead of 40 to the !-secretase cleavage site. The observed vertical shift in mutants (~2.5 Å) 
is in fact associated with a tilting of half of a helix turn (i.e., displacement of 2 amino acids). Interestingly, 
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A!38 and A!42  have been proposed to originate from the same sequential processing pathway, starting 
at the e-position 48, and directly linked to AICD49-99 production
14
. Consistent with this sequential model, 
we propose that the conformational changes in the T714I and V715A substrates, associated with reduced 
AICD50-99 levels, explain the preferential A!38 and A!42 production observed with these mutants. 
Interestingly, and apparently in contrast to the sequential cleavage model, the V717F and L723P mutants, 
although characterized by reduced AICD50-99 levels, do not show modifications in their A! profiles. This 
observation may reflect the existence of two or more different pathological molecular explanations, 
classifying FAD forms in different categories.  
The nearly complete loss of AICD50-99 production in mutants T714I, V715A, V71F and L723P, can be 
attributed, according to our model, to higher solvation states around positions 49 and 50, with the latter 
becoming more exposed to water molecules. One can speculate that the increased water accessibility to 
the leucine 49 may favor the cleavage at this position, or inhibit the cleavage at valine 50 by preventing 
the interaction at position 50 of APP-C99 with the hydrophobic transmembrane domain 1 of the "-
secretase catalytic component PS1.  
Together, our data reported here provide new insights into the therapeutic mechanism and potential of 
chemical "-secretase modulators. They are further expected to improve our current understanding of the 
pathological mechanism of familial AD. 
 
 
METHODS 
!-secretase inhibitors and modulators. "-secretase inhibitors Compound E and GSI XIX were 
purchased from Merck Millipore (Darmstadt, Germany). The heteroaryl-type GSM E2012 
(US2006/0004013) was obtained from Haoyuan Chemexpress Co. and the NSAID-type GSM-1 was 
synthesized at Syngene according to methods described in WO2006/043064. 
Molecular Biology.  
The pET21b vector encoding the cDNAs of human APP-C99-His was used as a template for the 
generation by PCR-amplification of all FAD APP-C99 mutants described in this study. The constructs were 
expressed in BL21(DE3) cells induced with 1 mM isopropyl-!-D-thiogalactopyranoside (IPTG) for 4 h at 
optic density 600 nm = 0.8. For the purification of APP-C99 mutants, harvested bacteria were lysed with 
10 mM Tris pH 7.0, 150 mM NaCl, 1 % Triton X-100, protease inhibitor cocktail (PI; Roche, Rotkreuz, 
Switerland), and passed through a high-pressure homogenizer (Emulsiflex-C5; Avestin, Inc., Mannheim, 
Germany). The obtained lysates were spun down at 5000 x g for 30 min and supernatants were incubated 
overnight with Ni-NTA agarose beads (Invitrogen, Basel, Switzerland) at 4 °C. Bound proteins were eluted 
in 1 % NP-40 containing 250 mM imidazole (pH 7.8), analyzed by Coomassie stained sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and quantified by BicinChoninic Acid (BCA; 
Pierce, Rockford, IL, USA). The normalization was validated by WB. Recombinant APP-C100-Flag and 
Notch N100-Flag substrates were also expressed in BL21(DE3) cells, but 100 mM glycine (pH 2.7)/1% 
NP40 was used for elution from M2-agarose beads.  
Western blotting and antibodies.  
Samples from !-secretase activity assays were run on 4–12 % Bis-Tris gels and transferred onto PVDF 
membranes to detect Ab, Flag-tagged APP- or Notch-intracellular domain (AICD-Flag and NICD-Flag) with 
Ab-specific 6E10 (1:1000; Covance, Berkeley, CA, USA) and Flag-specific M2 antibodies. Anti-
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mouse/rabbit/rat IgG conjugated to Alexa 680 were purchased from Invitrogen and the Odyssey infrared 
imaging system (LICOR) was used to detect the fluorescent signal.  
Whole cell extracts prepared in 50 mM HEPES buffer containing 1 % NP40 were separated by 
electrophoresis on NuPAGE® Novex® 4-12 % Bis-Tris Gels (Invitrogen, Carlsbad, CA, USA) for SDS-
PAGE analysis transferred onto nitrocellulose membranes, and probed with antibodies against APP-CTFs 
(Sigma-Aldrich GmbH, Buchs, Switzerland.). For detection of NICD, membranes were blocked with 5 % 
milk and incubated overnight with primary antibody Val1744 anti-Notch (Cell Signaling, Bioconcept, 
Allchwil, Switzerland) at 4 °C. Membranes were washed with 1x TBST (1x TBS + 0.1 % Tween 20) for 15 
min and incubated with HRP-conjugated secondary antibodies for 1 h at room temperature. Signal was 
detected with Super Signal West chemiluminescent substrate (Thermo Scientific, catalog number 34077). 
!-secretase purification. !-secretase used in this study was purified from 10 liters of PB suspension 
cultures by following the protocol described by Alattia et al. (submitted for publication). 
!-secretase activity assays. !-secretase assays using the recombinant APP- or Notch-based substrates 
were performed as previously reported29. Briefly, highly-purified !-secretase were solubilized in 0.2 % 
(wt/vol) CHAPSO, 50 mM HEPES (pH 7.0), 150 mM NaCl, 5 mM MgCl2 and 5 mM CaCl2, and incubated 
at 37 °C for 4 h with 1 mM substrate, 0.1 % (wt/vol) PC, 0.025 % (wt/vol) PE. The resulting products, APP 
intracellular domain AICD-Flag, AICD-His, Ab, and Notch intracellular domain NICD-Flag were detected 
with above-described antibodies, or analyzed by mass spectrometry. 
Immunoprecipitation-mass spectrometry (IP-MS) analysis of A" and AICD. A" and AICD generated 
in !-secretase in vitro assays with purified substrates were analyzed as previously described29 . Briefly, 
A"  was IP#d overnight using anti-A" antibody 4G8 (Covance, Berkeley, CA, USA) and protein G coupled 
to agarose resin (Roche Applied Science, Penzberg, Germany). For AICD or NICD detection, 12 mL 10 % 
Triton-X100 solution was added after the enzymatic reaction and incubated for 20 min at 55 °C prior to 
overnight immunoprecipitation at 4 °C with M2-anti Flag resin (Invitrogen, Carlsbad, CA, USA), or Protein 
G (Roche, Mannheim, Germany), coupled with anti-C-terminal AICD antibody. A" and AICD-Flag were 
eluted with 1:20:20 (v:v:v) 1 % (vol/vol) trifluroacetic acid:acetonitrile:H20, equally mixed with saturated 
CHCA (a-cyano 4-hydroxy cinnaminic acid), and analyzed by MALDI-TOF mass spectrometry in reflectron 
mode on an ABI 4800 MALDI-TOF/TOF mass spectrometer (Applied Biosystems, Carlsbad, CA, USA). 
Molecular masses were accurately measured and searched against amino acid sequences of human 
APP-C99 with addition of a methionine residue at the N-terminus and a Flag tag sequence (C100Flag) or 
a His tag sequence (C100His) at the C-terminus, or a A692G, E693G, D654N, T714I,V715A, I716V, 
V717F and L723P substitution. 
Molecular dynamics simulations and molecular docking. We used molecular dynamics (MD) 
simulations to characterize the TM domain of WT and APP with FAD mutations. In a first step, the NMR 
structure (PDB code 2LP127) was inserted and equilibrated in a 60 x 60 Å2 Palmitoyl Oleoly Phosphatidyl 
Choline (POPC) patch30 to relax the structure in a phospholipid bilayer. The system was solvated in 60 x 
60 x 100 Å2 water box, neutralized through the addition of NaCl at a concentration of 150 mM. After 30 ns, 
the equilibrated structure was used as initial seed to build the other three mutants (V714A, T715I and 
V717F) and WT-ligand complex. GSM-1 ligand was parameterized using CGenFF and ParamChem 
0.9.631. All MD simulations were performed using NAMD 2.8 engine, with the CHARMM27 force field, 
including CMAP corrections for the protein and CHARMM36 for the POPC membrane32,33. TIP3P water 
parameterization was used to describe the water molecules. The periodic electrostatic interactions were 
computed using the particle-mesh Ewald (PME) summation with a grid spacing smaller then 1 Å. All 
systems were equilibrated for 30 ns at 300K. Free molecular dynamics were performed up to 100 ns with 
a 2 fs integration time step using the RATTLE algorithm applied to all bonds. Constant temperature (300 
K) was imposed by using Langevin dynamics, with damping coefficient of 1.0 ps. Constant pressure of 1 
atm was maintained with a Langevin piston dynamics, 200 fs decay period and 50 fs time constant.  
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GSM-1 was docked on WT and APP mutants using SWISSDock
34,35
 and BSP-SLIM
36
; independently both 
approaches produced similar poses. Since these algorithms do not account for the presence of the 
membrane, we discarded all unphysical docking poses, e.g. the GSM-1 hydroxyl being buried in the 
hydrophobic membrane core. The conformation with the lowest energy was then selected for each 
system. 
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FIGURE LEGENDS  Figure 1 
 
 
 
 
 
 
Figures 1. GSMs alter g-site processing, but do not modulate !-site on APP and Notch in vitro.  a) 
Chemical structure of clinically tested small molecules NSAID-based phenylpiperidine-type GSM-1 and 
bridged aromatics E2012. b) GSMs do not inhibit the overall cell-free processing of APP as shown by WB 
analysis of A" and AICD at concentrations ranging from low nanomolar to low micromolar. Following 
immunoprecipitation, analysis by MALDI-TOF demonstrated the efficacy of GSMs on the g-site, where 
they shifted the production towards shorter A"38 and lowered A"42. Even at concentrations as high as 10 
mM, GSMs do not alter the !-site as evidenced by the IP/MS on the AICD products, AICD49-99 and 
AICD50-99. c) GSMs show no inhibition on Notch intracellular signaling products. In vitro NICD formation 
detected by WB is unaltered. The ratio of the two NICD products, NICD1744-1809 and NICD1743-1809, 
detected after IP/MS, also remained without change in the presence of 10 mM of both compounds. 
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Figure 2 
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Figure 2. Pathological mutations in APP cause altered processing at both  e- and g-sites. a) FAD-APP 
mutations differ by the onset, but are all clustered close to the a-secretase and !-secretase cleavage 
sites, as represented schematically in the left panel (color coding: a-secretase site mutations in green; !-
secretase site mutations in red). Different mean onsets are summarized in the right table. The earliest 
onset is reported for Austrian and German families at the age of early 50s.  b) IP/MS profiles of A" 
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generated from purified FAD-APP-C99 substrates show that mutations A692G, E693G, D694N, I716V, 
V717F and L723P have similar and WT-like A!38/40 and A!42/40 ratios. In contrast, T714I and V715A 
mutations in the transmembrane region led to a drastic increase in both A!38 and A!42 and A!38/40 and 
A!42/40 ratios. c) AICD profiles from the same reactions as analyzed by IP/MS. FAD-APP-C99 mutations 
close to the a-secretase site produce AICD49-99 and AICD50-99 in nearly equimolar ratios. Amino acid 
substitutions in close vicinity of the g-sites in the TMD strongly affect the yield of shorter AICD50-99. 
Figure 3 
 
 
  
Figure 3. GSMs potently shift the production at g-, but not at "-sites in APP with FAD mutations. a) IP/MS 
profiles of A! species produced from purified APP substrates with FAD mutations detected by IP/MS 
demonstrate the efficacy of GSMs towards the g-site processing. For all FAD-APP mutants tested, 
A!38/40 and A!42/40 ratios are strongly affected by 10 mM of GSM-1. Mutations T714I and V715A had 
the most elevated A!38/40, implying that amino acids between APP g- and "-sites are not essential for 
the GSM mechanism of action. b) IP/MS profiles of the "-site products from the same reactions provide 
supplementary evidence that GSMs do not influence the "-sites in APP. Even high concentrations of 
GSM-1 fail to restore the loss of shorter AICD50-99 in mutants T714I, V715A, V717F and L723P.   
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Figure 4 
 
 
 
 
 
 
Figure 4. Structural and dynamic models of the TM domain in WT and FAD-causing APP mutants.  a) The 
NMR structure of WT APP (PDB code: 2LP1
27
) and three FAD-causing mutants, namely T714I, V715A 
and V717F, were inserted in a POPC membrane bilayer and simulated with molecular dynamics. The g-
sites G709, V711 and A713 and !-sites L720 and V721 positions are indicated by blue spheres. b) The 
spatial distribution of A"42 cleavage site is reported for the four systems. The distribution is calculated 
along the axis orthogonal to the membrane bilayer surface and the reference putative position of the g-
site in wild-type conditions is highlighted with the blue area. c) The local bending of the APP helix is 
computed for the TM domain (with a standard error of 2.8 degrees). d) The coordination number of water 
molecules around the relevant residues at the !-site is reported for the WT and mutants. 
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ABSTRACT 
Hyaline Fibromatosis Syndrome (HFS) is an autosomal recessive disease caused by mutations in cmg2, 
a gene involved in extracellular matrix homeostasis. Sixty percent of patients carry a frameshift mutation at 
a mutational hotspot in exon 13, generally due to the insertion of one or two bases. We show in patient 
cells that these mutations lead to low cmg2 mRNA and undetectable protein levels. Ectopic expression of 
the proteins encoded by the mutated genes reveals that a 2 base insertion leads to the synthesis of a 
protein that is rapidly targeted to degradation due to the modified structure of the cytosolic tail, which 
instead of being hydrophilic and highly disordered as in wild type CMG2,  is folded  and exposes 
hydrophobic patches. In contrast, a one base insertion leads a truncated protein that properly localizes to 
the plasma membrane and retains partial function. We next show that targeting the non- sense mediated 
mRNA decay pathway leads to a rescue of CMG2 protein in cells from patients carrying 1 base insertion 
but not in those carrying 2 base insertions. 
 
INTRODUCTION 
Hyaline Fibromatosis Syndrome (HFS) is a rare autosomal recessive disease caused by mutations in 
Capillary Morphogenesis Gene 2 (cmg2) (Dowling et al, 2003; Hanks et al, 2003). The disease is 
progressive, disfiguring and disabling. As suggested by the name,it is characterized by the accumulation of 
amorphous, unidentified hyaline material in the skin and other organs of patients (Shieh et al, 2006; Urbina et 
al, 2004), which could be either a direct effect or a secondary consequence due to the alterations in the 
basal membrane of capillary vessels (Stucki et al, 2001). These non-cancerous tissue proliferations are 
the most outstanding external hallmark of the patients (Deuquet et al, 2011b). In addition, patients usually 
present papular skin lesions, gingival hyperplasia, and joint contractures (Urbina et al, 2004). Two allelic 
forms are now subsumed in HFS: Infantile Systemic Hyalinosis (ISH), the more severe form, whose 
patients have very early onset even at birth and suffer from severe diarrhea, recurrent infection and 
malnutrition that lead to death; and the milder form, Juvenile Hyaline Fibromatosis (JHF), for which afflicted 
individuals reach adulthood even though highly incapacitated by the cutaneous tumors (Deuquet et al, 
2009). Better pediatric care in severely affected infants allows some of them to survive infancy; these 
infants grow to develop the full-blown picture of JHF. Molecular results have confirmed that these 
disorders form a continuous phenotypic spectrum determined at least partially by the combination of 
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ABSTRACT  
Pathological amino acid substitutions in the amyloid precursor protein (APP) and chemical !-secretase 
modulators (GSMs) affect the processing of APP by the !-secretase complex, and the production of the 
amyloid-beta peptide A"42, the accumulation of which is considered causative of Alzheimer#s disease. 
We demonstrate here that mutations in the transmembrane domain of APP causing aggressive early-
onset familial Alzheimer#s disease (FAD) affect both !- and $-cleavage sites, by raising the A"42/40 ratio 
and inhibiting the production of AICD50-99, one of the two physiological APP intracellular domains (ICDs). 
This is in sharp contrast to GSMs, which shift A"42 production towards the shorter A"38, but 
unequivocally spare the $-site and APP- and Notch-ICDs production. Molecular simulations suggest that 
FAD mutations modulate the flexibility of the APP transmembrane domain and the presentation of its g-
site, modifying at the same time the solvation of the $-site.  
 
INTRODUCTION  
The main pathological hallmark of Alzheimer#s disease (AD) is the formation of toxic amyloid fibers that 
progressively accumulate into plaques, which leads to degeneration of the neighboring neuronal cells
1
. 
Further biochemical studies identified the main protein component of plaques to be a short fragment of 
APP, the 42 amino acid long peptide A"42
2
. Moreover, dominantly inherited mutations causing Familial 
Alzheimer#s disease (FAD) are found in APP as well as in the PSEN1 and PSEN2
3,4
 genes encoding for 
the catalytic subunit of the !-secretase complex, an intramembrane-cleaving protease which cleaves APP 
in the plasma membrane and generates the A" peptides
5
. Together, these findings clearly demonstrated 
the implication of APP, !-secretase and A" in both the sporadic and genetic forms of AD. They further 
highlighted the !-secretase-dependent APP processing as an attractive target for drug development.  
In addition to APP, !-secretase cleaves various other substrates regulating biological functions including 
development and stem cell differentiation. This unusual proteolytic complex indeed plays an important 
role in cell signaling pathways by processing different type-I transmembrane cell receptors including the 
Notch receptors, the Insulin receptor, and the Growth hormone receptor
6
. In the brain, it maintains 
synaptic contacts by regulating cleavage of neuronal adhesion molecules like Cadherins and 
Neurexins
7,8
. With the continuously growing number of substrates the need for understanding the exact 
molecular mechanism of this particular proteolytic processing arises.  
!-Secretase is composed of four subunits, presenilin (PS), Aph-1, Pen-2 and Nicastrin (NCT). The 
complex contains in total 19 a-helices embedded in the membrane bilayer, which allows the overall 
structure to adopt different conformations upon binding with the substrate or transition-state analog 
inhibitors
9
. Moreover, the catalytic aspartate residues (Asp257/385) in PS1 are buried into the lipid bilayer 
and surrounded by hydrophobic helices and the cryo-electron microscopy density maps suggested the 
existence of two pores in the globular structure of !-secretase, which can explain the entrance of water 
molecules necessary for the hydrolysis of the peptide bond
10
. Yet, a rigorous biochemical characterization 
of !-secretase complexes with FAD mutations revealed that they all represent a loss of enzymatic 
function, but they ultimately lead to altered A" production and elevated A"42/40 ratio
11,12
. Interestingly, 
FAD mutations in APP can show substrate cleavage patterns that differ from those of mutations in !-
secretase. The large extracellular domain of APP is first removed by b-secretase in the vicinity of the 
plasma membrane. Gain-of-function mutations in this b-site cause elevated levels of total Ab
13
.  !-
secretase processes the remaining 99-amino-acid APP-C terminal fragment (APP-C99) at $-sites close to 
inner layer of the membrane, and releases 49- and 50-amino-acid long APP- intracellular domains 
(AICD50-99 and AICD49-99). After this step, !-secretase sequentially continues to trim the residual 
transmembrane stub, finally producing A"42,  A"40 and A"38 peptides
14
. Mutations surrounding the $-
sites either increase the production of A"42,  which is more neurotoxic compared to the shorter and less 
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fibrillogenic A!40, or lead to elevated total amounts of the A! product without affecting A! ratios
12,15
.  
Amino acid substitutions in the g-site lead to high A!42/40 ratios and are characterized by the most 
prominent and earliest phenotypes of FAD
16
. 
Inhibiting the "-secretase activity to reduce A! production became an attractive therapeutic strategy to 
treat AD. However, "-secretase inhibitors (GSIs) tested in clinical trials not only did not meet their initial 
clinical endpoints, but also manifested severe off-target effects due to impaired Notch signaling, leading to 
gastrointestinal bleeding and increased risk of skin cancer
17
. Consequently, a concept of selective 
modulation of the "-secretase activity has emerged. A subset of non-steroidal anti-inflammatory drugs 
(NSAIDs) were the first Notch-sparing small molecules shown to selectively lower A!42 and subsequently 
raise A!38, both in vitro and in vivo
18,19
. These "-secretase modulators (GSMs) were initially shown to 
bind to APP, although some more recent studies demonstrated that they also can target "-secretase
20,21
.  
Although the precise molecular mechanism of action remains poorly understood, a number of these 
molecules have advanced to clinical trials
22
.  
In this report, we demonstrate that second generation GSMs, including the clinically tested E2012, 
effectively lower the production of toxic A!42, without affecting the e-cleavage sites of both APP and 
Notch substrates. In contrast, we show that the T714I, V715A, V717F and L723P FAD-APP mutations in 
the transmembrane (TM) region block the production of AICD50-99, the 49-amino-acid long AICD, without 
affecting the total amount of AICD. Moreover, mutations T714I and V715A elevated the A!42/40 and 
A!38/40 ratios, in contrast to I716V, V717F and L723P for which these profiles were comparable to those 
obtained with wild type APP. GSMs affected all mutants at their "-cleavage site, with the strongest effect 
on the A!38/40 and A!42/40 ratios in T714I and V715A, suggesting that these amino acid substitutions 
are important for the generation of A!42 and A!38 . In addition, we found that GSMs do not reverse the 
loss of AICD50-99 production caused by FAD mutations.  We rationalize these findings using molecular 
dynamics simulations of the APP TM segment embedded in the lipid bilayer, and propose that FAD-APP 
mutants and possibly GSMs affect the "-cleavage site by changing the flexibility, tilt angle and position of 
the substrate in the membrane. GSMs fail to recover e-cleavage, most likely because they affect the 
substrate-enzyme interface at a position which is distant from the #-site and closer to the outer layer of 
the membrane. Finally, FAD mutants had altered solvation at the e-cleavage site, which can explain the 
different product lines generated after the first step of the processing of APP. 
 
RESULTS 
GSMs affect the g- but not the e-cleavage of APP and Notch.  
We first investigated the effect of GSM-1 and E2012, two representative molecules of the two main 
classes of second generation GSMs: NSAID-based phenylpiperidine-type compounds and non-NSAID 
bridged aromatics, respectively (Fig. 1a). Although these compounds have different structures, they both 
modulate  "-secretase activity at low nanomolar concentrations in cells
23
. In enzymatic in vitro assays 
using highly purified "-secretase and recombinant APP-C100-Flag substrate, we first show that 
concentrations several fold higher than the cellular IC50 concentrations of GSM-1 and E2012 do not affect 
the overall amounts of A! and AICD, when compared to control levels (Fig. 1b, upper panels).  We next 
investigated in detail the effect of these molecules on all reaction products. For both compounds tested at 
10 mM, immunoprecipitation with 4G8 anti-A! antibody, combined with MALDI-TOF spectrometry (IP/MS) 
revealed a robust increase in A!38, associated with a decrease in A!42  (Fig.1b, middle panels).  At this 
concentration GSM-1 showed a stronger effect than E2012 on A!42/40  and A!38/40 ratios, while both 
compounds lowered A!43. IP/MS analyses of the C-terminal cleavage products revealed an unchanged 
equimolar production of the two AICDs (Fig. 1b, lower panels). Together, these results clearly 
demonstrate that GSMs affect the APP "-cleavage sites, while completely sparing the #-sites. Because of 
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the clinical relevance of GSMs and the Notch signaling pathway, we further questioned whether GSMs 
could interfere with the Notch intracellular domain (NICD) production. As shown in Figure 1c, GSMs did 
not influence total NICD production and did not affect the NICD cleavage profiles. Our in vitro findings 
were further confirmed in cell-based assays. First, intracellular accumulation of endogenous !-secretase 
substrates APP-C83 and APP-C99, which is a common characteristic among known !-secretase 
substrates in response to !-secretase inhibition, was assessed in HEK293T cells stably overexpressing 
APP with the FAD Swedish mutation KM670/671NL. In contrast to the control GSI, 1 and 10 mM E2012 or 
GSM-1 did not affect the levels of APP- CTFs (Supplementary Fig.1a). Next, treatments with E2012 and 
GSM-1 up to 1 mM in a cell-based luciferase assay in which AICD generation correlates with increased 
luciferase expression and induced luminescence emission, did not result in a significant inhibition of AICD 
release (Supplementary Fig. 1b). Additionally, the GSMs were tested in human lymphocytic leukemia 
SUP-T1 cells constitutively producing NICD. In contrast to the GSI XIX which completely abolished NICD 
production, E2012 and GSM-1 did not affect NICD production at concentrations up to 10 mM 
(Supplementary Fig. 2a). These findings were confirmed in a cellular Notch-based assay in which a 
luciferase reporter system is directly placed under the control of NICD
24
 (Supplementary Fig. 2b), as well 
as in HEK cells overexpressing NotchDE
25
 (Supplementary Fig. 2c). In the latter two assays, E2012 and 
GSM-1 concentrations up to 1 mM did not affect NICD production. At 10 mM, E2012, but not GSM-1, 
significantly reduced NICD production in DL4-Hela/N1-Hela co-cultures by 55% (***p<0.001) 
(Supplementary Fig. 2b). Taken together, we conclude that E2012 and GSM-1 do not alter the Notch and 
APP "-site cleavage at concentrations as high as 10x cellular IC50. At higher concentrations (100x cellular 
IC50), only the non-NSAID-based compound E2012 can inhibit to some extent intracellular signaling of 
Notch and APP in cell-based assays. 
   
APP mutations causing familial Alzheimer!s disease differentially alter g- and "-sites. 
APP mutations causing familial Alzheimer#s disease (FAD) can be grouped based on their localization at 
three different regions: at the b-secretase cleavage site, in close vicinity of the a-secretase cleavage site 
in the A$ region, or in the transmembrane domain (TMD) of APP, between the g- and the "-sites (Fig. 2a, 
left). These mutations differ not only by the onset of the disease (Fig. 2a, right), but also by the molecular 
fingerprint of the produced A$ peptides. Indeed, the vast majority of mutations in the a- and b-sites lead to 
overproduction of total A$ (mutations in the A$ region can also render the A$42 peptide more fibrinogenic 
and prone to aggregation) while mutations in the transmembrane region seem to be linked to an elevated 
A$42/40 ratio
12,26
. Because no information exists about how these mutations affect both the g- and e-
cleavage sites in APP, and because AICD has been suspected to play a role in the pathogenesis of 
Alzheimer#s disease, we analyzed A$ and AICD products generated from purified APP-C99 substrates 
carrying the FAD mutations listed in Figure 2a. All recombinant substrates were processed by purified !-
secretase (Supplementary Fig. 3). IP/MS analyses of the A$ and AICD profiles revealed that amino acid 
substitutions clustered near the a-secretase (A692G, E693G, D694N) apparently do not alter the A$ or 
AICD profiles, when compared to the control WT APP-C99 (Fig. 2b). In striking contrast, T714I and V175A 
mutations close to the transmembrane !-cleavage site lead to drastically increased A$42/40 and A$38/40 
ratios and to a total inhibition of the production of the shortest AICD50-99 (Fig. 2c). Interestingly, 
mutations closer to the e-cleavage sites (I716V, V717F and L723P) are characterized by an intermediate 
phenotype as they do not alter A$ profiles, but clearly lower the production of AICD50-99 (below detection 
levels for V717F and L723P) (Figs. 2b and c). Taken together, our data demonstrate that FAD-causing 
mutations in the transmembrane region of APP, but not close to the a-secretase site, affect both  g- and/or 
"-sites.  
 
GSMs affect the g- but not the e-cleavage of APP with FAD mutations.  
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To better understand the molecular mechanism by which GSMs shift A! production, as well as to verify 
whether GSMs can still lower A!42 and have potential therapeutic benefits in patients with FAD, we 
decided to test GSM-1 on APP-C99 with FAD mutations. GSM-1 was chosen because it was more potent 
in our in vitro "-secretase assay, and also because this compound did not affect e-cleavage in all cell-
based experiments. First, 10 mM GSM-1 did not affect the levels of total cleavage products (compare 
AICD and A! levels in Supplementary Figs. 3a and 3b), providing further evidence that GSMs do not 
modify the overall yield of "-secretase processing. Next, we found that GSM-1 conserved its A!42-
lowering and A!38-raising properties on all tested mutant substrates (Fig. 3a). However, GSM-1 did not 
influence the e-cleavage and none of the mutants tested recovered the wild-type phenotype of nearly 
equimolar production of AICD49-99 and AICD50-99 (compare AICD profiles in Figs. 3b and 2c). Our 
findings provide new evidence that GSMs lower A!42 production by interfering with the g-site in APP 
substrates with FAD mutations, strongly suggesting that none of the substituted amino-acid residues are 
crucial for the GSM-dependent modulation of APP processing by "-secretase. They further demonstrate 
that GSMs fail to reverse the effects on AICD production of FAD-causing mutations in the transmembrane 
domain of APP.  
  
Structural changes in the TM domain of APP with FAD-causing mutations  
To support our results mechanistically, we used molecular dynamics (MD) simulations to further insights 
into the structural and dynamic properties of the transmembrane domain (TMD) of wild-type APP and 
three FAD-mutants (T714I, V715A and V717F) in the membrane environment. These mutations were 
chosen because they either affect both "- and #-cleavage sites (T714I, V715A), or exclusively the #-site 
(V717F). The TM region of the APP-C99 NMR structure (PDB code 2LP127) was used and inserted into a 
phosphatidylcholine (POPC) lipid bilayer (Fig. 4a). MD simulations were carried out under $#%& 
physiological conditions (i.e., pH ~7, 1 atm, 300 K), mimicking as close as possible the conditions of the 
"-secretase enzymatic assay used in our study. For all systems, the secondary structure of APP 
fluctuated only marginally. Consistent with the NMR observations, the N-terminus amphiphilic helix 
(Q686–N698) lies on the membrane surface, and a lysine belt (K687, K699, K724–726) anchors the TMD 
and N-terminus helices, respectively, in and onto the membrane (Fig. 4a). During simulation, the helices 
tilted with respect to the membrane surface. We found that the V717F mutation affected the most the 
orientation of the TMD, tilting it by 45 ± 5 degrees, while the wild type and T714I and V715A mutants 
remained more vertical (36 ± 5, 38 ± 3 and 36 ± 3 degrees, respectively) (Fig. 4a and Supplementary Fig. 
4a). These mutations further shifted the TMD perpendicularly to the membrane surface. When measuring 
the position of the A!42 cleavage site (I712 - A713 peptide bond), T714I and V715A mutants shifted 
closer (2.9 ± 1.2 Å and 2.3 ± 0.9 Å, respectively) to the cytoplasmic interface compared to the WT, 
whereas V717F moved closer (-0.2 ± 1.3 Å) to the extracellular membrane layer (Fig. 4b). The combined 
effect of elevation and tilting perturbations of the APP TMD due to FAD-mutations is probably affecting the 
presentation to the enzyme of the "-cleavage site at position 42, correlating quantitatively with the 
changes in A!42/A!40 ratio (Fig. 2). Moreover, the flexibility of the transmembrane domain, estimated 
based on the local bending of the helix28, resulted to be much higher for T714I and V715A mutants, 
specifically at the G29XXXGXXXG37 region (Fig. 4c). 'olecular docking and simulations of GSM-1 
compound suggested the same region as the conserved drug-binding pocket (L701, G704 and G708 
being the most direct interactions with GSM-1, Supplementary Fig. 4) for both the wild-type and mutant 
APP. Thus, GSM-1 effect on T714I and V715A FAD mutants might cause an attenuation of their flexibility 
close to the g-site. For all three mutants, the hydration of the #-site at residue L720 was significantly 
decreased compared to the WT (Fig. 4d). In particular, for APP-WT one water molecule is in average 
within 3 Å of L720 backbone, while the water coordination number drops to less than 0.5 Å for V715A, 
and to nearly zero for T714I and V717F. This effect can be ascribed to the different water permeation 
properties of the APP C-terminus lysine belt combined with the perturbed helical orientation produced by 
the mutants. Together, our data support a model in which structural changes and, in particular, the 
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position of the !-cleavage site relative to the membrane surface can potentially modulate A" production, 
while the hydration of L720 can affect the e-cleavage site and the production of the two AICDs potentially 
implicated in signalling pathways and in the pathogenesis of AD. 
 
DISCUSSION  
Mutations in APP cause aggressive early-onset Alzheimer#s disease by triggering abnormal production, 
accumulation and aggregation of A" peptides. The most severe pathological phenotype is observed for 
mutations occurring in the transmembrane region and in close vicinity of the A"42 !-cleavage site, 
leading to elevated A"42/40 and A"38/40 ratios (Fig. 2). Small chemical !-secretase modulators (GSMs) 
are known to lower A"42 and raise A"38, without affecting the overall production of the A" peptides. In 
this study, we used second generation GSMs with a strong therapeutic potential (GSM-1 and E2012), in 
combination with APP substrates with FAD-causing mutations, (i) to better understand the molecular 
mechanisms of the !-secretase-dependent, intramembrane and sequential cleavage of the substrate, (ii) 
to identify changes in APP-cleavage profiles, potentially implicated in the pathogenesis of AD, and (iii) to 
further support the therapeutic potential of GSMs to safely treat sporadic as well as early-onset familial 
AD. We further demonstrate here that GSMs represent an attractive scaffold for structure-activity 
relationship design (SAR) of potent disease-modifying drugs against AD. As they do not affect the 
processing of the Notch substrate (Fig. 1), GSMs are expected to circumvent clinical side effects 
observed with GSIs and attributed to impaired Notch processing17. Moreover GSMs do not alter AICD 
production (Fig. 1) and thus are not likely to influence the downstream cell signaling functions of APP, 
again underlying the huge therapeutic potential of these compounds in sporadic AD cases. Additionally, 
our results confirm altered g-site processing in APP-FAD mutations, associated with an increase of A"42 
and A"38 and demonstrate that mutations located in close vicinity to the g-site do impede the production 
of the shorter $-site counterpart AICD50-99. Mutations T714I and V715A display the strongest phenotype 
at both g- and $-sites, with highest A"42/40 and A"38/40 ratios. Moreover, these mutations lead to the 
production of only one detectable AICD, suggesting a putative role of AICD in AD pathogenesis. These 
results might be explained with the sequential cleavage model of APP-CTF, in which the generation of 
A"40 is dependent on the AICD50-99, while A"42/38 is linked to AICD49-9914. Reduced AICD50-99 (as 
observed for some FAD mutants) is expected to be associated with less A"40 and more A"42/38, thus 
increasing the pathogenic ratio of A"42/40. The combination of higher A"42/40 ratio and the loss of 
AICD50-99 can explain the extreme aggressiveness of these APP mutations with regard to the onset of 
the disease. GSMs were still potent at the g-site of mutated APP substrates, but failed to rescue the 
phenotype at the e-cleavage site (Fig. 3). These findings clearly demonstrate that GSMs can be used for 
the treatment of patients with both sporadic and genetic forms of AD. To better understand the effect of 
GSM binding, we docked the GSM-1 compound on the ensemble of wild-type and FAD-mutants (T714I, 
V715A and V717F) conformations generated by MD simulations. GSM-1 strongly binds to the previously 
identified G29XXXGXXXG37 motif (Supplementary Fig.4), further supporting our observation that amino 
acids close to the g-sites of APP are not required for GSMs activity, again underlying the therapeutic 
potential of these compounds20. 
Rationalizing these results with structural models based on molecular simulations of wild type and mutant 
APP substrates, we propose that the observed effects on A" and AICD production can be triggered by 
combined changes in the flexibility, tilting angle, and positioning of both g- and $-sites in the membrane, 
along with the hydration levels at the $-sites. Such structural changes, by potentially modifying the 
presentation of the substrates to the enzymatic complex, might affect the !-secretase cleavage specificity. 
Consistent with this model, the elevated A"38/40 ratio observed in mutants T714I and V715A can be 
explained by the vertical shift of the helix in the membrane bilayer, with the consequent presentation of 
position 38  instead of 40 to the !-secretase cleavage site. The observed vertical shift in mutants (~2.5 Å) 
is in fact associated with a tilting of half of a helix turn (i.e., displacement of 2 amino acids). Interestingly, 
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A!38 and A!42  have been proposed to originate from the same sequential processing pathway, starting 
at the e-position 48, and directly linked to AICD49-99 production
14
. Consistent with this sequential model, 
we propose that the conformational changes in the T714I and V715A substrates, associated with reduced 
AICD50-99 levels, explain the preferential A!38 and A!42 production observed with these mutants. 
Interestingly, and apparently in contrast to the sequential cleavage model, the V717F and L723P mutants, 
although characterized by reduced AICD50-99 levels, do not show modifications in their A! profiles. This 
observation may reflect the existence of two or more different pathological molecular explanations, 
classifying FAD forms in different categories.  
The nearly complete loss of AICD50-99 production in mutants T714I, V715A, V71F and L723P, can be 
attributed, according to our model, to higher solvation states around positions 49 and 50, with the latter 
becoming more exposed to water molecules. One can speculate that the increased water accessibility to 
the leucine 49 may favor the cleavage at this position, or inhibit the cleavage at valine 50 by preventing 
the interaction at position 50 of APP-C99 with the hydrophobic transmembrane domain 1 of the "-
secretase catalytic component PS1.  
Together, our data reported here provide new insights into the therapeutic mechanism and potential of 
chemical "-secretase modulators. They are further expected to improve our current understanding of the 
pathological mechanism of familial AD. 
 
 
METHODS 
!-secretase inhibitors and modulators. "-secretase inhibitors Compound E and GSI XIX were 
purchased from Merck Millipore (Darmstadt, Germany). The heteroaryl-type GSM E2012 
(US2006/0004013) was obtained from Haoyuan Chemexpress Co. and the NSAID-type GSM-1 was 
synthesized at Syngene according to methods described in WO2006/043064. 
Molecular Biology.  
The pET21b vector encoding the cDNAs of human APP-C99-His was used as a template for the 
generation by PCR-amplification of all FAD APP-C99 mutants described in this study. The constructs were 
expressed in BL21(DE3) cells induced with 1 mM isopropyl-!-D-thiogalactopyranoside (IPTG) for 4 h at 
optic density 600 nm = 0.8. For the purification of APP-C99 mutants, harvested bacteria were lysed with 
10 mM Tris pH 7.0, 150 mM NaCl, 1 % Triton X-100, protease inhibitor cocktail (PI; Roche, Rotkreuz, 
Switerland), and passed through a high-pressure homogenizer (Emulsiflex-C5; Avestin, Inc., Mannheim, 
Germany). The obtained lysates were spun down at 5000 x g for 30 min and supernatants were incubated 
overnight with Ni-NTA agarose beads (Invitrogen, Basel, Switzerland) at 4 °C. Bound proteins were eluted 
in 1 % NP-40 containing 250 mM imidazole (pH 7.8), analyzed by Coomassie stained sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and quantified by BicinChoninic Acid (BCA; 
Pierce, Rockford, IL, USA). The normalization was validated by WB. Recombinant APP-C100-Flag and 
Notch N100-Flag substrates were also expressed in BL21(DE3) cells, but 100 mM glycine (pH 2.7)/1% 
NP40 was used for elution from M2-agarose beads.  
Western blotting and antibodies.  
Samples from !-secretase activity assays were run on 4–12 % Bis-Tris gels and transferred onto PVDF 
membranes to detect Ab, Flag-tagged APP- or Notch-intracellular domain (AICD-Flag and NICD-Flag) with 
Ab-specific 6E10 (1:1000; Covance, Berkeley, CA, USA) and Flag-specific M2 antibodies. Anti-
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mouse/rabbit/rat IgG conjugated to Alexa 680 were purchased from Invitrogen and the Odyssey infrared 
imaging system (LICOR) was used to detect the fluorescent signal.  
Whole cell extracts prepared in 50 mM HEPES buffer containing 1 % NP40 were separated by 
electrophoresis on NuPAGE® Novex® 4-12 % Bis-Tris Gels (Invitrogen, Carlsbad, CA, USA) for SDS-
PAGE analysis transferred onto nitrocellulose membranes, and probed with antibodies against APP-CTFs 
(Sigma-Aldrich GmbH, Buchs, Switzerland.). For detection of NICD, membranes were blocked with 5 % 
milk and incubated overnight with primary antibody Val1744 anti-Notch (Cell Signaling, Bioconcept, 
Allchwil, Switzerland) at 4 °C. Membranes were washed with 1x TBST (1x TBS + 0.1 % Tween 20) for 15 
min and incubated with HRP-conjugated secondary antibodies for 1 h at room temperature. Signal was 
detected with Super Signal West chemiluminescent substrate (Thermo Scientific, catalog number 34077). 
!-secretase purification. !-secretase used in this study was purified from 10 liters of PB suspension 
cultures by following the protocol described by Alattia et al. (submitted for publication). 
!-secretase activity assays. !-secretase assays using the recombinant APP- or Notch-based substrates 
were performed as previously reported29. Briefly, highly-purified !-secretase were solubilized in 0.2 % 
(wt/vol) CHAPSO, 50 mM HEPES (pH 7.0), 150 mM NaCl, 5 mM MgCl2 and 5 mM CaCl2, and incubated 
at 37 °C for 4 h with 1 mM substrate, 0.1 % (wt/vol) PC, 0.025 % (wt/vol) PE. The resulting products, APP 
intracellular domain AICD-Flag, AICD-His, Ab, and Notch intracellular domain NICD-Flag were detected 
with above-described antibodies, or analyzed by mass spectrometry. 
Immunoprecipitation-mass spectrometry (IP-MS) analysis of A" and AICD. A" and AICD generated 
in !-secretase in vitro assays with purified substrates were analyzed as previously described29 . Briefly, 
A"  was IP#d overnight using anti-A" antibody 4G8 (Covance, Berkeley, CA, USA) and protein G coupled 
to agarose resin (Roche Applied Science, Penzberg, Germany). For AICD or NICD detection, 12 mL 10 % 
Triton-X100 solution was added after the enzymatic reaction and incubated for 20 min at 55 °C prior to 
overnight immunoprecipitation at 4 °C with M2-anti Flag resin (Invitrogen, Carlsbad, CA, USA), or Protein 
G (Roche, Mannheim, Germany), coupled with anti-C-terminal AICD antibody. A" and AICD-Flag were 
eluted with 1:20:20 (v:v:v) 1 % (vol/vol) trifluroacetic acid:acetonitrile:H20, equally mixed with saturated 
CHCA (a-cyano 4-hydroxy cinnaminic acid), and analyzed by MALDI-TOF mass spectrometry in reflectron 
mode on an ABI 4800 MALDI-TOF/TOF mass spectrometer (Applied Biosystems, Carlsbad, CA, USA). 
Molecular masses were accurately measured and searched against amino acid sequences of human 
APP-C99 with addition of a methionine residue at the N-terminus and a Flag tag sequence (C100Flag) or 
a His tag sequence (C100His) at the C-terminus, or a A692G, E693G, D654N, T714I,V715A, I716V, 
V717F and L723P substitution. 
Molecular dynamics simulations and molecular docking. We used molecular dynamics (MD) 
simulations to characterize the TM domain of WT and APP with FAD mutations. In a first step, the NMR 
structure (PDB code 2LP127) was inserted and equilibrated in a 60 x 60 Å2 Palmitoyl Oleoly Phosphatidyl 
Choline (POPC) patch30 to relax the structure in a phospholipid bilayer. The system was solvated in 60 x 
60 x 100 Å2 water box, neutralized through the addition of NaCl at a concentration of 150 mM. After 30 ns, 
the equilibrated structure was used as initial seed to build the other three mutants (V714A, T715I and 
V717F) and WT-ligand complex. GSM-1 ligand was parameterized using CGenFF and ParamChem 
0.9.631. All MD simulations were performed using NAMD 2.8 engine, with the CHARMM27 force field, 
including CMAP corrections for the protein and CHARMM36 for the POPC membrane32,33. TIP3P water 
parameterization was used to describe the water molecules. The periodic electrostatic interactions were 
computed using the particle-mesh Ewald (PME) summation with a grid spacing smaller then 1 Å. All 
systems were equilibrated for 30 ns at 300K. Free molecular dynamics were performed up to 100 ns with 
a 2 fs integration time step using the RATTLE algorithm applied to all bonds. Constant temperature (300 
K) was imposed by using Langevin dynamics, with damping coefficient of 1.0 ps. Constant pressure of 1 
atm was maintained with a Langevin piston dynamics, 200 fs decay period and 50 fs time constant.  
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GSM-1 was docked on WT and APP mutants using SWISSDock
34,35
 and BSP-SLIM
36
; independently both 
approaches produced similar poses. Since these algorithms do not account for the presence of the 
membrane, we discarded all unphysical docking poses, e.g. the GSM-1 hydroxyl being buried in the 
hydrophobic membrane core. The conformation with the lowest energy was then selected for each 
system. 
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FIGURE LEGENDS  Figure 1 
 
 
 
 
 
 
Figures 1. GSMs alter g-site processing, but do not modulate !-site on APP and Notch in vitro.  a) 
Chemical structure of clinically tested small molecules NSAID-based phenylpiperidine-type GSM-1 and 
bridged aromatics E2012. b) GSMs do not inhibit the overall cell-free processing of APP as shown by WB 
analysis of A" and AICD at concentrations ranging from low nanomolar to low micromolar. Following 
immunoprecipitation, analysis by MALDI-TOF demonstrated the efficacy of GSMs on the g-site, where 
they shifted the production towards shorter A"38 and lowered A"42. Even at concentrations as high as 10 
mM, GSMs do not alter the !-site as evidenced by the IP/MS on the AICD products, AICD49-99 and 
AICD50-99. c) GSMs show no inhibition on Notch intracellular signaling products. In vitro NICD formation 
detected by WB is unaltered. The ratio of the two NICD products, NICD1744-1809 and NICD1743-1809, 
detected after IP/MS, also remained without change in the presence of 10 mM of both compounds. 
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Figure 2 
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Figure 2. Pathological mutations in APP cause altered processing at both  e- and g-sites. a) FAD-APP 
mutations differ by the onset, but are all clustered close to the a-secretase and !-secretase cleavage 
sites, as represented schematically in the left panel (color coding: a-secretase site mutations in green; !-
secretase site mutations in red). Different mean onsets are summarized in the right table. The earliest 
onset is reported for Austrian and German families at the age of early 50s.  b) IP/MS profiles of A" 
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generated from purified FAD-APP-C99 substrates show that mutations A692G, E693G, D694N, I716V, 
V717F and L723P have similar and WT-like A!38/40 and A!42/40 ratios. In contrast, T714I and V715A 
mutations in the transmembrane region led to a drastic increase in both A!38 and A!42 and A!38/40 and 
A!42/40 ratios. c) AICD profiles from the same reactions as analyzed by IP/MS. FAD-APP-C99 mutations 
close to the a-secretase site produce AICD49-99 and AICD50-99 in nearly equimolar ratios. Amino acid 
substitutions in close vicinity of the g-sites in the TMD strongly affect the yield of shorter AICD50-99. 
Figure 3 
 
 
  
Figure 3. GSMs potently shift the production at g-, but not at "-sites in APP with FAD mutations. a) IP/MS 
profiles of A! species produced from purified APP substrates with FAD mutations detected by IP/MS 
demonstrate the efficacy of GSMs towards the g-site processing. For all FAD-APP mutants tested, 
A!38/40 and A!42/40 ratios are strongly affected by 10 mM of GSM-1. Mutations T714I and V715A had 
the most elevated A!38/40, implying that amino acids between APP g- and "-sites are not essential for 
the GSM mechanism of action. b) IP/MS profiles of the "-site products from the same reactions provide 
supplementary evidence that GSMs do not influence the "-sites in APP. Even high concentrations of 
GSM-1 fail to restore the loss of shorter AICD50-99 in mutants T714I, V715A, V717F and L723P.   
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Figure 4 
 
 
 
 
 
 
Figure 4. Structural and dynamic models of the TM domain in WT and FAD-causing APP mutants.  a) The 
NMR structure of WT APP (PDB code: 2LP1
27
) and three FAD-causing mutants, namely T714I, V715A 
and V717F, were inserted in a POPC membrane bilayer and simulated with molecular dynamics. The g-
sites G709, V711 and A713 and !-sites L720 and V721 positions are indicated by blue spheres. b) The 
spatial distribution of A"42 cleavage site is reported for the four systems. The distribution is calculated 
along the axis orthogonal to the membrane bilayer surface and the reference putative position of the g-
site in wild-type conditions is highlighted with the blue area. c) The local bending of the APP helix is 
computed for the TM domain (with a standard error of 2.8 degrees). d) The coordination number of water 
molecules around the relevant residues at the !-site is reported for the WT and mutants. 
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specific CMG2 gene mutations ((Deuquet et al, 2011a; Deuquet et al, 2011b). 
The responsible gene cmg2 is expressed in all tissues except the brain, consistent with development of 
normal intelligence in patients (Deuquet et al, 2011b; Stucki et al, 2001). Cmg2 encodes a 55kDa type I 
transmembrane protein, consisting of an extracellular N-terminal von Willebrand factor type A domain 
(vWA) followed by an Ig-like domain, a single transmembrane helix and a cytosolic tail  (Deuquet et al, 2011a; 
Deuquet et al, 2011b). vWA domains, also called I-domain  of  integrins, contain a metal ion-dependent 
adhesion site (MIDAS) motif with which they interact with extracellular matrix (ECM) proteins such as 
collagens (Engel & Chiquet, 2011). The CMG2 vWA domain has been proposed to bind collagen IV and 
laminin (Bell et al, 2001). The exact function of the CMG2 Ig-like domain has not been determined. It was 
however shown to contain two disulfide bonds essential for proper CMG2 folding in the endoplasmic 
reticulum (ER) (Deuquet et al, 2011a). The CMG2 cytoplasmic tail is composed of 148 residues and 
contains multiple post-translational modification sites such as palmitoylation (Abrami et al, 2006), 
phosphorylation (Abrami et al, 2010) and ubiquitination (Abrami et al, 2010), modifications that are 
important for the surface dynamics and plasma membrane turn over of the protein (Deuquet et al, 
2011b). 
So far, more than 150 cases of HFS have been reported and some 34 different mutations, mostly in exons, 
have been identified (Deuquet et al, 2011b). Among them, exon 13 is a hot spot for frameshift mutations, 
which include insertion of one or two bases –c.1073-1074insC (hereafter referred to as insC), c.1073-
1074insCC (insCC)– and deletion of one base –c.1074delT (delT). These three frameshift mutations 
account for approximately 60% of all the pathogenic alleles. The frequency of insertions and deletions at 
positions 1073-1074 is likely due to its proximity to a low complexity, GC-rich, region encoding a stretch of 
proline residues (Fig 1A) that could constitute a vulnerable site for errors during DNA replication. 
Here, we have investigated the molecular consequences of the frameshift mutations in exon 13, which 
encodes the beginning of the cytosolic tail of CMG2. We first show that in fibroblasts derived from patients 
carrying such mutations, the mRNA level of cmg2 was drastically lower than in fibroblasts from healthy  
donors.  This is most likely due to the generation of a premature stop codon that would be recognized by 
the nonsense-mediated mRNA decay (NMD) pathway (Rebbapragada & Lykke- Andersen, 2009). This 
observation would point to the NMD pathway as a potential therapeutic target. We however first studied 
the effects of the insC, insCC and delT mutations at the protein level by ectopic expression of the 
corresponding cDNAs in HeLa cells. In this system, we found the insCC and delT mutations lead to 
mutant CMG2 proteins – CMG2insCC
 
and CMG2
delT
– that are rapidly targeted to ER associated degradation 
(ERAD). Patients with this mutation would therefore not benefit from drugs targeting the NMD pathway and 
consistently silencing upf1, a central factor of this mRNA decay pathway, did not rescue the CMG2
insCC 
and 
CMG2
delT  
protein expression. In contrast, CMG2
insC
, a mutation that occurs at the same hotspot but causes 
a different shift in the reading frame, was well expressed in HeLa cells and properly targeted to the cell 
surface, where it was competent for ligand binding. Importantly, in patient fibroblasts, silencing upf1 led to 
a partial restoration of CMG2
insC
 
protein, to its proper targeting to the cell surface where it exhibited the 
ability to bind a surrogate ligand. 
This study shows that certain HFS patients could benefit from therapies that would target the NMD 
pathway. They however also highlights the importance of an in depth analysis of the consequences of 
specific mutations to determine the appropriate potential treatment. 
RESULTS AND DISCUSSION 
 
Analysis of frameshift mutations in HFS patients 
The three frameshift mutations in exon 13 of cmg2 that have been identified in HFS patients all lead to 
premature stop codons. The mutated insC, insCC and delT genes encode for CMG2 proteins that have 
modified and shorter cytosolic tails of 29, 67, 66 amino acids respectively, compared to the 148 residue wild 
type CMG2 tail (Fig. 1A.) Note that the insCC and delT mutations lead to the same altered reading frame 
and thus to the same cytosolic tail, with the exception of one additional residue at position 359 of 
CMG2insCC. 
 
To understand the consequences of these frameshift mutations, we analyzed fibroblasts from five previously 
described patients (Table 1) (Deuquet et al, 2011a; Dowling et al, 2003). Patient 1 is homozygous for the 
insC single nucleotide insertion (Deuquet et al, 2011a). All other patients are compound heterozygotes, 
carrying one of the three frameshift mutations on one allele and one missense mutation on the other. 
Patient 2 (Dowling et al, 2003) carries the insC mutation and a c.566T>C transversion, which causes a 
p.I198T amino acid substitution (Table 1). Patient 3 (Deuquet et al, 2011a) carries the insC mutation and a 
c.928G>T transversion resulting in a p.V310F missense mutation (Table 1). Patient 4 (Hanks et al, 
2003) carries the insCC mutation and a missense mutation c.566T>C as Patient 2. Patient 5 (Deuquet et 
al, 2011a) carries the delT mutation and a c.115G>T transversion leading to the p.C39F amino acid 
substitution (Table 1). All patients suffer from the severe infantile form of HFS, with the exception of 
patient 3, who suffers from a somewhat milder form possibly due to better pediatric care (Deuquet et al, 
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2011a; Dowling et al, 2003). We performed a real-time quantitative PCR analysis of mRNA extracted 
from the patient fibroblasts. The cmg2 mRNA levels were significantly lower in patient cells than the 
healthy control fibroblasts (Fig. 1B). Patient 1, the only one carry a frameshift mutation on both alleles, 
showed the lowest mRNA level. The compound heterozygous patients had cmg2 mRNA levels ranging 
from 46% to 72% of that of the control fibroblasts. The decrease of mRNA level observed in patient-
derived fibroblasts is presumably due to the non-sense mediated mRNA decay (NMD) pathway, which can 
recognize the presence of a premature stop codon in mRNA caused by frameshift mutations (Rebbapragada 
& Lykke-Andersen, 2009). The NMD pathway would thus target both alleles in Patient 1 and only one 
allele in all other patients. 
We next analyzed protein extracts from the patient cells by Western blotting using an anti-human CMG2 
monoclonal antibody (Deuquet et al, 2011a). As expected, a band corresponding to full-length CMG2 
(55kDa) was readily detected for control fibroblasts. A weaker band of similar molecular weight was 
detected for cells from the compound heterozygous patients as previously observed (Deuquet et al, 
2011a). However none of the truncated CMG2 forms  (CMG2
insC
:  42kDa, CMG2
insCC 
and CMG2
delT
: 45kDa) 
could be detected, even at high exposure or following immunoprecipitation using an antibody against the 
N-terminal ectodomain of CMG2 (data not shown) consistent with the low mRNA levels. 
 
Ectopic expression of CMG2
insC
, CMG2insCC
 
and CMG2
delT
 
 
The above observations show that the mRNA levels of the frame-shifted cmg2 variants are very low, which 
could account for the absence of CMG2, and suggest that the NMD pathway might be a potential therapeutic 
target. Before exploring this option, we however first investigated whether  the  CMG2
insC
, CMG2insCC
  
and 
CMG2
delT 
proteins can be properly expressed in tissue culture cells upon transfection with the appropriate 
cDNAs. Unexpectedly, CMG2
insCC 
and CMG2
delT 
were essentially undetectable by Western blotting 
whereas CMG2
insCC
, which migrated at an expected molecular weight of 42 kDa, was expressed at 
similar levels as CMG2
WT 
(Fig 2A). The low expression of CMG2insCC
 
and CMG2
delT 
was not due to 
reduced synthesis as shown by performing a 5-minute metabolic pulse (Fig. 2B). Immunofluorescence on 
non-permeabilized cells using a monoclonal antibody directed towards the ectodomain of CMG2 showed 
that ectopically expressed CMG2
insC  
was properly targeted to the cell surface (Fig. 2C). To investigate 
whether it was capable of binding ligands, we monitored binding of the anthrax protective antigen (PA), 
used as a surrogate ligand (Deuquet et al, 2011b; van der Goot  & Young, 2009). For this, we used Hela 
cells in which the expression of the second anthrax toxin receptor, TEM8, was silenced by lentiviral 
mediated silencing using an shRNA construct against TEM8 (Fig. S1). As shown both by Western blotting 
(Fig. 2D) and by immunofluorescence (Fig. 2C), CMG2
insC 
was fully PA-binding competent. Thus CMG2
insC 
retains the ability of WT CMG2 to bind a specific ligand, 
 
in agreement with a previous report (Liu & Leppla, 2003). Since CMG2
insC 
lack most of the WT tail, it is 
unlikely to retain the full CMG2 function. This is supported by the fact that point mutations in the cytosolic tail 
have been reported in HFS patients (Deuquet et al, 2011b). The precise consequences of the later 
mutations have not yet been addressed. Patients homozygous for such mutations however suffer from the 
mildest form of the disease as opposed to patients carrying the c.1073-1074insC mutation (Deuquet et al, 
2011b). Altogether these observations suggest that if the cmg2 mRNA could be stabilizes in patients 
carrying the c.1073-1074insC mutation, symptoms might be attennuated. 
 
CMG2insCC
 
and CMG2
delT 
are powerful ERAD substrates 
The absence of detectable CMG2
insCC/delT
 upon ectopic expression, despite normal synthesis, indicates that 
these two CMG2 mutants undergo accelerated degradation. A metabolic pulse-chase analysis revealed 
that indeed the two mutant CMG2 proteins had a half-life of about 20 mins (Fig. 3A). Degradation of 
CMG2
insCC 
and CMG2
delT 
could be inhibited by treating cells with the proteasome inhibitor MG132 (Fig. 
3BC) (Kisselev & Goldberg, 2001). Not only were the levels of metabolically labeled proteins after a 25 min 
pulse similar to that of CMG2
WT 
(Fig. 3BC), but the proteins could also be detected by western blotting 
following 4 or 8h MG132 treatment (Fig.3D).  In contrast, no rescue of CMG2
insCC 
and CMG2
delT 
was 
observed following treatment with either Bafilomycin A, an inhibitor of the vacuolar ATPase (Drose & 
Altendorf, 1997) or leupeptin, an inhibitor of lysosomal proteases (Aoyagi et al, 1969). These observations 
indicate that CMG2
insCC 
and CMG2
delT 
are rapidly degraded by the proteasome and not in lysosomes. We 
next investigated whether the MG132 rescued proteins were properly trafficked through the biosynthetic 
pathway. We have previously shown that CMG2 is glycosylated (Abrami et al, 2006; Deuquet et al, 
2009). Due to the modifications of the N-linked glycans in the Golgi, CMG2 migrates as a smear that is 
insensitive to treatment with Endoglycosidase H (Endo H), an enzyme that only removes the non-complex 
oligosaccharides. While the majority of expressed CMG2
WT  
and CMG2
inC
 were insensitive to EndoH 
treatment, MG132 rescued CMG2insCC
 
and CMG2
delT
, which migrated as a well-defined band, was EndoH 
sensitive (Fig. 3E), indicating that these mutant CMG2 molecules were unable to reach the Golgi. Altogether, 
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the above observations show that CMG2
insCC 
and CMG2
delT 
are rapidly degraded by the ER associated 
degradation (ERAD) pathway and that even MG132-rescued CMG2
insCC 
and CMG2
delT 
cannot exit the 
compartment. This is in marked contrast to previously characterized HFS CMG2 mutants for which surface 
expression could be rescued with proteasome inhibitors (Deuquet et al, 2011a). Consistent with the 
notion that CMG2
insCC 
and CMG2
delT 
are efficient ERAD substrates, we found that the MG132 rescued 
proteins were polyubiquinated (Fig. 3F), a hallmark of proteins destined to degradation. This 
ubiquitination signature was markedly different to the mono- ubiquitination of CMG2 observed during 
anthrax toxin endocytosis  (Fig. 3F, cells treated with PA) (Abrami et al, 2010). 
 
Structural predictions of the CMG2
insCC/delT
 tail 
In order to understand why CMG2
insCC/delT
 are powerful ERAD substrates, we analyzed the primary 
sequence of their cytosolic tail (Fig. 1A) and compared it to that of the WT protein. Little is known about the 
structure of the cytosolic tail of CMG2
WT
. We tested five different secondary structure prediction algorithms 
which all indicated that the CMG2
WT 
tail is mostly composed of random coil (Fig. 4A) as is the much 
shorter CMG2
insC 
tail. We therefore performed disorder predictions (Dosztanyi et al, 2005), which indeed 
predicted that residues 342 to ! 450 are highly disordered (Fig. 4B, left panel). Disordered domains 
generally are rich in charged residues and poor in hydrophobic residues (Dyson & Wright, 2005; Tompa, 
2012) and consistently, the calculated hydrophobic index (Gasteiger E., 2005) was negative along the entire 
length of the cytoplasmic tail of CMG2
WT 
(Fig. 4C), as it was for CMG2
insC
. Similar analyses on the 
CMG2delT
 
tail led to markedly different results. The CMG2
delT 
tail was predicted to be largely structured, 
based both on secondary structure (Fig. 4A) and disorder (Fig. 4B, right panel) predictions. Moreover 
most of the tail showed a positive hydrophobic index (Fig. 4C, right panel). To further strengthen these 
predictions, we investigated the structure of the CMG2
delT 
tail using molecular dynamics (MD) under 
physiological conditions. The CMG2 helical transmembrane domain was inserted into a lipid membrane 
bilayer and linked to the CMG2
delT 
cytosolic tail, initially modeled as random coil. During the MD simulation, 
the tail spontaneously folded into a domain showing three structured "-helices, in good agreement with 
the secondary structure prediction for the CMG2
delT 
tail (Fig. 4B). The hydrophobic core produced by the 
helical arrangement stabilizes the cytosolic domain in a globular fold (Figs. 4C, D), which remains in close 
contact with the membrane surface due to the presence of several lysine residues (K361, K365, K399 and 
K404) interacting with the lipid head-groups. Thus the insCC and delT hotspot mutations lead to the 
synthesis of a cytosolic tail that has drastically different properties from that of the original CMG2 tail. 
Instead of being intrinsically disordered and hydrophilic, the CMG2
insCC/delT 
tail is predicted to form a 
compact well-folded domain. This domain however exposed hydrophobic patches that are likely to be 
recognized by the ER quality control machinery and thus targeted to ERAD (Hegde & Ploegh, 2010). These 
findings are rather counterintuitive in the sense that the native CMG2 tail despite its lack of predicted 
structure is not seen by the ER quality control system as problematic. In contrast the CMG2
insCC/delT 
tail, 
although well structured, is immediately spotted. 
 
The CMG2
insCC/delT 
tail sequence is sufficient for targeting to degradation 
In order to experimentally validate some of the above predictions, we performed Circular Dichroism (CD) on a 
synthetic peptide corresponding to the sequence of the CMG2delT
 
tail. The far UV CD spectrum of the 
peptide was typical of that of polypeptide rich in "-helices, with two negative peaks at 222 and 208nm 
(Fig 5A). We next analyzed the capacity of the peptide to bind 8-anilinonaphthalene-1-sulfonic acid (ANS), 
a fluorescent dye that increases its quantum yield when binding hydrophobic patches (Slavik, 1982). As 
a control peptide, we used a 40 residues peptide of the human ß-amyloid  (Iacovache et al, 2011).  
Unfortunately, we were unable to produce the WT CMG2 cytosolic tail recombinantly, presumably due to its 
unstructured nature. As shown in Fig. 5B, the CMG2delT
 
tail peptide showed strong ANS binding 
capacity, confirming the predicted presence of surface-exposed hydrophobic patches. We next analyzed 
whether the CMG2
delT 
tail sequence is sufficient to target a transmembrane protein to ERAD. We therefore 
generated a chimera between CD4 and the CMG2
delT 
tail. CD4 is a type I transmembrane protein 
widely used in the construction of chimeric proteins to study membrane trafficking and protein targeting 
(Jackson et al, 1990; Nilsson et al, 1989; Shin et al, 1991). It has a very stable ectodomain containing 3 
disulfide bonds, a single transmembrane helix and a 40 residue cytoplasmic tail.  This tail was swapped with 
that of CMG2
delT  
generating CD4-tail
mut
. While CD4 expression was readily detectable upon ectopic 
expression in Hela cells, CD4-tail
mut 
expression was very low (Fig. 5C, top panel), even though 
synthesis was normal (Fig. 5C, bottom panel). This was due to post-translational degradation via the 
proteasome, as revealed by the ability of MG132 to rescue expression (Fig. 5C, top panel). We also fused 
the CMG2
delT 
tail sequence to a soluble cytosolic protein, namely EGFP (EGFP-tail
mut
), and found that it 
was also rapidly targeted to degradation via the proteasome (Fig. 5D). Thus the CMG2
delT 
tail sequence is 
a well-folded domain, which exposes hydrophobic patches. Most likely due to this exposed hydrophobicity, 
the domain is efficiently recognized by quality control systems both at the surface of the ER and in the 
cytosol, targeting the protein to proteasomal degradation. These observations show that targeting the 
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NMD pathway in patients carrying the insCC or delT frameshift mutations is pointless, since the mRNA that 
would be rescued encodes for a protein that is immediately be recognized by the folding quality control 
machinery and targeted to degradation at the ER level. 
 
Inhibiting NMD pathway can rescue CMG2insC 
Figure 2 illustrates that, in contrast to CMG2
insCC 
and CMG2
delT
, ectopically expressed CMG2
insC 
is 
normally trafficked through the biosynthetic pathway, and reaches the cell surface where it can bind a 
surrogate ligand, altogether indicating that the protein is at least partially functional. We therefore 
investigated whether blocking the NMD pathway in patient fibroblasts, to inhibit mRNA degradation, would 
lead to a partial rescue of CMG2
insC
. We chose to silence the expression of Upf1, a member of the group I 
RNA helicase and ATPase family (Bhattacharya et al, 2000), which is crucial for the initiation of the NMD 
pathway (Isken et al, 2008). Knock down of upf1 was recently shown to rescue the phenotypes of Ulrich 
Disease and long-QT Syndrome in fibroblasts (Gong et al, 2011; Usuki et al, 2006). Upf1 expression could be 
efficiently silenced by siRNA in fibroblasts from patients 1, 4 and 5, which harbor the insC, insCC and 
delT respectively, as well as in fibroblasts from a healthy control (Fig. 6A). Remarkably, CMG2
insC 
could 
be detected by Western blotting (Fig. 6B) and by FACS analysis (Fig. 6CD) upon Upf1 silencing in Patient 
1 cells. Due to the homozygosity of Patient 1 and the low level of cmg2 mRNA expressed in the 
fibroblasts, we could detect a significant increase in cmg2 mRNA upon Upf1 silencing (Fig. S2). 
Consistent with the ectopic expression studies (Fig. 2), CMG2
insC 
rescued by Upf1 silencing was properly 
targeted to the cell surface of fibroblasts (Fig. 6CD). No rescue of CMG2
insCC 
and CMG2
delT 
could be 
observed upon Upf1 silencing in cells from patients 4 and 5 (Fig. 6B), as expected from their efficient 
targeting to ERAD. 
 
Conclusion 
The present analysis of the HFS frameshift mutations in exon 13 allows us to draw several interesting 
conclusions. Firstly, it highlights the importance of depth analyses of the molecular consequences of the 
specific mutations found in a given patient, be it HFS or another monogenic disease, in order to evaluate the 
potential therapeutic targets. Indeed not only the site of a mutation is crucial but the exact nature of the 
insertion/deletion, i.e. the change in reading frame. Secondly, our study underlines that the genotype-
phenotype analyses should be performed at the mRNA, the protein and the functional level, before 
significant conclusions can be drawn in term of therapeutic strategy and targets. And finally, more specific 
to HFS, our study shows that the HFS c.1073-1074insCC and c.1074delT mutations lead to defects not 
only at the mRNA level but also at the protein folding level. This leave little hope for a chemical 
based therapy to rescue CMG2 expression levels and thereby function recovery, leaving gene replacement 
as the only possibility in these patients. In contrast, a potential drug based therapy is not to be excluded 
for patient carrying the c.1073-1074insC mutation,  fortunately  the  most  frequent  of  the  three  frameshift 
mutations (Deuquet et al, 2011b). Indeed our study indicates that rescuing the cmg2 mRNA in these 
patients allows the synthesis of a viable protein and point to the NMD pathway as a potential therapeutic 
target. Consistent with the differences we observe in terms of protein properties between CMG2
insC 
and 
CMG2
insCC/delT
, a survey of the literature indicates that patients harboring the c.1073-1074insCC or 
c.1074delT mutations always suffer from the severe form of the disease, while more moderate 
symptoms are reported for patients with the c.1073-1074insC mutations, further raising the hope that even 
limited mRNA rescue could have an impact on the severity of the symptoms. 
 
MATERIALS AND METHODS 
 
Cell culture, plasmids, transfections and real time q-PCR 
Primary patient-derived fibroblasts were grown in Dulbeccon!s Modified Eagle Medium (DMEM) medium 
(Gibco) at 37 °C complemented with fetal bovine serum (FBS) and penicillin and streptomycin. HeLa cells 
(ATCC) were grown in complete Modified eagles medium (MEM) (Sigma) at 37 °C supplemented with 
fetal bovine serum (FBS), L-glutamine, non-essential amino acids (NEAA), and penicillin and streptomycin. 
The human CMG2 (isoform 4, Swiss-Port P58335-4, GenBank AK091721.1) gene, tagged with a V5 
epitope at the C-terminus, was cloned in the pcDNA3.1/V5-HIS- TOPO expression vector (Invitrogen). 
Mutations were generated with the QuickChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). 
The full- length cDNAs encoding EGFP and human CD4 was cloned from pEGFP-C2 (Invitrogen) and   
pCD4-CMX (a gift from D. Trono), respectively, into the pcDNA3.1/V5-HIS-TOPO expression vector 
(Invitrogen). To construct the plasmids expressing chimeric protein EGFP-tail
mut 
or CD4-tail
mut
, the full-length 
EGFP, the 1254bp from 5! end of CD4 and the 156bp from 3! end of CMG2 delT were cloned. The EGFP 
or CD4 fragment was then ligated with the fragment corresponding to the mutant tail with an NdeI cutting 
site designed at one end of them. The final cDNAs expressing the chimeric protein was inserted into the 
pcDNA3.1/V5-HIS-TOPO expression vector (Invitrogen). The 49 amino acids corresponding to the 
CMG2delT
 
cytosolic tail were synthesized by EZBiolab. For the real-time PCR, RNA was extracted from a 
5 cm dish using the RNeasy kit (Qiagen). 1 mg of the total RNA extracted was used for the reverse 
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transcription using random hexamers and superscript II (Invitrogen). A 1:40 dilution of the cDNA was 
used to perform the real-time PCR using SyBr green reagent (Roche). mRNA levels were normalized 
using three housekeeping genes: TATA-binding protein (TBP), ß- microglobulin and ß-glucoronidase 
(GUS). 
 
Toxin, Antibodies and Reagents 
The toxin subunit PA and biotin-labeled PA were a gift from S. Leppla. The anti-PA antibody was 
purchased from List Biological Laboratories, Inc. The anti-human CMG2 monoclonal antibodies 2F6, 
generated in our lab, was previously described (Deuquet et al, 2011a). Polyclonal antibody against 
calnexin was from Eurogenetec, polyclonal goat anti human CMG2 and polyclonal goat anti human CD4 
antibodies were from R&D Systems, anti-ubiqutin antiboday from Santa Cruz, anti-EGFP-HRP antibody 
from the D. Trono laboratory. Protein G-agarose-conjugated beads and Protein A-agarose-conjugated beads 
were from GE Healthcare. MG132, from Sigma and  Bortezomib,  from  Santa  Cruz,  were  dissolved  in  
DMSO  and  used  at  a  final concentration of 10 µM in complete medium. Bafilomycin was from Sigma 
and was dissolved in absolute ethanol and used at a final concentration of 0.1 µM. Leupeptin was 
purchased from Roche, dissolved in water and used at a final concentration of 250 µg/ ml. Bis-ANS  
(4,4!-dianilino-1,1!-binaphthyl-5,5!-disulfonic acid, dipotassium salt) was from Invitrogen, dissolved in water 
and used  a  final concentration of 50 µM. Treatments with EndoH were performed as previously described 
(Abrami et al, 2006). The fixation reagent BD CellFix and permeabilization reagent FACS Permeabilizing 
Solution 2 were from BD BioScience. 
 
Immunoprecipitation and RNAi experiments 
siRNA of human upf1 was purchased from Qiagen. As control siRNA we used the following target 
sequence of the viral glycoprotein VSV-G: 5!attgaacaaacgaaacaagga 3!.  For gene silencing, transfections 
of 100nM siRNAs were carried out with Lipofectamine 2000 (Invitrogen) and the cells were analyzed 72h 
after transfection.  For immunoprecipitation, cells were washed three times with PBS and then were lysed by 
incubation for 30 min at 4 °C with 0.5 % NP-40, 500 mM Tris-HCl (pH 7.4), 20 mM EDTA, 10 mM NaF, 30 
mM sodium pyrophosphate decahydrate, 2 mM benzamidine, 1 mM PMSF, 1 mM NEM and a cocktail of 
protease inhibitors (Roche). Cell lysates were centrifuged for 3 min at 2000 g and the supernatants were 
precleared with protein G-agarose conjugated beads and were incubated for 16 h at 4°C with antibodies 
and beads. The beads were washed three times with the same lysis buffer and were resuspended in 
sample buffer (4 x). The samples were heated at 95°C for 5 min and migrated on SDS-PAGE. Western 
blotting was performed with the iBlot (Invitrogen) according to the manufacturers instructions. 
Quantification of the blots was done using the Typhoon Imager (Image QuantTool, GE healthcare). 
 
Metabolic labeling 
For metabolic labeling, Hela cells were transfected for 24 h with respective cDNA and cells were 
starved with methionine/cysteine-free medium, incubated for a 5 min or 25 min pulse at 37 °C with 50 
µCi/ml [35S] methionine (Hartman Analytics). For chasing experiments, already pulsed cells were incubated 
for different chase time period at 37 °C in complete medium with a 10-fold excess of non-radioactive 
methionine and cysteine. Cells were then lysed with lysis buffer described above and immunoprecipitations 
were performed with cell lysates using protein A-agarose conjugated beads and respective antibodies. 
Samples were then migrated on SDS-PAGE after which the gel was incubated with a fixative solution (25 
% isopropanol, 65 % H2O, 10 % acetic acid), followed by a 30 min incubation with signal enhancer 
Amplify NAMP100 (Amersham). The dried gels were exposed to a Hyperfilm MP (Amersham) or 
quantified with the Typhoon Imager (Image QuantTool, GE healthcare). 
 
Molecular dynamics simulations 
Molecular dynamics (MD) simulations were used to further characterize the CMG2 cytoplasmic domain. 
As a first step, delT sequence and the corresponding section of the wild type (i.e. P342—S401) were 
modelled as a random coil. To explore efficiently the conformational space of these peptides, the MD 
simulations were carried out in the generalized Born implicit solvent.  This solvent approximation, where the 
water molecules are described as a dielectric continuum, considerably reduces the computational time, 
allowing to reach hundreds of ns long simulations. In a second step, the equilibrated cytoplasmic tails were 
linked to CMG2 helical TM domain. The resulting proteins were inserted and equilibrated in a 80x80 Å2 
Palmitoyl Oleoly Phosphatidyl Choline (POPC) membrane patch (Humphrey et al, 1996) to characterize its 
structure in a phospholipid bilayer. 
All simulations were performed using NAMD (Phillips et al, 2005) engine, with the CHARMM27 force field 
(Brooks et al, 2009), including CMAP corrections. For the explicit solvent simulations, TIP3P water  
(Jorgensen et al, 1983) parameterization was used to describe the water molecules. The spatial overlapping 
of lipid molecules and protein were removed and the resulting protein-membrane system was solvated in 
variable-size water box, neutralized through the addition of NaCl at a concentration of 150 mM. The 
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periodic electrostatic interactions were computed using the particle- mesh Ewald (PME) summation with 
a grid spacing smaller then 1 Å. All systems were first minimized by 2000 conjugate gradient steps. All 
systems were subsequently gradually headed from 0 to 300 K in 800 ps with a constraint on the protein 
backbone scaffold. Finally, the systems were equilibrated for 10 ns at 300K. Free molecular dynamics of 
all equilibrated system were performed with a 2 fs integration time step using the RATTLE algorithm applied 
to all bonds. Constant temperature (300K) was imposed by using Langevin dynamics (Brunger & Brooks, 
1984), with damping coefficient of 1.0 ps. In explicit solvent simulations, constant pressure of 1 atm 
was maintained with a Langevin piston dynamics (Feller et al, 1995), 200 fs decay period and 50 fs time 
constant. First, we performed 300 ns-long simulations for the characterization of each of the cytoplasmic 
tails folding in implicit solvent. Two simulations, lasting 100 ns each, were then carried out on the model 
of CMG2 transmembrane and cytoplasmic tail. 
 
Hydrophobicity plot, disorder tendency and secondary structure prediction 
The hydrophobicity of sequences corresponding to the cytosolic tail of WT CMG2 or delT mutant (starting 
from A359 and H359 for WT and delT respectively) was analyzed using the online ExPASy tool ProtScale 
(http://web.expasy.org/protscale/). The disorder tendency was predicted with IUPred 
(http://iupred.enzim.hu/). All data were extracted and plotted with Prism graphpad 5. No structural data 
are currently available for CMG2 wild type and delT cytoplasmic domain. We used secondary structure 
prediction tools to estimate the structural content of these domains: HNN, Jpred, NetSurfP, PSIpred, 
ProteinPredict. The final estimated structure was obtained by averaging the output of these different 
algorithms. 
 
Circular Dichroism (CD) 
CD experiments were carried out at room temperature on a Jasco J-815 spectrometer. Cells with 0.1cm 
path length were used. The synthetic peptide of CMG2 delT was diluted to a concentration of 20 µM in a 
buffer containing 20 mM Na2HPO4 (pH 7.4) and 40 % of acentonitrile. The buffer spectrum was subtracted 
for each sample. 
 
Flow Cytometric Analysis 
To permeabilize the cells, cells were fixed with BD CellFix reagent for 15 min and permeabilized by 
FACS Permeabilizing Solution 2 for 20 min at room temperature. Either permeabilized or non-
permeabilized cells were incubated with anti-hCMG2 antibody for 30 min on ice. And after two times of wash 
with PBS + 20 mM EDTA + 2 % FCS, the cells were then incubated with a fluorescent secondary 
antibody for another 30 min on ice. Cells were washed for three times before they were fixed in the end. The 
stained cells were evaluated with Accuri C6 (BD BioScience). FACS data were analyzed using FlowJo 
software (FlowJo). 
 
ANS binding assay 
Binding of ANS was measured in 96-well plate with the spectrofluorimeter SpectraMax plate reader 
(Molecular Device). An excitation wavelength of 360 nm and an emission wavelength of 470 nm were 
applied. Synthetic peptide or purified protein was dissolved or diluted to a final concentration of 0.1 
mg/ml with 20 mM sodium phosphate, pH 7.4 and 2 % acetonitrile. The final concentration of ANS was 50 
µM. 
 
Immunofluorescence Microscopy 
Hela cells were fixed with 3% paraformaldehyde for 20 min and lablelled with an anti-hCMG2 antibody 
followed by Alexa-conjugated anti-rat (555 nm) and Alexa- conjugated streptavidin antibody (647 nm). The 
nuclei were stained by Hoeschst dye. Images were acquired using a 63x lens on LSM-710 Laser scanning 
microscope (Carl Zeiss Microimaging, Inc.). The Fiji software was used for the processing of the images.  
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FIGURE LEGENDS 
 
Figure 1: Analysis of frameshift mutations in HFS patients. A: amino acid sequence alignment of 
CMG2
WT
, CMG2
insCC
, CMG2
delT 
and CMG2
insC 
generated with Jalview. Sequences were highlighted 
according to the percentage of identity. B: mRNA levels of cmg2 in patient-derived fibroblasts were 
analyzed by quantitative RT-PCR. The values representing each mRNA level were plotted as the percentage 
of control 1 (ctrl1) fibroblast. Error bars represent standard errors  (n>3).  Two-tailed paired t-test analysis 
between ctrl1 and patient-derived fibroblasts was performed. *** : p < 0.001. C: 20 µg of total cell extracts 
from patient-derived fibroblasts were analyzed by SDS- PAGE under non-reducing condition and Western 
blotting using the 2F6 anti– hCMG2 antibody. 
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Figure 2: Ectopic expression of CMG2
insC
, CMG2insCC
 
and CMG2delT A: Hela cells were transfected 
or not (ctrl) for 48 h with cDNA expressing either WT or mutant CMG2. 20 µg of total cell extracts were 
analyzed by SDS-PAGE under non-reducing condition and Western blotting using the 2F6 anti–hCMG2 
and anti- calnexin antibodies. B: Hela cells were transfected or not (ctrl) for 24 h with cDNA expressing 
either WT or mutant CMG2. Cells were pulsed for 5 min with [
35
S] cysteine/methionine. 
Immunoprecipitation was performed using anti-hCMG2 antibody and samples were analyzed by SDS-
PAGE and autoradiography. Quantification was performed using the Typhoon Imager. Error bars represent 
standard errors (n=3). Two-tailed paired t- test analysis was performed. *** : p < 0.001. C: tem8 knocked-
down Hela cells were transfected or not (ctrl) for 48 h with cDNA expressing either WT or insC CMG2. 
Cells were incubated with anthrax PA at a final concentration of 500 ng/ml on ice for 1h and then shifted 
to 37
o
 C for 20 min before they are lysed. 20 µg of total cell extracts were analyzed by SDS-PAGE under 
non- reducing or reducing condition and Western blotting using the 2F6 anti–hCMG2 antibody, anti-PA and 
anti-calnexin antibodies. The dotted lines represent the non- transfected control cells and the solid lines 
CMG2
WT 
or CMG2
insC
. D: tem8 knocked-down Hela cells grown on coverslips were transfected or not (ctrl) 
for 48 h with cDNA expressing either WT or CMG2
insC
. Cells were incubated with biotin-labeled anthrax 
PA at a final concentration of 1 µg/ml on ice for 1h and then shifted to 37°C for 5 min before fixation 
and labeling with anti-hCMG2 and streptavidin antibodies and Hoechst. The scale bars represent 10 !m. 
 
 
 
Figure 3: CMG2insCC
 
and CMG2delT
 
are powerful ERAD substrates. A: Hela cells were transfected or 
not (ctrl) for 24 h with cDNA expressing either WT or mutant CMG2. Cells were pulsed for 5 min with 
[
35
S] cysteine/methionine and then chased for different time periods. Immunoprecipitation was performed 
using anti-hCMG2 antibody and samples were analyzed by SDS-PAGE and autoradiography. 
Quantification was performed using the Typhoon Imager. For each experiment, the intensities of signals 
were normalized to that of the same cDNA at time t = 0 min. Error bars represent standard errors (n=3). 
The curve was smoothed by nonlinear fit according to the one phase decay model using the software Prism 
graphpad 5. B: Hela cells were transfected or not (ctrl) for 24 h with cDNA expressing either WT or mutant 
CMG2. Cells were treated with 10 µM MG132 or not for 4 h prior to being pulsed for 25 min with [
35
S] 
cysteine/methionine. Immunoprecipitation was performed using anti-hCMG2 antibody and samples were 
analyzed by SDS-PAGE and autoradiography. C: Quantification for WT or mutant CMG2 with or without 
MG132 treatment in the 25 min radiolabeling experiments was performed using the Typhoon Imager. 
Error bars represent standard errors (n=3). D: Hela cells were transfected or not (ctrl) for 48 h with cDNA 
expressing either WT or mutant CMG2. Cells were treated or not (ctrl) with 10 µM MG132 for 4 h or 8 h, or 
with 100 µM Bafilomycin for 4 h, or with 250 µg/ml leupeptin for 16 h. 20 µg of total cell extracts were 
analyzed by SDS-PAGE under non-reducing condition and Western blotting using the 2F6 anti–hCMG2 
antibody and anti-calnexin antibody. E: Hela cells were transfected or not (ctrl) for 48 h with cDNA 
expressing either WT or mutant CMG2 and were treated or not with 10 µM MG132 for 4 h. Cell lysates 
were subjected to immunoprecipitation with an anti-hCMG2 antibody. The products from 
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immunoprecipitation were treated with or without EndoH and were analyzed by SDS-PAGE and Western 
blotting using anti-hCMG2 antibody. F: Hela cells were transfected or not (ctrl) for 48 h with cDNA 
expressing either WT or mutant CMG2. Cells were either treated with or without 10 µM MG132 for 4 h or 
treated with 500 ng/ml anthrax PA at 4°C for 1 h followed by at 37
o 
C for 10 min. Cell lysates were 
immunoprecipitated with an anti-hCMG2 antibody and were subsequently analyzed by SDS-PAGE and 
Western blotting using anti-ubiquitin antibody and anti-hCMG2 antibody. 
 
 
Figure 4: Structural predictions of the CMG2insCC/delT tail. A: Sequence and structural content for 
WT CMG2 and CMG2delT
 
cytoplasmic tail. The sequences were color coded with polar residues in 
black, non polar in green, positively and negatively charged residues in red and blue respectively. The 
predicted secondary structure was the average output of five secondary structure prediction tools. B: 
Hydrophobicity plot of the cytosolic tails of WT CMG2 and CMG2delT
  
(starting from A359 and H359 for 
WT CMG2 and CMG2delT
  
respectively). The curves! surfaces below the value of zero were colored in 
blue, representing the hydrophilic portion whereas the surfaces above zero in red, representing the 
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hydrophobic portion. C:  Disorder prediction for the cytosolic tails of WT CMG2 and CMG2delT. The curves! 
surfaces above the threshold of 0.5 were colored in red, representing the predicted disordered portion. D:  
Molecular dynamics based model of CMG2delT
  
cytosolic tail. The modeled structure was linked to CMG2 
transmembrane (TM) domain. The protein was color coded as follows: polar residues in white, non polar in 
green, acidic and basic residues in red and blue respectively. The cytoplasmic hydrophobic core interacts 
with the membrane surface. Side chains of critical residues are shown in ball and sticks. 
 
 
Figure 5: The CMG2insCC/delT tail sequence is sufficient for targeting to degradation. 
A: Far UV CD spectra of the cytoplasmic tails of CMG2delT. A synthetic peptide corresponding to the 
cytoplasmic tail of CMG2delT
 
(starting from H359) was dissolved in 20 mM sodium phosphate (pH 7.4) with 
40% acetonitrile and its far UV CD spectrum was analyzed with a Jasco J-815 spectrometer. B: Binding of 
the hydrophobic dye ANS to control (ctrl) and CMG2delT
 
cytoplasmic tail. Synthesized peptides of ctrl and 
delT cytoplasmic tail were dissolved in 20 mM sodium phosphate (pH 7.4) with 2% acetonitrile to a final 
concentration of 0.1 mg/ml respectively. 50 µM ANS was added to each sample and the relative 
fluorescence unit (RLU) was measured with a SpectraMax plate reader (Molecular Device). The graph 
showed was one representative result. C: Hela cells were transfected or not (ctrl) for 48 h with cDNA 
expressing either WT EGFP or mutated tail (cytoplasmic tail of CMG2delT
 
starting from H359) fused 
chimeric EGFP. Cells were treated or not with 10 µM MG132 for 4 h or 8 h. 20 µg of total cell extracts were 
analyzed by SDS-PAGE and Western blotting using anti- EGFP antibody and anti-calnexin antibody. To 
ensure that proteins were well synthesized, 24 h-transfected or not Hela cells with or without 1 h 10 µM 
MG132 treatment were pulsed for 5 min with [
35
S] cysteine/methionine in parallel. Immunoprecipitation was 
performed using anti-EGFP antibody and the samples were analyzed by SDS-PAGE and autoradiography. 
D: Hela cells were transfected or not (ctrl) for 48 h with cDNA expressing either WT CD4 or chimeric 
protein composed of the ectodomain and transmembrane part of CD4 and the mutated cytoplasmic tail of 
CMG2delT
 
(starting from H359). Cells were treated or not with 10 µM MG132 for 4 h or 8 h. 20 µg of 
total cell extracts were analyzed by SDS-PAGE and Western blotting using anti-CD4 antibody and anti- 
calnexin antibody. To ensure that proteins were well synthesized, 24 h-transfected or not Hela cells with or 
without 1 h 10 µM MG132 treatment were pulsed for 5 min with [
35
S] cysteine/methionine in parallel. 
Immunoprecipitation was performed using anti-CD4 antibody and the samples were analyzed by SDS-PAGE 
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and autoradiography. 
 
Figure 6: Inhibiting NMD pathway can rescue CMG2
insC 
in patient-derived fibroblasts. 
A: mRNA levels of upf1 in patient-derived fibroblasts after 72 h knocking down with or without siRNA 
targeting upf1 were analyzed by quantitative RT-PCR. Under the condition that cells were without siRNA 
targeting upf1, a control siRNA against vsvg was used. The values representing each mRNA level were 
plotted as the percentage of fibroblast without siRNA targeting upf1. Error bars represent standard errors 
(n>4). Two-tailed paired t-test analysis between the same patient-derived fibroblasts with or without siRNA 
targeting upf1 was performed. *** : p < 0.001. B: Ctrl1 and patient-derived fibroblasts were transfected with 
or without siRNA targeting upf1 for 72 h. Under the condition that cells were without siRNA targeting upf1, 
a control siRNA against vsvg was used. 10µg of total cell extracts were analyzed by SDS-PAGE under non-
reducing condition and Western blotting using anti-hCMG2 antibody and anti-calnexin antibody. C: Ctrl1 and 
Patient1 (P1) derived fibroblasts were transfected with or without siRNA targeting upf1 for 72 h. Under the 
condition that cells were without siRNA targeting upf1, a control siRNA against vsvg was used. Both 
permeabilized and non- permeabilized cells were stained with anti-hCMG2 antibody for 30 min on ice 
followed by a secondary fluorescent antibody staining for 30 min. The cells were then washed, fixed and 
analyzed on a FACS analyzer Accuri C6 (BD BioScience). D: The mean fluorescence intensity of each 
sample from the FACS data shown above was extracted with the software FlowJo 7.6. Mean fluorescence 
intensities representing either the total amount of CMG2 expressed or the surface CMG2 were plotted as 
the percentage of that of Ctrl1 without siRNA targeting upf1 respectively. Error bars represent standard 
errors (n=4). Two-tailed paired t-test analysis was performed. * : p < 0.05. 
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Nucleotide numbering reflects cDNA numbering with +1 corresponding to the A of the ATG translation initiation codon in the 
reference sequence, according to the nomenclature proposed by the Human Genome Variation Society (www.hgvs.org/
mutnomen). The initiation codon is codon 1. !
Yan et al., Table 1!
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ribosome–translocon complex
Asvin KK Lakkaraju1,4, Laurence Abrami1,4,
Thomas Lemmin2, Sanja Blaskovic1,
Be´atrice Kunz1, Akio Kihara3, Matteo Dal
Peraro2 and Franc¸oise Gisou van der Goot1,*
1Global Health Institute, Ecole Polytechnique Fe´de´rale de Lausanne
(EPFL), Lausanne, Switzerland, 2Institute of Bioengineering, Ecole
Polytechnique Fe´de´rale de Lausanne (EPFL), Lausanne, Switzerland and
3Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo,
Japan
A third of the human genome encodes N-glycosylated
proteins. These are co-translationally translocated into
the lumen/membrane of the endoplasmic reticulum (ER)
where they fold and assemble before they are transported
to their final destination. Here, we show that calnexin, a
major ER chaperone involved in glycoprotein folding is
palmitoylated and that this modification is mediated by
the ER palmitoyltransferase DHHC6. This modification
leads to the preferential localization of calnexin to the
perinuclear rough ER, at the expense of ER tubules.
Moreover, palmitoylation mediates the association of
calnexin with the ribosome–translocon complex (RTC)
leading to the formation of a supercomplex that recruits
the actin cytoskeleton, leading to further stabilization of
the assembly. When formation of the calnexin–RTC super-
complex was affected by DHHC6 silencing, mutation of
calnexin palmitoylation sites or actin depolymerization,
folding of glycoproteins was impaired. Our findings thus
show that calnexin is a stable component of the RTC in a
manner that is exquisitely dependent on its palmitoylation
status. This association is essential for the chaperone to
capture its client proteins as they emerge from the trans-
locon, acquire their N-linked glycans and initiate folding.
The EMBO Journal (2012) 31, 1823–1835. doi:10.1038/
emboj.2012.15; Published online 7 February 2012
Subject Categories: proteins
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Introduction
More than a third of the human genome encodes for mem-
brane proteins or proteins secreted into the extracellular
milieu. These proteins are generally synthesized with an
N-terminal signal sequence that targets the translating ribo-
some to the endoplasmic reticulum (ER) where it docks onto
the translocon (Braakman and Bulleid, 2011). The translocon
is a multiprotein transmembrane complex composed of a
central sec61a tetrameric pore to which associate a number of
accessory proteins such as sec61b, sec62 or the TRAP (trans-
locon-associated protein) complex (Skach, 2007). Once the
ribosome is docked onto the translocon, synthesis resumes
and the nascent protein is co-translationally translocated
through the sec61 channel to the lumen of the ER. As the
newly synthesized protein emerges from the translocon, it is
handled sequentially by a variety of enzymes, in particular
leading to the addition of N-linked glycans and the formation
of disulphide bonds, which together increase the solubility
and stability of the protein, as well as chaperones that
promote folding by preventing aggregation of intermediates.
N-glycosylation is carried out by the oligosaccharyltrans-
ferase (OST), a hetero-oligomeric complex, which associates
with the ribosome–translocon complex (RTC), allowing the
addition of the branched oligosaccharide co- or post-transla-
tionally (Chavan and Lennarz, 2006). To prevent aggregation
or too rapid folding, which might hinder N-glycosylation
(McGinnes and Morrison, 1994), the OST (Li et al, 2008)
and the general chaperone BiP/Grp78 (Hammond and
Helenius, 1994) maintain the polypeptide in a folding
competent state.
Glycoproteins are subsequently handled by the lectin-
binding chaperones calnexin and calreticulin (Aebi et al,
2010). Calnexin is a type I membrane protein and calreticulin
is its soluble homologue. Proteins that undergo N-glycosyla-
tion acquire en bloc a glucose3-mannose9-N-acetylglucosa-
mine2 oligosaccharide. Calnexin/calreticulin can only bind
monoglucosylated glycans. Oligosaccharide trimming is
therefore required. This occurs immediately after the oligo-
saccharide has been transferred to the protein, first by ER
glucosidase I, which removes the first glucose, and then by
glucosidase II, which removes the second. The third glucose
is also trimmed by glucosidase II, but its removal requires
separation and repositioning of the enzyme with respect to
the substrate (Deprez et al, 2005). This repositioning provides
a time window during which the monoglucosylated polypep-
tide can interact with calnexin/calreticulin.
Glucose trimming must be rapid since calnexin was shown
to bind proteins not only post-translationally but also co-
translationally (Chen et al, 1995). It has been reported that
upon signalling, MAP kinase and casein kinase 2-dependent
phosphorylation of calnexin on Ser-563 allows its association
with ribosomes (Chevet et al, 1999). We here investigated
whether other mechanisms control the ability of calnexin to
capture its substrates. Calnexin recently came up in four
large-scale profiling studies of S-acylated proteins (Martin
and Cravatt, 2009; Yang et al, 2010; Yount et al, 2010; Merrick
et al, 2011). S-acylation is the addition of a fatty acid,
generally C16, palmitate, but possibly also C18, stearate
(Kordyukova et al, 2010), to cytosolic cysteine residues via
a thioester bond (Linder and Deschenes, 2007). This mod-
ification is mediated by transmembrane palmitoyltrans-
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ferases harbouring a conserved cytosolic DHHC domain, 23
of which are present in the human genome (Greaves and
Chamberlain, 2011). In validation of these profiling studies
and in agreement with a study published during the revision
of this manuscript (Lynes et al, 2011), we show that calnexin
can be palmitoylated on two juxtamembranous cysteines and
that this modification is mediated by a single palmitoyltrans-
ferase, DHHC6, out of the 16 DHHC enzymes present in the
mammalian ER. S-acylation controls the localization of cal-
nexin within the ER network, favouring its targeting to the
central ER. While being a single copy organelle, the ER is
indeed compartmentalized into a variety of still poorly char-
acterized domains that allow it to fulfil its multiple functions,
which in addition to protein folding include quality control,
synthesis of most cellular lipids and storage/control of in-
tracellular calcium (Pendin et al, 2011). The most apparent,
morphologically distinct, ER regions are the highly branched
tubular network that extends to the cell periphery, the dense
perinuclear ER, which is formed by sheet-like structures, and
the nuclear membrane (Puhka et al, 2007; Pendin et al, 2011).
The two latter regions composed the rough ER, where the
RTC complexes reside.
We found that calnexin is a stable component of the RTC
and this association relies on calnexin S-acylation. Formation
of the calnexin–RTC supercomplex leads to the recruitment of
the actin cytoskeleton, which further stabilizes the assembly.
The here-identified acylation-dependent interaction of cal-
nexin with the RTC complex allows it to efficiently capture
nascent glycosylated polypeptide chains, as they emerge from
the translocon, and promote their folding.
Results
Calnexin is palmitoylated in the ER on two
juxtamembrane cysteines
Four profiling studies (Martin and Cravatt, 2009; Yang et al,
2010; Yount et al, 2010; Merrick et al, 2011) identified,
with high confidence, calnexin as an S-acylated protein in
mammalian cells. By immunoprecipitation of either the en-
dogenous or tagged calnexin from 3H-palmitate-labelled cells,
we validated these profiling studies: the protein indeed
incorporated radiolabelled palmitate, which could be
removed by hydroxylamine hydrochloride treatment, indicat-
ing the involvement of a thioester bond (Figure 1A). This
does not exclude that calnexin could be modified with either
shorter or longer acyl chains as found for certain viral
proteins (Kordyukova et al, 2010). 3H-palmitate incorporation
occurred on both juxtamembranous cysteines (Figure 1B),
although somewhat more efficiently on Cys-502, which is
conserved in most species as well as in the testis-specific
calnexin homologue, calmegin (Supplementary Figure S1).
In contrast to other lipid modifications, S-acylation is
reversible (Greaves and Chamberlain, 2011). Proteins such
as Ras indeed undergo dynamic (o30min) cycles of palmi-
toylation–depalmitoylation, and these cycles are crucial for
their function (Rocks et al, 2010). In contrast to Ras, we found
that 3H-palmitate turnover on calnexin is slow (Figure 1C). As
a consequence, palmitoylated calnexin must accumulate in
cells and we indeed found, as described below, that at steady
state the vast majority of the protein is lipid modified.
Palmitoylation of calnexin mostly occurs after it has been
fully synthesized, since inhibition of protein synthesis with
cycloheximide 1 h prior to 3H-palmitate labelling only mildly
affected palmitoylation (18±4% decrease; Figure 1D).
Calnexin palmitoylation is mediated by DHHC6
We next identified the palmitoyltransferase that modifies cal-
nexin. PCR analysis revealed that all DHHC enzymes, with the
exception of DHHC15, 19 and 22, are expressed in HeLa cells
(Supplementary Figure S2A). RNAi duplexes were screened for
their efficiency in silencing these enzymes (Supplementary
Table S1; Supplementary Figure S2A). Silencing of DHHC
enzymes had minor effects (o25% change) on 3H-palmitate
incorporation into endogenous calnexin with the exception of
DHHC5 and DHHC6 (Figure 2A and B). Importantly, three
different siRNA duplexes against DHHC6 led to a similar
decrease in calnexin palmitoylation (Figure 2A) as did an
shRNA construct against the non-coding region of DHHC6
(Supplementary Figure S2B). Recomplementation of shRNA-
treated cells with a DHHC6 expression plasmid restored cal-
nexin palmitoylation (Supplementary Figure S2B), indicating
that the observed effect is not due to an off target effect of the
shRNA or RNAi duplexes.
3H-palmitate incorporation experiments were also per-
formed upon ectopic expression of calnexin–HA. Only
DHHC6 silencing led to a marked decrease in palmitoylation
(Figure 2C; Supplementary Figure S2C). We currently have no
clear explanation as to why DHHC5 silencing affects palmi-
toylation of endogenous but not ectopically expressed cal-
nexin. DHHC6 localizes to the ER (Supplementary Figure S2D
and (Gorleku et al, 2011), consistent with the calnexin
localization, while DHHC5 is mostly found in the Golgi
apparatus (Supplementary Figure S2D). This however does
not exclude its presence in the ER. Since DHHC6 is itself
palmitoylated (personal communication; Gorleku et al, 2011),
our findings raise the possibility—which will be tested
in future studies—that DHHC5 palmitoylates DHHC6 or
somehow regulates its function.
We next performed the reverse experiments, we monitored
the effect of DHHC overexpression. An increase in palmitoy-
lation of endogenous as well as ectopically expressed calnex-
in was observed upon DHHC6 overexpression but for none of
the other enzymes (Figure 2D; Supplementary Figure S2E and
F). Analysis of the two single cysteine calnexin mutants
showed that both cysteines are modified by the same
DHHC6 enzyme (Supplementary Figure S2E and F).
Altogether, these observations show that DHHC6 modifies
calnexin on both sites. Consistent with the ubiquitous
expression of calnexin, we found that the DHHC6 expression
is equally broad (Supplementary Figure S3A).
Since many of the experiments described in the present
work involve DHHC6 silencing, we tested whether DHHC6
siRNA triggers the unfolded protein response. A gene profil-
ing analysis using Affimetrix chips revealed that while slight
changes in expression were observed for GADD45 (!1.3-
fold), BiP (1.32-fold), XBP-1 (1.4-fold), HERP (1.5-fold),
these changes are minor in comparison to what is observed
upon UPR activation. Usually UPR induction leads to 4–27-
fold increase in the expression levels of these genes at the
mRNA level (Lee et al, 2003). Also, we did not observe
significant XBP-1 splicing.
As a side note, DHHC6 overexpression had no effect on the
palmitoylation of four other proteins known to be S-acylated
that transit through the ER: the Transferrin receptor (Alvarez
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Figure 1 Calnexin is palmitoylated in the ER. (A) HeLa cells were transfected or not (endogenous) for 48 h with calnexin–WT–GFP or
calnexin–AA–GFP. Cells were incubated with 3H-palmitic acid for 2 h. Cell extracts were treated or not with 1M hydroxylamine hydrochloride
pH 7.2 (1 h at room temperature) prior to immunoprecipitation using anti-calnexin or anti-GFP antibodies. Immunoprecipitates were split into
two, run on SDS–PAGE and analysed by autoradiography or western blotting. (B) HeLa cells were transfected 24h with calnexin–WT–HA or
calnexin–CA–HA, calnexin–AC–HA or calnexin–AA–HA, labelled with 3H-palmitic acid and analysed as in (A) by autoradiography or western
blotting (anti-HA). See Supplementary Figure S1 for positions of the cysteines. (Bottom panel) Autoradiograms were quantified using the
Typhoon Imager. Errors correspond to standard deviations (n¼ 5). (C) Non-transfected HeLa cells were labelled as in (A). The cells were then
washed and incubated in the normal medium and cell lysis was performed at different time points followed by immunoprecipitation
as described in (A). Samples were analysed by autoradiography and the quantification was performed using the Typhoon Imager (n¼ 3).
(D) HeLa cells were pretreated or not with cycloheximide (CHX) for 1 h followed by 3H-palmitic acid labelling in the presence or absence of the
drug. Immunoprecipitation was preformed using anti-calnexin antibodies Samples were analysed by autoradiography and western blotting
(anti-calnexin). Quantification was performed using the Typhoon Imager. Errors correspond to standard deviations (n¼ 3). **Po0.01.
Figure 2 Calnexin is palmitoylated by DHHC6. (A) HeLa cells were transfected for 72 h with different DHHC siRNA or control siRNA (Ctrl).
Cells were incubated with 3H-palmitic acid for 2 h prior to immunoprecipitation using anti-calnexin antibodies. Immunoprecipitates were split
into two, run on SDS–PAGE and analysed by either autoradiography (3H-palmitate) or western blotting (anti-calnexin). (B) Autoradiograms and
western blots from (A) were quantified using the Typhoon Imager. Errors correspond to standard deviations (n¼ 4). **Po0.01. For the identity
of the siRNAs see Supplementary Table S1, for their efficiency see Supplementary Figure S2A. (C) HeLa cells were transfected 72 h with
calnexin–WT–HA or calnexin–CA–HA, or calnexin–AC–HA and DHHC siRNAs, labelled with 3H-palmitic acid. Immunoprecipitates using anti-
HA antibodies were split into two, run on SDS–PAGE gels and analysed by either autoradiography or western blotting (see Supplementary
Figure S2C). Autoradiograms and western blotting were quantified using the Typhoon Imager. Errors correspond to standard deviations (n¼ 4).
(D) HeLa cells were transfected 24 h with human DHHC cDNA, labelled with 3H-palmitic acid. Immunoprecipitates using anti-calnexin
antibodies were analysed and quantified as in (B) (n¼ 4). For analysis of cysteine mutants see Supplementary Figure S2E and F. (E) HeLa cells
were transfected for 72 h with DHHC6 siRNA or control siRNA (Ctrl). (Left panel) Cells were labelled with 3H-palmitic acid as analysed as in
(A). (Right panel) In all, 50mg of cell extracts was analysed using 2D gel ZOOM IPGRunner system (Invitrogen) followed by western blotting
using anti-calnexin and anti-actin antibodies.
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et al, 1990), the Wnt co-receptor LRP6 (Abrami et al, 2008)
and the two anthrax toxin receptors TEM8 and CMG2
(Abrami et al, 2006) (Supplementary Figure S3B), suggesting
a certain specificity towards calnexin.
We next investigated what percentage of the calnexin
population is S-acylated at steady state in HeLa cells. We
previously found that glycosylphosphatidyl inositol-anchored
proteins do not migrate in 2D gels unless their lipid moiety
has been removed (Fivaz et al, 2000). We inferred that
palmitoylation might also affect protein migration in 2D
gels. Cell extracts from control and DHHC6 RNAi-treated
Hela cells were analysed by 2D-PAGE followed by western
blotting against calnexin, and actin as an internal control.
The analysis was performed 72 h after transfection with
DHHC6 siRNA. This did not affect the total level of endogenous
calnexin when compared with control cells, as evidenced by 1D
SDS–PAGE (Figure 2E, left panel; also seen in Figure 2A,
bottom blot). As a striking validation of our strategy, DHHC6
silencing led to a 9.1±0.9 (n¼ 4)-fold increase of the calnexin
signal following 2D-PAGE, while the actin signal was unaf-
fected (Figure 2E, right panels). The increase in calnexin
staining upon DHHC6 silencing demonstrated that at least
90% of cellular calnexin is DHHC6 modified at steady state
in HeLa cells. Since both sites can be modified (Figures 1B and
2C; Supplementary Figure S2C, E and F), depalmitoylation is
slow and must be slow on both sites (Figure 1C), the acylated
calnexin population revealed by the 2D gel analysis is most
likely modified on both sites.
In Figure 2D, we show that overexpression of DHHC6 leads
to a E2.5-fold increase in the incorporation of 3H-palmitate
into calnexin. This might at first appear inconsistent with the
observation that 490% of calnexin is palmitoylated. It is
however important to note that only calnexin molecules with
free cysteines can incorporate 3H-palmitate. Thus, the bulk of
cellular calnexin (490%) is ‘silent’ in the 3H-palmitate
incorporation assay and we are monitoring the incorporation
of 3H-palmitate in the remaining population. The rate at
which this small population of calnexin with free cysteines
becomes modified depends on the abundance of the enzyme.
Thus, upon DHHC6 overexpression, incorporation rates in-
crease due to an increased amount of the enzyme and so does
the signal after our 2 h standard incorporation (Figure 2D).
Palmitoylation is predicted to affect the conformation of
calnexin
Using predictive computational methods, we next analysed
whether palmitoylation is expected to modify the structure of
the transmembrane domain (TMD) and/or cytosolic tail of
calnexin. Using a topology prediction algorithm (Viklund
et al, 2008), we first predicted that the membrane-embedded
residues span from Trp-482 to Cys-502. The TMD was then
modelled as an ideal a-helix based on secondary structure
predictions and consistent with the UniProt annotations
(P27824). We further extended the helical sequence to
include residues Glu-478 through Ser-510, in order to gain
information on the conformation of the cytosolic tail. The
atomistic transmembrane model was inserted into a lipid
membrane bilayer and refined using molecular dynamics
(MD) simulations under physiological-like conditions (e.g.,
pH B7, 1 a.t.m., 298 K). Only small fluctuations of the
secondary structure were observed, which support the pre-
dicted helical conformation and the match with the hydro-
phobic interior of the bilayer. The helix tilted by B301 with
respect to the membrane surface normal. A distortion of
30±51 in the direction of the helix axis was observed at the
level of Pro-494 (Figure 3A), as expected from the helix
breaking capacity of this residue (Chang et al, 1999). This
proline thus breaks the rotational symmetry of the helix with
respect to its main axis. The full conservation of this residue
in calnexin and calmegin (Supplementary Figure S1) suggests
that the TMD kink might be of functional importance.
We next included palmitate moieties at positions Cys-502
(CyP502), Cys-503 (CyP503) or both (CyP502–503).
Palmitoylation did not affect the proline-induced kink and
only marginally affected the helix tilt. The MD simulations
however predicted a palmitoyl-dependent orientation of the
cytosolic tail with respect to the helix axis (Figure 3B).
Interestingly, palmitoylation at position 503 is predicted to
have a more pronounced effect on the conformation of the
cytosolic tail, indicating that both sites are not equivalent and
that one of the two might have a regulatory role, predictions
that will be tested in the future. Combined with the asym-
metric nature of the TMD, these simulations raise the inter-
esting possibility that palmitoylation may affect the
conformation of calnexin, which in turn could modify its
Figure 3 Modelling of the effect of palmitoylation on calnexin conformation. (A) The atomistic models of the helical TMD of calnexin were
equilibrated in a solvated DOPC membrane bilayer using MD simulations. Cys-502, Cys-503 and Pro-494 are shown in licorice representation.
The approximate position of the membrane bilayer is shown by dashed lines. (B) Palmitoylation affects the orientation of the cytosolic tail of
calnexin with respect to the axis of the transmembrane helix.
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affinity for membrane domains and/or its capacity to interact
with proteins in the membrane or in the cytoplasm.
DHHC6 affects calnexin localization
Palmitoylation of membrane proteins has been proposed to
modify their affinity for specific plasma membrane micro/
nano domains (Charollais and Van Der Goot, 2009; Levental
et al, 2010). We therefore investigated whether DHHC6 silen-
cing would alter the distribution of calnexin. Under control
conditions, immunofluorescence staining of calnexin is
observed in all three major ER compartments (Figure 4A,
for additional images see Supplementary Figure S4A),
Figure 4 Effect of DHHC6 silencing on calnexin localization. (A) HeLa cells were transfected with either a control shRNA or shRNA against
DHHC6 for 8 days, fixed in methanol and stained with anti-calnexin and anti-nucleoporin antibodies. Bar: 10mm. (B) HeLa cells grown on cover
slips were transfected for 72 h with either control siRNA or siRNA against DHHC6 and were incubated or not with fluorescent Transferrin,
washed, fixed in methanol and immunostained with any one of the following antibodies: calnexin, BiP, TRAPa. Each image represents the sum
of all the stacks taken in z-axis. To visualize more cells see Supplementary Figure S4A. Bar: 10mm. (C) HeLa cells were transfected with either a
control shRNA or shRNA targeting DHHC6 for 8 days. On day 6, the cells were transfected with either an empty vector or human DHHC6 cDNA
bearing a myc-tag for complementation. The cells were fixed and stained with anti-calnexin, anti-nucleoporin and Hoechst dye. The cells were
analysed manually for the presence or absence or restoration of the nuclear membrane staining of calnexin. In all, 50 cells were analysed per
condition per experiment. Error bars represent the standard deviation (n¼ 3). (D) The cells from (A) were imaged and the Pearson correlation
coefficient for co-localization between calnexin and nucleoporins was determined by monitoring 15 cells/experiment from each condition
(n¼ 3). (E, F) Confocal stacks of cells treated as in (B) were analysed manually and the number of cells showing nuclear or no nuclear
membrane staining for calnexin (C), BiP (D) or TRAPa was determined. Three independent experiments were analysed and 50 cells were
counted for each experiment. Error bars represent standard deviations.
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resembling the staining of the soluble lumenal ER chaperone
BiP and the transmembrane RTC-associated protein TRAPa
(Figure 4B, for additional images see Supplementary
Figure S4A).
When silencing DHHC6, the first observation was a change
in cell morphology: cells were somewhat less elongated (see
Transferrin staining bottom of Figure 4B) and the average cell
footprint wasB30% larger (Supplementary Figure S5A). The
nuclear staining and size was however unaltered (Figure 4A).
When viewing through confocal stacks of a lawn of cells
stained for calnexin (Supplementary Movie S1A versus
Supplementary Movie S1B), it readily appeared that calnexin
staining was lost from the nuclear envelope upon DHHC6
silencing. This was confirmed by quantifying the cells show-
ing a nuclear envelope calnexin staining and those that did
not, by eye for multiple cells over multiple experiments
(Figure 4C). It agreement, the Pearson coefficient of co-
localization of calnexin with nucleoporins strongly decreased
upon DHHC6 silencing (Figure 4D; Supplementary Figure
S4B). Importantly, nuclear membrane localization of calnexin
was restored upon recomplementation with the DHHC6-
expressing plasmid (Figure 4C; Supplementary Figure S4B).
Disappearance from the nuclear membrane was specific to
calnexin, since BiP and TRAPa staining was unaffected by
DHHC6 silencing (Figure 4B, E and F; Supplementary Figure
S4A). While disappearance from the nuclear membrane was
obvious, other changes in calnexin staining, in particular in
the dense and complex perinuclear ER could not be quanti-
fied in satisfactory manner. Our interpretation of the change
in calnexin distribution is that palmitoylation increases the
affinity of calnexin for ER sheets, which encompasses the
entire rough ER and of which the nuclear membrane is the
most exacerbated form.
Palmitoylation regulates the interaction of calnexin with
the RTC
The observation that DHHC6 expression favours the localiza-
tion of calnexin to the rough ER prompted us to investigate
whether calnexin interacts with the RTC under steady-state
conditions. The central translocon component sec61a, as well
as the translocon-associated protein TRAPa and the riboso-
mal subunit L12 were recovered upon immunoprecipitation
of endogenous calnexin (Figure 5A). The interaction of
calnexin with sec61a and L12 was abolished upon RNAi
silencing of TRAPa (Figure 5A), indicating first that the
observed interaction of calnexin with sec61a and L12 is
specific, and not due to bulk co-isolation of membrane
proteins in detergent/lipid micelles. Moreover, the observa-
tion indicates that the TRAP complex mediates the interaction
of calnexin with the RTC. Interestingly, TRAPa silencing
did not affect the localization of calnexin to the nuclear
membrane (Supplementary Figure S5B), showing that
DHHC6-induced perinuclear calnexin localization is not due
to its interaction with RTCs.
We next silenced DHHC6 by shRNA treatment for 8 days,
in order to reduce the cellular pool of S-acylated calnexin.
Upon long-term DHHC6 silencing, co-immunoprecipitation of
TRAPa, sec61a and L12 with calnexin decreased by E80%
(Figure 5B and C; Supplementary Figure S6A). Importantly,
interaction of calnexin with the RTC was restored by transfec-
tion with DHHC6-expressing plasmid (Figure 5B and C;
Supplementary Figure S6A). RTC interaction experiments
were next carried out using the single and double cysteine
mutants of calnexin, the S563A mutant, where the phosphor-
ylation site promoting ribosome association is modified
(Chevet et al, 1999), and the P494L mutant, where the
transmembrane proline (Figure 3A) is substituted with a
hydrophobic residue to remove the kink in the TM helix. It
should be noted that the two latter mutations did not prevent
palmitoylation (personal communication). The calnexin–RTC
interaction was abolished upon mutation of Ser-563 to ala-
nine (Figure 5D; Supplementary Figure S6B), indicating the
importance of this residue even in resting cells (Chevet et al,
1999). The RTC interaction was also severely affected by the
P494L mutation, pointing out a central role of TMD confor-
mation for the association (Figure 5D). Most strikingly,
mutation of either S-acylation site abolished the calnexin–
RTC interaction (Figure 5D). Thus, not only must calnexin be
acylated to interact with the RTC, it has to be modified on
both cysteines.
Figure 5 Palmitoylation regulates the interaction of calnexin with the RTC. (A) HeLa cells were transfected for 72 h with either the control
siRNA or a siRNA against TRAPa. Immunoprecipitates against anti-calnexin were analysed by western blotting for calnexin, TRAPa, Sec61a and
L12. (B) HeLa cells were transfected for 8 days with control shRNA or the shRNA against DHHC6. On day 6, the cells were retransfected either
with an empty plasmid (lanes 1 and 2) or with a plasmid-expressing DHHC6. The cells were lysed on day 8 and immunoprecipitated using
mouse anti-calnexin antibody. Immunoprecipitates were analysed SDS–PAGE followed by western blotting against calnexin, TRAPa, Sec61a
and L12. For the analysis of the total cell lysates see Supplementary Figure S6A. (C) Western blots from (B) were quantified using the Image J
software and the error bars represent the standard deviation (n¼ 3). (D) HeLa cells were transfected for 48 h with either WT, single or double
cysteine calnexin mutants, mutant of the phosphorylation calnexin site S563A or of the TMD proline. Immunoprecipitates against anti-HA
were analysed by western blotting against: TRAPa, Sec61a, Sec62, Sec61b and L12. For the analysis of the total cell lysates see Supplementary
Figure S6B.
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Actin is recruited and stabilizes the calnexin–RTC
supercomplex
Stabilization of certain membrane protein complexes/clusters
has been found to be dependent on the actin cytoskeleton
(Abrami et al, 2010). We probed whether the calnexin–RTC
supercomplex interacts with actin. Actin was pulled down
upon immunoprecipitation of sec61a, TRAPa as well as
calnexin (Figure 6A). The interaction between sec61a or
TRAPa with actin was strongly diminished upon silencing
of calnexin (Figure 6B), indicating first that the interaction
observed in Figure 6A is specific and not due to contamina-
tion by this abundant protein, and second that calnexin plays
a crucial role in the binding of actin to the RTC.
The interaction of calnexin with actin was dependent on its
palmitoylation status as indicated by the decrease in actin
association upon DHHC6 silencing (Figure 6C). Calnexin–
actin interaction was restored upon transfection with the
DHHC6-expressing plasmid (Supplementary Figure S6C).
The importance of palmitoylation for calnexin–actin interac-
tion was confirmed by the weak association of the single and
double cysteine calnexin mutants with actin (Figure 6D). The
fact that DHHC6 silencing had a more pronounced effect than
mutation of the palmitoylation sites might be due to indirect
effects of unidentified ER DHHC6 targets.
Altogether, the above observations raised the possibility
that actin can only be recruited to calnexin–RTC supercomplex
Figure 6 Calnexin palmitoylation promotes interaction with actin. (A) HeLa cells lysates were immunoprecipitated using either anti-Sec61a
anti-TRAPa, anti-calnexin antibodies or no antibody. The immunoprecipitates were analysed by western blotting against actin, calnexin and
TRAPa. Blotting against Sec61a could not be performed as it migrates at the same molecular weight as the antibody heavy chain. (B) HeLa cells
were transfected for 6 days with either shRNA against luciferase or shRNA against calnexin and lysed. After immunoprecipitation against
Sec61a (left panel) or TRAPa (right panel), samples were analysed by western blotting against actin, calnexin and TRAPa. As in (A), Sec61a
could not be probed. (C) HeLa cells were transfected with a control siRNA, siRNA against DHHC6 or DHHC3 and lysed. Immunoprecipitates
against calnexin were analysed by western blotting against calnexin and actin. Quantification was performed using the Typhoon Imager. Error
bars correspond to standard deviations (n¼ 4). (D) HeLa cells were transfected or not for 48 h with cDNA-expressing calnexin–HA–WT, double
or single cysteine mutants, and lysed Immunoprecipitates against HA were analysed by western blotting against HA and actin and quantified
using the Typhoon Imager. Error bars correspond to standard deviations (n¼ 4). Total cell extracts (TCE) were probed for actin. (E) HeLa cells
were treated for 30min at 371C with either DMSO, Latrunculin A or Nocodazole or 15min with puromycin or water, which was used as a
control. The cells were lysed and immunoprecipitated with rabbit anti-calnexin antibody. The immunoprecipitates and the total cell extracts
were migrated on SDS–PAGE followed by western blot to reveal calnexin, actin, TRAPa and L12 (n¼ 3). (F) The treatment with Latrunculin A
and Nocodazole was performed as in (E). Immunoprecipitates against calnexin were analysed by SDS–PAGE and followed by western blotting
against calnexin, TRAPa and Sec61a. Western blots were quantified using the Image J software and the error bars correspond to standard
deviations (n¼ 3). ***Po0.001, *Po0.05.
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when it is fully assembled. To test this possibility, we stripped
off ribosomes from the ER membrane by a 15-min puromycin
treatment. Strikingly, calnexin then no longer interacted with
either the translocon or actin (Figure 6E), indicating that indeed
actin can only bind to the fully assembled supercomplex.
Moreover, the puromycin effect shows that calnexin is recruited
to the translocon only when the ribosome has docked.
In reverse, we investigated whether actin polymerization
was important for the stabilization of the supercomplex.
Inhibiting actin polymerization by a short latrunculin A
treatment was sufficient to decrease the interaction of calnex-
in with L12, TRAPa and sec61a (Figure 6E and F), while
nocodazole, which disrupts microtubules, had no effect
(Figure 6E and F).
Palmitoylation of calnexin promotes the folding of
glycosylated proteins
Finally we investigated whether the calnexin–RTC interaction
is important for the lectin chaperone function. We first
analysed the effect of silencing either calnexin, TRAPa or
DHHC6 on the production—that is, an overall read out for
synthesis, folding and secretion—of total glycoproteins.
Silencing of any of the three proteins led to a significant
decrease in total glycoproteins as monitored by a 20-min 35S
Cys/Met pulse, followed by precipitation with the lectin,
concavalin A (Figure 7A; Supplementary Figure S7A). The
30% drop in detected glycoproteins is consistent with the
known redundancy of the folding systems for glycoproteins
(Braakman and Bulleid, 2011). As a control, we monitored the
Figure 7 Palmitoylation of calnexin promotes the folding of glycosylated proteins. (A) HeLa cells were transfected with either the control
siRNA or siRNAs against DHHC6, TRAPa or DHHC3 for 72 h and shRNA against calnexin for 144 h. The cells were labelled with 35S-
methionine/cysteine for 20min. The cytosolic proteins were isolated by semi-permeabilizing the cells using digitonin. The glycoproteins were
separated from the non-cytosolic fraction by using Con-A agarose beads. The glycoprotein fraction was run on SDS–PAGE and the radiolabelled
products were visualized by Typhoon phosphoimager. The radiolabelled lanes were quantified using the Typhoon Imager and the histograms
were plotted as the ratio of glycoproteins to the cytosolic proteins in each sample. The error bars represent the standard deviation (n¼ 4).
***Po0.001. For the autoradiograms of glycoproteins and cytosolic proteins see Supplementary Figure S7A and B. (B) HeLa cells were co-
transfected with either control siRNA or siRNA against DHHC6 and the pSEAP2 plasmid. The cell medium was replaced with fresh medium in
all the plates so that the SEAP secreted in the final 24 h was quantified. The SEAP secreted was normalized to the total amount of protein
present in each sample and expressed as percentage of SEAP secreted by the control. *Po0.05. (C) HeLa cells were transfected with either the
control shRNA or the shRNA against calnexin. At 96 h post-transfection, cells were transfected with the pSEAP2 vector and either empty vector
or the vector-expressing WT or mutant calnexins. At 120 h post-transfection, the cell medium was replaced with fresh medium in order to
assess the SEAP accumulated in the last 24 h. The measured SEAP values were normalized to the total amount of the protein present in each
sample and the values were plotted as a percentage of the shLuc transfection. ***Po0.001, **Po0.01, *Po0.05. (D) HeLa cells were either co-
transfected with GFP–PrP and the control siRNA or the siRNA targeting DHHC6, TRAPa. Calnexin was silenced by shRNA and GFP–PrP was
transfected 96h after the shRNA transfection. Cell lysates were prepared and equal amounts of the proteins were analysed by western blotting
for GFP, calnexin, TRAPa, Sec61a, GAPDH. PrPp indicates the precursor form of GFP–PrP and PrPm the mature form. (E) HeLa cells were
transfected with GFP–PrPwt for 24 h, treated with either DMSO, Latranculin A or Nocodazole for 30min at 371C and prior to 30min 35S-
methionine–cysteine pulse labelling in the presence of the drugs. The cell lysates were immunoprecipitated with anti-GFP antibody and the
immunoprecipitates were analysed by SDS–PAGE followed by Typhoon phosphoimaging. PrPp indicates the precursor and PrPm the mature
form of the GFP–PrP protein. (F) To monitor the binding of calnexin to the substrates, HeLa cells were treated with either shRNA against
DHHC6 (left panel) or shRNA against calnexin (right panel). The cells depleted of endogenous calnexin were recomplemented with either the
WTor AA mutant. The cells were pulse labelled with 35S-methionine–cysteine for 10min followed by a chase of 3min either in the presence of
CSTor not. The lysate was immunoprecipitated using anti-calnexin antibody and migrated on a SDS–PAGE followed by fixation and drying of
the cells. The radiolabelled products were revealed by Typhoon phosphoimager.
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production of cytosolic, that is, non-N-glycosylated, proteins
and found that silencing of calnexin, TRAPa or DHHC6 had
no effect (Supplementary Figure S7B).
Next, we analysed the production of two specific
glycoproteins: a soluble version of alkaline phosphatase
(SEAP, secreted alkaline phosphatase), which provides a
quantitative readout upon secretion, again used as an overall
read out for synthesis, folding and secretion (Lakkaraju et al,
2008) and the prion protein (PrP), which undergoes a
characteristic change in migration by SDS–PAGE upon folding
and maturation (Fons et al, 2003).
DHHC6 silencing led to a 30% decrease in SEAP secretion
(Figure 7B). In contrast, secretion of the non-glycosylated
protein bovine preprolactin, a well-studied protein transloca-
tion substrate (Lakkaraju et al, 2008), was not affected by
DHHC6 silencing (Supplementary Figure S7C).
To assess the direct involvement of calnexin and the
importance of its palmitoylation status, we silenced calnexin
by shRNA and recomplemented the cells with wild-type (WT)
or mutant calnexins (Supplementary Figure S7D). Calnexin
silencing led to a 70% drop in SEAP secretion, which could
be restored to 480% of control cells, upon recomplementa-
tion with the WT protein (Figure 7C). In contrast, no recovery
was observed upon recomplementation with palmitoylation-
deficient calnexin (AA mutant) (Figure 7C), while single
cysteine and S563A mutants led to a very weak recovery
(Figure 7C). Altogether, these observations show that
DHHC6-mediated palmitoylation of calnexin on both
cysteines is required for optimal folding and secretion of SEAP.
We next monitored maturation of GFP-tagged PrP, which
upon expression in control cells migrates by SDS–PAGE
predominantly in a mature form with some precursor form
(Figure 7D). Neither the mature nor the precursor PrP forms
were detectable by western blotting upon silencing of calnex-
in, TRAPa or DHHC6. Synthesis of PrP precursor was, how-
ever, unaffected by the calnexin, TRAPa or DHHC6 silencing
as determined by a 5-min 35S-pulse labelling of PrP (bottom
of panel Figure 7D and quantification Supplementary Figure
S7E). Thus, in the absence of these proteins, PrP is rapidly
degraded following synthesis. A similar rapid post-transla-
tional degradation of PrP was observed upon Latrunculin
A treatment (Figure 7E), further supporting that proper
folding of PrP requires the fully assemble calnexin–RTC
supercomplex.
Altogether, the above experiments indicate that S-acylation
controls the ability of calnexin to acts as a chaperone. To
address this point specifically, we monitored the binding of
monoglucosylated substrates to calnexin. DHHC6 was
silenced or not using shRNA and newly synthesized proteins
were metabolically labelled. After detergent solubilizing the
cells, calnexin–substrate complexes were isolated by immu-
noprecipitation against calnexin. As a control, cells were
pretreated or not with castanospermine (CST), a specific
inhibitor of a-glucosidases, which prevents the generation
of monoglucosylated proteins (Hammond and Helenius,
1994). Importantly, CST had no effect on either palmitoyla-
tion or depalmitoylation of calnexin (not shown). Also,
catanospermine did not alter the cellular localization of
calnexin nor its interaction with the RTC (not shown).
After a pulse of metabolic labelling, a well-defined pattern
of calnexin substrates was detected in control cells, which
was absent in CST-treated cells (Figure 7F, left panel). DHHC6
silencing led to a drastic decrease in the amount of calnexin-
bound substrates, without affecting their pattern (Figure 7F,
left panel). Even when the metabolic pulse was followed by a
chase period, substrate binding could not be observed in
DHHC6-silenced cells, indicating that not only co- but also
post-translational binding was defective. To confirm that non-
acylated calnexin is unable to capture its substrates, substrate
binding of the AA palmitoylation-deficient mutant calnexin
was monitored in comparison to WT, in cells where endo-
genous calnexin was silenced by shRNA. As shown in
Figure 7F (right panel), palmitoylation-deficient calnexin
failed to bind its substrates. This observation, however,
does not necessarily mean that the capacity of calnexin to
binding monoglucosylated proteins per se is affected. It
reveals that in the cellular context, calnexin must be palmi-
toylated and be part of the RTC complex to grab its substrates.
If substrates are not captured co-translationally, they either
aggregate or are handled by other folding systems in the ER,
but calnexin will not bind them post-translationally.
Discussion
Calnexin is a transmembrane chaperone that aids in the
folding of glycosylated proteins by binding to monoglucose
residues on the branched N-linked oligosaccharide and thus
protects the protein from aggregation. The interaction of
calnexin with nascent chains has been observed 415 years
ago (Chen et al, 1995), but little information was available on
the specific mechanisms that may facilitate this co-transla-
tional interaction. We here report that calnexin is a stable
component of the RTCs, as is the OST, leading to the forma-
tion of a supercomplex. This interaction occurs via the
translocon-associated complex TRAP. Based on X-ray crystal-
lography and single particle analysis, a model of the translo-
con complex has been proposed wherein TRAPa interacts
with sec61a, the latter interacting via the opposing face of the
molecule with sec61b (Menetret et al, 2008). Our findings
thus allow a rough positioning of calnexin in this super-
complex, sandwiching TRAPa between calnexin and the
translocon (Figure 8).
Formation and stabilization of calnexin–RTC supercom-
plex requires several factors. As previously described (Chevet
et al, 2010), Ser-563 is critical possibly due to its phosphor-
ylation. The kinked conformation of the TMD also influences
the interaction, as indicated by the disruptive effect of
mutating the highly conserved TM Pro-494. Importantly,
calnexin must be palmitoylated.
Despite the presence of 12 (Ohno et al, 2006) to 16 (our
unpublished observations in Hela cells) palmitoyltransferase
in the mammalian ER, the S-acylation of calnexin is per-
formed by a single enzyme, DHHC6. The involvement of a
single DHHC enzyme was rather unexpected since these
enzymes are thought to have broad overlapping specificities
at least for soluble substrates (Greaves and Chamberlain,
2011). Also, in contrast to soluble substrates such as Ras,
calnexin does not undergo dynamic cycles of palmitoylation–
depalmitoylation. As a consequence, at steady state, the
S-acylated form, and most likely the dual acylated form,
accumulates and almost the entire pool of cellular calnexin is
modified in resting cells as shown by our 2D gel analysis. The
observed slow rate of palmitate turnover might be due to the
close proximity, and possibly even embedding, of the cysteine
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residues in the membrane, which would render them inac-
cessible to cytosolic thioesterases, of which only one has so
far been identified, the soluble enzyme APT1 (Dekker et al,
2010). Recently, it has been observed for b1-adrenergic re-
ceptor that the susceptibility of cysteines to thioesterases
indeed correlates with distance from the TMD (Zuckerman
et al, 2011).
S-acylation of calnexin promotes its interaction with the
RTC in two ways: First, palmitoylation affects the ability of
calnexin to interact with the TRAP complex, possibly by
influencing the conformation of the TMD and/or the cytosolic
tail as suggested by the MD simulations. Second, palmitoyla-
tion favours the association of calnexin with the nuclear
membrane, and probably with sheet-like ER structures in
general. Calnexin spans the membrane only once and it is
therefore unlikely that it has any membrane curvature sen-
sing capacity. Since protein and lipid compositions are likely
different in ER tubules versus ER sheets (Shibata et al, 2008,
2010), palmitoylation may favour the partitioning of calnexin
to sheet-like structures, in a manner similar to raft partition-
ing of transmembrane proteins at the plasma membrane
(Levental et al, 2010). Calnexin has also been shown to
localize to mitochondrial-associated membranes (MAM),
sites of interaction between the ER and mitochondria
(Myhill et al, 2008; de Brito and Scorrano, 2010). During
the revision of this manuscript, localization of calnexin as
well as of TMX, a transmembrane ER-thioredoxin, to MAMs
was reported to depend on palmitoylation of these two type I
membrane proteins (Lynes et al, 2011). Future studies should
elucidate whether and how S-acylation-dependent localiza-
tion of calnexin to the various ER domains is controlled.
Interestingly, once fully assembled, the calnexin–RTC
supercomplex recruits the actin cytoskeleton, which in turn
is required to stabilize the assembly. While in yeast and
plants where cortical ER is known to move along actin cables
(Du et al, 2004), few reports describe interactions between
actin and the ER in animal cells (Du et al, 2004). Actin is well
known to interact with the nuclear envelope via Nesprins,
large transmembrane proteins involved in nuclear position-
ing and nuclear envelope architecture (Lombardi et al, 2011).
However, interactions with the rest of the ER have not been
reported with the exception of a study showing that actin
controls the diffusion of newly synthesized glycoproteins in
the ER lumen and thereby reduces aggregation during folding
(Nagaya et al, 2008). Our observations raise the possibility
that this is due to the handling of these glycoproteins by the
calnexin–RTC supercomplexes.
Altogether, the present work leads to a model where
DHHC6-mediated S-acylation favours the partitioning of cal-
nexin into the rough ER and, in addition, allows it to interact
with RTC components leading to the formation of a super-
complex, which subsequently recruits the actin cytoskeleton,
the polymerization of which in turn is required to maintain
the assembly (Figure 8). When the nascent polypeptide chain
emerges from the translocon pore, it arrives into a folding
prone microenvironment: the OST and BiP initially keep it in
an unfolded state to allow optimal N-glycosylation and also
await the full synthesis of folding units. By being an integral
part of the ribosome–translocon supercomplex, calnexin is
ideally positioned to capture its client protein following
appropriate glucose trimming, protecting the protein from
aggregation as it undergoes oxidative folding, further benefit-
ing from the calnexin-associated oxidoreductase ERp57.
Materials and methods
Cell culture, plasmids, transfections and real-time PCR
HeLa cells (ATCC) were grown in complete modified Eagle’s
medium (MEM) (Sigma) at 371C supplemented with 10% fetal
bovine serum (FBS), 2mM L-glutamine, penicillin and streptomy-
cin. RPE1 cells were grown in complete Dulbeccos MEM (DMEM)
(Gibco) supplemented with 10% FBS, 2mM L-glutamine, penicillin
and streptomycin. Mammalian expression plasmids harbouring
human C-terminally tagged Calnexin–HA and Calnexin–GFP were
generated by cloning the calnexin cDNA into pCDNA3 vector
bearing the HA tag or GFP. Constructs to express single- or double-
point mutation of calnexin were generated using the Quickchange
(Stratagene) strategy following the manufacturer’s instructions.
Isoform 1 of human tumour endothelial marker 8 (TEM8) cDNA
tagged with a HA epitope was cloned in the pIREShyg2 vector.
Plasmid encoding human myc–LRP6 was provided by Dr G
Davidson. GFP–PrP was provided by Dr Chiara Zurzolo. PPL-3f
was provided by Dr Katharina Strub. Human DHHC cDNA were
cloned in pCE puro-His–myc or flag-expressing plasmids. Plasmids
were transfected into cells for 24 or 48 h (2mg cDNA/9.6 cm2 plate)
using Fugene (Roche Diagnostics Corporation). For control trans-
fections, we used an empty pCDNA3 plasmid. shRNA against
calnexin were generated from the p.Super.Retro.Puro vector
containing the hairpin insert against the following target sequence
present at the 30 UTR of calnexin gene: 50-gagcttgatctgtgatttc-30
(Supplementary Table S1). As a control, we used shRNA against the
target sequence in firefly luciferase gene: 50-CGTACGCGGAATACTT
CGA-30. shRNA against DHHC6 was generated by cloning the
hairpin insert against the target region in the 30 UTR of DHHC6:
50CCTAGTGCCATGATTTAAA30 (Supplementary Table S1).
For the real-time PCR, RNA was extracted from a six-well dish
using the RNeasy kit (Qiagen). In all, 1mg of the total RNA
extracted was used for the reverse transcription using random
hexamers and superscript II (Invitrogen). A 1:40 dilution of the
cDNA was used to perform the real-time PCR using SyBr green
reagent (Roche). mRNA levels were normalized using three
housekeeping genes: TATA-binding protein, b-microglobulin and
b-glucoronidase. Total RNA of different human tissues was obtained
from Amsbio.
Antibodies and reagents
Polyclonal antibodies against calnexin were generated against the
C-terminal peptide: CDAEEDGGTVSQEEEDRKPK in rabbit; rat
Peripher
al ER Perinuclear
 ER
Calx
DHHC6
Calx
Tra
pα OST
Sec61
RibosomemRNA
Actin
ER lumen
Figure 8 Molecular consequences of calnexin palmitoylation.
When its palmitoylation sites are free, calnexin preferentially loca-
lizes to the peripheral tubular ER. Upon S-acylation by DHHC6,
calnexin partitions preferentially into the rough ER and associates
with TRAPa, altogether ensuring that calnexin efficiently interacts
with the RTC. Once the calnexin–RTC has assembled into a super-
complex, actin is recruited and stabilizes the assembly. In this
configuration, calnexin is positioned to efficiently grab nascent
glycoproteins as they emerge from the translocon pore, acquire
their N-linked glycan from which the two external glucoses have
been trimmed.
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antibodies against purified CMG2 were produced in our laboratory;
anti-HA and anti-GFP were from Roche; Anti-flag M2 antibody from
Sigma; anti-HA–agarose-conjugated beads, used for the immuno-
precipitations from Roche (Applied Science, IN); anti-calnexin
monoclonal and anti-myc antibodies from Santa Cruz; anti-actin
antibodies from Millipore; anti-Transferrin receptor antibodies from
Zymed; anti-Nuclear Pore Complex Proteins (Mab414), anti-Sec61a,
anti-BiP antibodies from Abcam. Anti-L12 antibodies were provided
Dr K Strub. Anti-TRAPa antibody was provided by Dr R Hegde.
Protein G-agarose-conjugated beads were from GE Healthcare, HRP
secondary antibodies were from Pierce, and Alexa-conjugated
secondary antibodies from Molecular Probes. Latrunculin A (used
at a concentration of 0.4mg/ml for 30min or 1 h) and Nocodazole
(used at a concentration of 10mM for 30min or 1 h) were from
Sigma. CST was purchased from Calbiochem and used at a
concentration of 1mM. Puromycin was purchased from Calbiochem
and used at a concentration of 200mM for 15min to strip the ER of
ribosomes in HeLa cells.
Immunoprecipitation and RNAi experiments
siRNA against human DHHC were purchased from Qiagen (see
Supplementary Table S1). As control siRNA we used the following
target sequence of the viral glycoprotein VSV-G: 50attgaacaaacgaa
acaagga30. For gene silencing, Hela cells were transfected for 72 h
with 100 pmol/9.2 cm2 dish of siRNA using interferrin (Polyplus)
transfection reagent.
For all immunoprecipitations unless specified, cells were lysed
30min at 41C in IP buffer (0.5%NP-40, 500mM Tris–HCl pH 7.4,
20mM EDTA, 10mM NaF, 2mM benzamidine, and a cocktail of
protease inhibitors; Roche) followed by centrifugation for 3min at
2000 g. The supernatants were precleared with protein G-agarose-
conjugated beads and incubated 16 h at 41C with antibodies and
beads. The beads were washed for three times with the IP buffer
and resuspended in the sample buffer (2! ) after the final wash.
The samples were heated at 951C for 5min and migrated on
SDS–PAGE. Western blotting was performed using the iBlot
(Invitrogen) according to the manufacturer’s instructions. Quanti-
fication of the blots was done using either the Typhoon Imager or
Image J software.
Radiolabelling experiments
To monitor palmitoylation, HeLa cells transfected with either the
WTor mutant calnexin constructs were incubated for 2 h at 371C in
IM (Glasgow minimal essential medium buffered with 10mM
Hepes, pH 7.4) with 200mCi/ml 3H palmitic acid (9,10-3H(N))
(American Radiolabeled Chemicals, Inc.). The cells were washed
and the cell lysate was extracted followed by immunoprecipitation
with tag specific antibodies in the case of exogenously expressed
calnexin and calnexin antibody in case of endogenous protein. After
the washes, beads were incubated for 5min at 901C in non-reducing
sample buffer (2! ) prior to SDS–PAGE. After the SDS–PAGE, the
gel was incubated with a fixative solution (25% isopropanol, 65%
H2O, 10% acetic acid), followed by a 30-min incubation with signal
enhancer Amplify NAMP100 (Amersham). The dried gels were
exposed to a Hyperfilm MP (Amersham). Chemical removal of
S-palmitoylation was performed by treating cell extracts for 1 h at
room temperature with 1M hydroxylamine hydrochloride (Sigma)
pH 7.2. Protein synthesis was blocked by 1h treatment with 10mg/ml
cycloheximide (Sigma) at 371C.
To monitor the ability of calnexin to bind substrates, HeLa cells
were first transfected with the shRNA against calnexin for 7–9 days.
After 96 h, cells were retransfected with either the WT or the AA
mutant calnexin for 48 h.
Cells were pretreated or not for 1 h with 1mM CST, a specific
inhibitor of a-glucosidases and pulse labelled with 100mCi/ml
35S-methionine/cysteine for 10min followed by a 3-min chase in the
presence or absence of drug. Cells were harvested in an isotonic
HEPES buffer (pH 6.8) containing 2%CHAPS and protease inhibitor
cocktail. Post-nuclear supernatants, obtained by centrifuging the
sample at 10 000 g for 10min, were submitted to immunoprecipita-
tion overnight with anti-calnexin antibody followed by incubation
with protein G agarose beads for 2 h at 41C.
To monitor the synthesis and maturation of GFP–PrP protein,
HeLa cells transfected with GFP–PrP under different experimental
conditions were labelled with 100mCi/ml 35S-methionine/cysteine
for 30min. The cells were then lysed in lysis buffer composed of
0.1M Tris–HCl pH 8 and 1% SDS. The cell lysate was heated at 951C
for 10min with occasional stirring until the lysate is no more
viscous. The cleared lysate was diluted in the RIPA buffer (150mM
NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, 50mM Tris–HCl
(pH 8), 1mM EDTA, and 1! protease inhibitor cocktail).
Immunoprecipitation was performed using an anti-GFP antibody.
For all the experiments, samples were analysed by 4–12%
gradient SDS–PAGE, followed by fixing and drying of the gels. The
radiolabelled products were revealed using Typhoon phosphoima-
ger and the quantified using the Typhoon Imager (Image QuantTool,
GE Healthcare).
Glycoprotein analysis
Fractionation of newly synthesized glycoproteins was performed in
35mm dishes. Cells were metabolically labelled with 50mCi/ml of
35S-Methionine/cysteine mix for 20min, followed by a wash with
ice-cold PBS. Cytosolic proteins were extracted by treating the cells
with 150mg/ml of digitonin in KHM buffer (110mM KAc, 20mM
Hepes, pH 7.2, 2mM MgAc2) for 5min. After the recovery of
cytosolic extract, the cells were washed once again in the KHM
buffer and resuspended in 500ml of the IP buffer to extract the non-
cytosolic proteins. The glycoproteins were separated from the non-
cytosolic protein fraction by incubation with Con-A beads (GE
Healthcare) for 1 h. Equal amounts of total protein were loaded on
the Con-A beads from all the samples Con-A beads selectively bind
to the glycoproteins. The beads were washed for three times with
the IP buffer and the glycoproteins were eluted by 300ml of IP buffer
containing 0.25M a-methyl-D-mannopyranoside. Both the cytosolic
and glycoprotein fractions were migrated on 4–20% SDS–PAGE
gradient gels. The gels were fixed, dried and further analysed for
autoradiography.
Calnexin complementation and SEAP assay
For the complementation assay, HeLa cells were transfected with
shRNA against calnexin and the transfected cells were selected by
treating with puromycin (3mg/ml) for 24 h. At 72 h post-transfec-
tion, the cells were split into six-well plates and the day after were
transfected with the control plasmid, the WTor the mutant calnexin
cDNAs and when required with the pSEAP2 reporter plasmid.
SEAP assay was performed using Great EscAPe SEAP Chemilu-
minescence Kit 2.0 (Clonetech). The cell medium was changed 24h
before the SEAP assay was done in order to monitor the SEAP
secreted for 24 h when the RNAi or the over expression is most
effective. Assay was performed in a 96-well plate, using 15ml of the
growth medium according to the manufacturer’s instructions. The
Chemiluminescence signal was collected by Spectra Max multiwell
plate reader and the data were analysed by Soft Max Pro 5 software.
DHHC6 recomplementation
For the complementation assay, HeLa cells were transfected with
shRNA against DHHC6 followed by selection of transfected cells by
treating with puromycin (3mg/ml) for 24 h. The cells were further
transfected on day 6 with the cDNA-expressing human DHHC6
without its 30 UTR for complementation. The functional assays were
performed on day 8 to analyse the restoration of phenotypes
observed by the loss of DHHC6.
Immunofluorescence microscopy
Immunofluorescence in HeLa was done as described previously
with the exception of the fixative used. To label the plasma
membrane of the cells, the cells were treated with 5mg/ml of FITC-
labelled Transferrin (Molecular Probes) for 1 h at 41C. This was
followed by washes at 41C and fixation. Cells were fixed and
permeabilized with methanol at "201C for 4min. Cells were further
labelled with the appropriate primary antibody, followed by
labelling with Alexa-conjugated goat anti-rabbit or anti-mouse IgG
(405, 488, 568nm). The nuclei were stained by Hoechst dye. Images
were acquired using a ! 63 lens on LSM-710 Laser scanning
microscope (Carl Zeiss Microimaging, Inc.). The Zen software was
used for the processing of the images and the 3D stacks. The movie
animations and the summation of the z-stacks were done using the
Image J software. To calculate the Pearson correlation coefficient,
four different regions on the nuclear membrane were analysed for
15 cells. Each condition was subjected to a total of 60 regions and
the Pearson coefficient was calculated using Coloc 2 plugin in FIJI
software.
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MD simulations
We used MD simulations to characterize the calnexin TM domain at
the atomistic level in the membrane environment. As a first step,
the ideal helical TM model was inserted and equilibrated in a
60! 60 A˚2 palmitoyl oleoly phosphatidyl choline membrane patch
(Humphrey et al, 1996) to characterize its structure and dynamics
in a phospholipid bilayer. A Palmitoyl group was then covalently
linked to C502 and C503 sulphur atoms to form the single and
double palmitoylated calnexin models.
All simulations were performed using the NAMD (Phillips et al,
2005) engine, in combination with the CHARMM27 force field
brooks, including CMAP corrections. TIP3P water (Jorgensen et al,
1983) parameterization was used to describe the water molecules.
The spatial overlapping of lipid molecules and protein were
removed and the resulting protein-membrane system was solvated
in variable-size water box, at a salt concentration of 150mM NaCl.
The periodic electrostatic interactions were computed using the
particle-mesh Ewald summation with a grid spacing smaller than
1 A˚. All systems were first minimized by 2000 conjugate gradient
steps, and subsequently gradually heated from 0 to 300K in 800 ps
with a constraint on the protein backbone scaffold. Finally, the
systems were equilibrated for 10 ns at 300K. Free MD of all
equilibrated system were run for not less than 50ns with a 2-fs
integration time step using the RATTLE algorithm applied to all
bonds, and trajectories collected for analysis. Constant temperature
(300K) was imposed by using Langevin dynamics (Brunger and
Brooks, 1984), with damping coefficient of 1.0 ps. Constant
pressure of 1 a.t.m. was maintained with a Langevin piston
dynamics (Feller et al, 1995) 200 fs decay period and 50 fs time
constant.
Statistical analysis
All experiments were performed at least three times, independently.
Two-tailed t-tests were performed to evaluate the significance of
the data.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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